Sanofi-Aventis
Industry and Market Reports

 

List of associated reports

Below is a list of reports where Sanofi-Aventis is mentioned. The list of reports for the company is categorised by Industry, Region and report type. This categorisation along with the number of reports in each category is shown in the region on the left.

Many of the reports mention companies other than Sanofi-Aventis in the same report. This provides an indication of potential competitors or associated to Sanofi-Aventis. The relevance ranking is a measure of how many times both companies are mentioned in the same reported. These associated companies can me clicked to find out more about the company.

View Report: Research and Experts Market Report: Central Retinal Vein Occlusion Global Clinical Trials Review, H2, 2016

Central Retinal Vein Occlusion Global Clinical Trials Review, H2, 2016


2016-12-21
GlobalData's clinical trial report, “Central Retinal Vein Occlusion Global Clinical Trials Review, H2, 2016" provides an overview of Central Retinal Vein Occlusion clinical trials scenario. This report provides top line data relating to...
  • Market Report
  • Healthcare
  • Global
  • $2,500.00
  • Report 05IC-GDHC4011CTIDB has a star rating of 4.3 out of 5
  • Go to More information on Report 05IC-GDHC4011CTIDB
  • View Report: Research and Experts Market Report: Branch Retinal Vein Occlusion Global Clinical Trials Review, H2, 2016

    Branch Retinal Vein Occlusion Global Clinical Trials Review, H2, 2016


    2016-12-21
    GlobalData's clinical trial report, “Branch Retinal Vein Occlusion Global Clinical Trials Review, H2, 2016" provides an overview of Branch Retinal Vein Occlusion clinical trials scenario. This report provides top line data relating to the...
  • Market Report
  • Healthcare
  • Global
  • $2,500.00
  • Report 05IC-GDHC4010CTIDB has a star rating of 4.3 out of 5
  • Go to More information on Report 05IC-GDHC4010CTIDB
  • View Report: Research and Experts Market Report: Dermatitis Global Clinical Trials Review, H2, 2016

    Dermatitis Global Clinical Trials Review, H2, 2016


    2016-12-14
    GlobalData's clinical trial report, “Dermatitis Global Clinical Trials Review, H2, 2016" provides an overview of Dermatitis clinical trials scenario. This report provides top line data relating to the clinical trials on Dermatitis. Report...
  • Market Report
  • Dermatology
  • Global
  • $2,500.00
  • Report 05IC-GDHC3997CTIDB has a star rating of 5.0 out of 5
  • Go to More information on Report 05IC-GDHC3997CTIDB
  • View Report: Research and Experts Market Report: Atopic Dermatitis Global Clinical Trials Review, H2, 2016

    Atopic Dermatitis Global Clinical Trials Review, H2, 2016


    2016-12-14
    GlobalData's clinical trial report, “Atopic Dermatitis Global Clinical Trials Review, H2, 2016" provides an overview of Atopic Dermatitis clinical trials scenario. This report provides top line data relating to the clinical trials on Atopic...
  • Market Report
  • Dermatology
  • Global
  • $2,500.00
  • Report 05IC-GDHC3995CTIDB has a star rating of 4.9 out of 5
  • Go to More information on Report 05IC-GDHC3995CTIDB
  • View Report: Research and Experts Market Report: Genital Herpes Global Clinical Trials Review, H2, 2016

    Genital Herpes Global Clinical Trials Review, H2, 2016


    2016-12-14
    GlobalData's clinical trial report, “Genital Herpes Global Clinical Trials Review, H2, 2016" provides an overview of Genital Herpes clinical trials scenario. This report provides top line data relating to the clinical trials on Genital...
  • Market Report
  • Infectious Disease
  • Global
  • $2,500.00
  • Report 05IC-GDHC3992CTIDB has a star rating of 4.4 out of 5
  • Go to More information on Report 05IC-GDHC3992CTIDB
  • View Report: Research and Experts Market Report: High-Grade Glioma - Pipeline Review, H2 2016

    High-Grade Glioma - Pipeline Review, H2 2016


    2016-12-30
    Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide High-Grade Glioma – Pipeline Review, H2 2016, provides an overview of the High-Grade Glioma (Oncology) pipeline landscape.

    High­ly gra­de glio­mas...

  • Market Report
  • Oncology
  • Global
  • $2,000.00
  • Report 05IB-GMDHC8917IDB has a star rating of 4.8 out of 5
  • Go to More information on Report 05IB-GMDHC8917IDB
  • View Report: Research and Experts Market Report: Usher Syndrome - Pipeline Review, H2 2016

    Usher Syndrome - Pipeline Review, H2 2016


    2016-12-30
    Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Usher Syndrome – Pipeline Review, H2 2016, provides an overview of the Usher Syndrome (Genetic Disorders) pipeline landscape.

    Usher syndrome is an inherited...

  • Market Report
  • Genetic Disorders
  • Global
  • $2,000.00
  • Report 05IB-GMDHC8903IDB has a star rating of 4.3 out of 5
  • Go to More information on Report 05IB-GMDHC8903IDB
  • View Report: Research and Experts Market Report: Glioblastoma Multiforme (GBM) - Pipeline Review, H2 2016

    Glioblastoma Multiforme (GBM) - Pipeline Review, H2 2016


    2016-12-30
    Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Glioblastoma Multiforme (GBM) – Pipeline Review, H2 2016, provides an overview of the Glioblastoma Multiforme (GBM) (Oncology) pipeline landscape.

    Glioblastoma...

  • Market Report
  • Oncology
  • Global
  • $2,500.00
  • Report 05IB-GMDHC8858IDB has a star rating of 5.0 out of 5
  • Go to More information on Report 05IB-GMDHC8858IDB
  • View Report: Research and Experts Market Report: Diarrhea Global Clinical Trials Review, H2, 2016

    Diarrhea Global Clinical Trials Review, H2, 2016


    2016-11-30
    GlobalData's clinical trial report, “Diarrhea Global Clinical Trials Review, H2, 2016" provides an overview of Diarrhea clinical trials scenario. This report provides top line data relating to the clinical trials on Diarrhea. Report includes...
  • Market Report
  • Gastrointestinal
  • Global
  • $2,500.00
  • Report 05IC-GDHC3946CTIDB has a star rating of 4.9 out of 5
  • Go to More information on Report 05IC-GDHC3946CTIDB
  • View Report: Research and Experts Market Report: Liver Cirrhosis Global Clinical Trials Review, H2, 2016

    Liver Cirrhosis Global Clinical Trials Review, H2, 2016


    2016-11-30
    GlobalData's clinical trial report, “Liver Cirrhosis Global Clinical Trials Review, H2, 2016" provides an overview of Liver Cirrhosis clinical trials scenario. This report provides top line data relating to the clinical trials on Liver...
  • Market Report
  • Gastrointestinal
  • Global
  • $2,500.00
  • Report 05IC-GDHC3942CTIDB has a star rating of 4.9 out of 5
  • Go to More information on Report 05IC-GDHC3942CTIDB
  • View Report: Research and Experts Market Report: Infectious Diarrhea Global Clinical Trials Review, H2, 2016

    Infectious Diarrhea Global Clinical Trials Review, H2, 2016


    2016-11-30
    GlobalData's clinical trial report, “Infectious Diarrhea Global Clinical Trials Review, H2, 2016" provides an overview of Infectious Diarrhea clinical trials scenario. This report provides top line data relating to the clinical trials on...
  • Market Report
  • Gastrointestinal
  • Global
  • $2,500.00
  • Report 05IC-GDHC3933CTIDB has a star rating of 4.3 out of 5
  • Go to More information on Report 05IC-GDHC3933CTIDB
  • View Report: Research and Experts Market Report: Eosinophilic Esophagitis Global Clinical Trials Review, H2, 2016

    Eosinophilic Esophagitis Global Clinical Trials Review, H2, 2016


    2016-11-30
    GlobalData's clinical trial report, “Eosinophilic Esophagitis Global Clinical Trials Review, H2, 2016" provides an overview of Eosinophilic Esophagitis clinical trials scenario. This report provides top line data relating to the clinical...
  • Market Report
  • Gastrointestinal
  • Global
  • $2,500.00
  • Report 05IC-GDHC3922CTIDB has a star rating of 4.2 out of 5
  • Go to More information on Report 05IC-GDHC3922CTIDB
  • View Report: Research and Experts Market Report: Aurora Kinase B (Aurora 1 or Aurora And IPL1 Like Midbody Associated Protein 1 or Serine/Threonine Protein Kinase 12 or Serine/Threonine...

    Aurora Kinase B (Aurora 1 or Aurora And IPL1 Like Midbody Associated Protein 1 or Serine/Threonine Protein Kinase 12 or Serine/Threonine Protein Kinase 5 or Serine/Threonine Protein Kinase Aurora B or STK1 or AURKB or EC 2.7.11.1) - Pipeline Review, H2 20


    2016-11-30
    Global Markets Direct’s, ‘Aurora Kinase B (Aurora 1 or Aurora And IPL1 Like Midbody Associated Protein 1 or Serine/Threonine Protein Kinase 12 or Serine/Threonine Protein Kinase 5 or Serine/Threonine Protein Kinase Aurora B or STK1 or AURKB...
  • Market Report
  • Pharmaceuticals
  • Global
  • $3,500.00
  • Report 05IB-GMDHC0687TDB has a star rating of 4.2 out of 5
  • Go to More information on Report 05IB-GMDHC0687TDB
  • View Report: Research and Experts Market Report: Aurora Kinase A (Aurora 2 or Serine/Threonine Protein Kinase 15 or Serine/Threonine Protein Kinase 6 or Serine/Threonine Protein...

    Aurora Kinase A (Aurora 2 or Serine/Threonine Protein Kinase 15 or Serine/Threonine Protein Kinase 6 or Serine/Threonine Protein Kinase Aurora A or Aurora/IPL1 Related Kinase 1 or AURKA or EC 2.7.11.1) - Pipeline Review, H2 2016


    2016-11-30
    Global Markets Direct’s, ‘Aurora Kinase A (Aurora 2 or Serine/Threonine Protein Kinase 15 or Serine/Threonine Protein Kinase 6 or Serine/Threonine Protein Kinase Aurora A or Aurora/IPL1 Related Kinase 1 or AURKA or EC 2.7.11.1) - Pipeline Review,...
  • Market Report
  • Pharmaceuticals
  • Global
  • $3,500.00
  • Report 05IB-GMDHC0686TDB has a star rating of 4.2 out of 5
  • Go to More information on Report 05IB-GMDHC0686TDB
  • View Report: Research and Experts Market Report: Colorectal Cancer - Pipeline Review, H2 2016

    Colorectal Cancer - Pipeline Review, H2 2016


    2016-12-28
    Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Colorectal Cancer – Pipeline Review, H2 2016, provides an overview of the Colorectal Cancer (Oncology) pipeline landscape.

    Colon cancer is cancer that starts...

  • Market Report
  • Oncology
  • Global
  • $2,500.00
  • Report 05IB-GMDHC8870IDB has a star rating of 4.9 out of 5
  • Go to More information on Report 05IB-GMDHC8870IDB
  • View Report: Research and Experts Market Report: Acute Myelocytic Leukemia (AML, Acute Myeloblastic Leukemia) - Pipeline Review, H2 2016

    Acute Myelocytic Leukemia (AML, Acute Myeloblastic Leukemia) - Pipeline Review, H2 2016


    2016-12-28
    Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Acute Myelocytic Leukemia – Pipeline Review, H2 2016, provides an overview of the Acute Myelocytic Leukemia (Oncology) pipeline landscape.

    Acute myelocytic...

  • Market Report
  • Oncology
  • Global
  • $2,500.00
  • Report 05IB-GMDHC8869IDB has a star rating of 4.9 out of 5
  • Go to More information on Report 05IB-GMDHC8869IDB
  • View Report: Research and Experts Market Report: Human Immunodeficiency Virus (HIV) Infections (AIDS) - Pipeline Review, H2 2016

    Human Immunodeficiency Virus (HIV) Infections (AIDS) - Pipeline Review, H2 2016


    2016-12-28
    Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Human Immunodeficiency Virus Infections (AIDS) – Pipeline Review, H2 2016, provides an overview of the Human Immunodeficiency Virus Infections (AIDS) (Infectious...
  • Market Report
  • Infectious Disease
  • Global
  • $2,500.00
  • Report 05IB-GMDHC8867IDB has a star rating of 4.9 out of 5
  • Go to More information on Report 05IB-GMDHC8867IDB
  • View Report: Research and Experts Market Report: Ovarian Cancer - Pipeline Review, H2 2016

    Ovarian Cancer - Pipeline Review, H2 2016


    2016-12-28
    Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Ovarian Cancer – Pipeline Review, H2 2016, provides an overview of the Ovarian Cancer (Oncology) pipeline landscape.

    Ovarian cancer is any cancerous growth...

  • Market Report
  • Oncology
  • Global
  • $2,500.00
  • Report 05IB-GMDHC8866IDB has a star rating of 4.9 out of 5
  • Go to More information on Report 05IB-GMDHC8866IDB
  • View Report: Research and Experts Market Report: Non-Small Cell Lung Cancer - Pipeline Review, H2 2016

    Non-Small Cell Lung Cancer - Pipeline Review, H2 2016


    2016-12-28
    Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Non-Small Cell Lung Cancer – Pipeline Review, H2 2016, provides an overview of the Non-Small Cell Lung Cancer (Oncology) pipeline landscape.

    Non-small cell...

  • Market Report
  • Oncology
  • Global
  • $2,500.00
  • Report 05IB-GMDHC8864IDB has a star rating of 4.9 out of 5
  • Go to More information on Report 05IB-GMDHC8864IDB
  • View Report: Research and Experts Market Report: Pancreatic Cancer - Pipeline Review, H2 2016

    Pancreatic Cancer - Pipeline Review, H2 2016


    2016-12-28
    Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Pancreatic Cancer – Pipeline Review, H2 2016, provides an overview of the Pancreatic Cancer (Oncology) pipeline landscape.

    Pancreatic cancer is a disease in...

  • Market Report
  • Oncology
  • Global
  • $2,500.00
  • Report 05IB-GMDHC8862IDB has a star rating of 4.9 out of 5
  • Go to More information on Report 05IB-GMDHC8862IDB
  • View Report: Research and Experts Market Report: Prostate Cancer - Pipeline Review, H2 2016

    Prostate Cancer - Pipeline Review, H2 2016


    2016-12-21
    Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Prostate Cancer – Pipeline Review, H2 2016, provides an overview of the Prostate Cancer (Oncology) pipeline landscape.

    Prostate cancer is a form of cancer that...

  • Market Report
  • Oncology
  • Global
  • $2,500.00
  • Report 05IB-GMDHC8860IDB has a star rating of 4.9 out of 5
  • Go to More information on Report 05IB-GMDHC8860IDB
  • View Report: Research and Experts Market Report: Multiple Myeloma (Kahler Disease) - Pipeline Review, H2 2016

    Multiple Myeloma (Kahler Disease) - Pipeline Review, H2 2016


    2016-12-21
    Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Multiple Myeloma (Kahler Disease) – Pipeline Review, H2 2016, provides an overview of the Multiple Myeloma (Kahler Disease) (Oncology) pipeline landscape.

    Multiple...

  • Market Report
  • Oncology
  • Global
  • $2,500.00
  • Report 05IB-GMDHC8844IDB has a star rating of 4.9 out of 5
  • Go to More information on Report 05IB-GMDHC8844IDB
  • View Report: Research and Experts Market Report: Hypertension - Pipeline Review, H2 2016

    Hypertension - Pipeline Review, H2 2016


    2016-12-21
    Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Hypertension – Pipeline Review, H2 2016, provides an overview of the Hypertension (Cardiovascular) pipeline landscape.

    Hypertension, also referred to as high...

  • Market Report
  • Cardiovascular
  • Global
  • $2,000.00
  • Report 05IB-GMDHC8829IDB has a star rating of 4.9 out of 5
  • Go to More information on Report 05IB-GMDHC8829IDB
  • View Report: Research and Experts Market Report: Retinitis Pigmentosa (Retinitis) - Pipeline Review, H2 2016

    Retinitis Pigmentosa (Retinitis) - Pipeline Review, H2 2016


    2016-12-21
    Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Retinitis Pigmentosa (Retinitis) – Pipeline Review, H2 2016, provides an overview of the Retinitis Pigmentosa (Retinitis) (Ophthalmology) pipeline landscape.

    Retinit...

  • Market Report
  • Healthcare
  • Global
  • $2,000.00
  • Report 05IB-GMDHC8828IDB has a star rating of 4.8 out of 5
  • Go to More information on Report 05IB-GMDHC8828IDB
  • View Report: Research and Experts Market Report: Kidney Cancer (Renal Cell Cancer) - Pipeline Review, H2 2016

    Kidney Cancer (Renal Cell Cancer) - Pipeline Review, H2 2016


    2016-12-21
    Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Kidney Cancer (Renal Cell Cancer) – Pipeline Review, H2 2016, provides an overview of the Kidney Cancer (Renal Cell Cancer) (Oncology) pipeline landscape.

    Kidney...

  • Market Report
  • Oncology
  • Global
  • $2,500.00
  • Report 05IB-GMDHC8816IDB has a star rating of 5.0 out of 5
  • Go to More information on Report 05IB-GMDHC8816IDB
  • View Report: Research and Experts Market Report: Osteoarthritis Global Clinical Trials Review, H2, 2016

    Osteoarthritis Global Clinical Trials Review, H2, 2016


    2016-11-22
    GlobalData's clinical trial report, “Osteoarthritis Global Clinical Trials Review, H2, 2016" provides an overview of Osteoarthritis clinical trials scenario. This report provides top line data relating to the clinical trials on Osteoarthritis....
  • Market Report
  • Unassigned
  • Global
  • $2,500.00
  • Report 05IC-GDHC3909CTIDB has a star rating of 4.9 out of 5
  • Go to More information on Report 05IC-GDHC3909CTIDB
  • View Report: Research and Experts Market Report: Enterocolitis Global Clinical Trials Review, H2, 2016

    Enterocolitis Global Clinical Trials Review, H2, 2016


    2016-10-31
    GlobalData's clinical trial report, “Enterocolitis Global Clinical Trials Review, H2, 2016" provides an overview of Enterocolitis clinical trials scenario. This report provides top line data relating to the clinical trials on Enterocolitis....
  • Market Report
  • Gastrointestinal
  • Global
  • $2,500.00
  • Report 05IC-GDHC3902CTIDB has a star rating of 4.3 out of 5
  • Go to More information on Report 05IC-GDHC3902CTIDB
  • View Report: Research and Experts Market Report: Hepatobiliary Disease Global Clinical Trials Review, H2, 2016

    Hepatobiliary Disease Global Clinical Trials Review, H2, 2016


    2016-10-31
    GlobalData's clinical trial report, “Hepatobiliary Disease Global Clinical Trials Review, H2, 2016" provides an overview of Hepatobiliary Disease clinical trials scenario. This report provides top line data relating to the clinical trials...
  • Market Report
  • Gastrointestinal
  • Global
  • $2,500.00
  • Report 05IC-GDHC3900CTIDB has a star rating of 4.2 out of 5
  • Go to More information on Report 05IC-GDHC3900CTIDB
  • View Report: Research and Experts Market Report: Cholecystitis Global Clinical Trials Review, H2, 2016

    Cholecystitis Global Clinical Trials Review, H2, 2016


    2016-10-31
    GlobalData's clinical trial report, “Cholecystitis Global Clinical Trials Review, H2, 2016" provides an overview of Cholecystitis clinical trials scenario. This report provides top line data relating to the clinical trials on Cholecystitis....
  • Market Report
  • Gastrointestinal
  • Global
  • $2,500.00
  • Report 05IC-GDHC3898CTIDB has a star rating of 4.3 out of 5
  • Go to More information on Report 05IC-GDHC3898CTIDB
  • View Report: Research and Experts Market Report: Ascites Global Clinical Trials Review, H2, 2016

    Ascites Global Clinical Trials Review, H2, 2016


    2016-10-31
    GlobalData's clinical trial report, “Ascites Global Clinical Trials Review, H2, 2016" provides an overview of Ascites clinical trials scenario. This report provides top line data relating to the clinical trials on Ascites. Report includes...
  • Market Report
  • Gastrointestinal
  • Global
  • $2,500.00
  • Report 05IC-GDHC3896CTIDB has a star rating of 4.4 out of 5
  • Go to More information on Report 05IC-GDHC3896CTIDB
  • View Report: Research and Experts Market Report: Thromboembolism Global Clinical Trials Review, H2, 2016

    Thromboembolism Global Clinical Trials Review, H2, 2016


    2016-10-31
    GlobalData's clinical trial report, “Thromboembolism Global Clinical Trials Review, H2, 2016" provides an overview of Thromboembolism clinical trials scenario. This report provides top line data relating to the clinical trials on Thromboembolism...
  • Market Report
  • Cardiovascular
  • Global
  • $2,500.00
  • Report 05IC-GDHC3887CTIDB has a star rating of 4.9 out of 5
  • Go to More information on Report 05IC-GDHC3887CTIDB
  • View Report: Research and Experts Market Report: Venous Thromboembolism Global Clinical Trials Review, H2, 2016

    Venous Thromboembolism Global Clinical Trials Review, H2, 2016


    2016-10-31
    GlobalData's clinical trial report, “Venous Thromboembolism Global Clinical Trials Review, H2, 2016" provides an overview of Venous Thromboembolism clinical trials scenario. This report provides top line data relating to the clinical trials...
  • Market Report
  • Cardiovascular
  • Global
  • $2,500.00
  • Report 05IC-GDHC3886CTIDB has a star rating of 4.9 out of 5
  • Go to More information on Report 05IC-GDHC3886CTIDB
  • View Report: Research and Experts Market Report: Ventricular Fibrillation Global Clinical Trials Review, H2, 2016

    Ventricular Fibrillation Global Clinical Trials Review, H2, 2016


    2016-10-31
    GlobalData's clinical trial report, “Ventricular Fibrillation Global Clinical Trials Review, H2, 2016" provides an overview of Ventricular Fibrillation clinical trials scenario. This report provides top line data relating to the clinical...
  • Market Report
  • Cardiovascular
  • Global
  • $2,500.00
  • Report 05IC-GDHC3885CTIDB has a star rating of 4.2 out of 5
  • Go to More information on Report 05IC-GDHC3885CTIDB
  • View Report: Research and Experts Market Report: Atrial Flutter Global Clinical Trials Review, H2, 2016

    Atrial Flutter Global Clinical Trials Review, H2, 2016


    2016-10-31
    GlobalData's clinical trial report, “Atrial Flutter Global Clinical Trials Review, H2, 2016" provides an overview of Atrial Flutter clinical trials scenario. This report provides top line data relating to the clinical trials on Atrial Flutter....
  • Market Report
  • Cardiovascular
  • Global
  • $2,500.00
  • Report 05IC-GDHC3883CTIDB has a star rating of 4.2 out of 5
  • Go to More information on Report 05IC-GDHC3883CTIDB
  • View Report: Research and Experts Market Report: Bile Duct Cancer (Cholangiocarcinoma) Global Clinical Trials Review, H2, 2016

    Bile Duct Cancer (Cholangiocarcinoma) Global Clinical Trials Review, H2, 2016


    2016-10-31
    GlobalData's clinical trial report, “Bile Duct Cancer (Cholangiocarcinoma) Global Clinical Trials Review, H2, 2016" provides an overview of Bile Duct Cancer (Cholangiocarcinoma) clinical trials scenario. This report provides top line data...
  • Market Report
  • Oncology
  • Global
  • $2,500.00
  • Report 05IC-GDHC3879CTIDB has a star rating of 4.9 out of 5
  • Go to More information on Report 05IC-GDHC3879CTIDB
  • View Report: Research and Experts Market Report: Medullary Thyroid Cancer Global Clinical Trials Review, H2, 2016

    Medullary Thyroid Cancer Global Clinical Trials Review, H2, 2016


    2016-10-31
    GlobalData's clinical trial report, “Medullary Thyroid Cancer Global Clinical Trials Review, H2, 2016" provides an overview of Medullary Thyroid Cancer clinical trials scenario. This report provides top line data relating to the clinical...
  • Market Report
  • Oncology
  • Global
  • $2,500.00
  • Report 05IC-GDHC3877CTIDB has a star rating of 4.6 out of 5
  • Go to More information on Report 05IC-GDHC3877CTIDB
  • View Report: Research and Experts Market Report: Recurrent Malignant Glioma Global Clinical Trials Review, H2, 2016

    Recurrent Malignant Glioma Global Clinical Trials Review, H2, 2016


    2016-10-31
    GlobalData's clinical trial report, “Recurrent Malignant Glioma Global Clinical Trials Review, H2, 2016" provides an overview of Recurrent Malignant Glioma clinical trials scenario. This report provides top line data relating to the clinical...
  • Market Report
  • Oncology
  • Global
  • $2,500.00
  • Report 05IC-GDHC3874CTIDB has a star rating of 4.7 out of 5
  • Go to More information on Report 05IC-GDHC3874CTIDB
  • View Report: Research and Experts Market Report: Bile Duct Cancer (Cholangiocarcinoma) - Pipeline Review, H2 2016

    Bile Duct Cancer (Cholangiocarcinoma) - Pipeline Review, H2 2016


    2016-12-14
    Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Bile Duct Cancer (Cholangiocarcinoma) – Pipeline Review, H2 2016, provides an overview of the Bile Duct Cancer (Cholangiocarcinoma) (Oncology) pipeline landscape.

    Bi...

  • Market Report
  • Oncology
  • Global
  • $2,000.00
  • Report 05IB-GMDHC8808IDB has a star rating of 5.0 out of 5
  • Go to More information on Report 05IB-GMDHC8808IDB
  • View Report: Research and Experts Market Report: Metastatic Breast Cancer - Pipeline Review, H2 2016

    Metastatic Breast Cancer - Pipeline Review, H2 2016


    2016-12-07
    Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Metastatic Breast Cancer - Pipeline Review, H2 2016, provides an overview of the Metastatic Breast Cancer (Oncology) pipeline landscape.

    Metastatic breast cancer...

  • Market Report
  • Oncology
  • Global
  • $2,500.00
  • Report 05IB-GMDHC8794IDB has a star rating of 4.9 out of 5
  • Go to More information on Report 05IB-GMDHC8794IDB
  • View Report: Research and Experts Market Report: Pseudomonas aeruginosa Infections - Pipeline Review, H2 2016

    Pseudomonas aeruginosa Infections - Pipeline Review, H2 2016


    2016-12-07
    Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Pseudomonas aeruginosa Infections - Pipeline Review, H2 2016, provides an overview of the Pseudomonas aeruginosa Infections (Infectious Disease) pipeline landscape.

    ...

  • Market Report
  • Infectious Disease
  • Global
  • $2,000.00
  • Report 05IB-GMDHC8783IDB has a star rating of 4.9 out of 5
  • Go to More information on Report 05IB-GMDHC8783IDB
  • View Report: Research and Experts Market Report: Non-Hodgkin Lymphoma - Pipeline Review, H2 2016

    Non-Hodgkin Lymphoma - Pipeline Review, H2 2016


    2016-11-30
    Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Non-Hodgkin Lymphoma - Pipeline Review, H2 2016, provides an overview of the Non-Hodgkin Lymphoma (Oncology) pipeline landscape.

    Non-Hodgkin lymphoma (also known...

  • Market Report
  • Oncology
  • Global
  • $2,500.00
  • Report 05IB-GMDHC8759IDB has a star rating of 4.9 out of 5
  • Go to More information on Report 05IB-GMDHC8759IDB
  • View Report: Research and Experts Market Report: Intestinal Cancer Global Clinical Trials Review, H2, 2016

    Intestinal Cancer Global Clinical Trials Review, H2, 2016


    2016-10-30
    GlobalData's clinical trial report, “Intestinal Cancer Global Clinical Trials Review, H2, 2016" provides an overview of Intestinal Cancer clinical trials scenario. This report provides top line data relating to the clinical trials on Intestinal...
  • Market Report
  • Oncology
  • Global
  • $2,500.00
  • Report 05IC-GDHC3866CTIDB has a star rating of 5.0 out of 5
  • Go to More information on Report 05IC-GDHC3866CTIDB
  • View Report: Research and Experts Market Report: Hematological Tumor Global Clinical Trials Review, H2, 2016

    Hematological Tumor Global Clinical Trials Review, H2, 2016


    2016-10-30
    GlobalData's clinical trial report, “Hematological Tumor Global Clinical Trials Review, H2, 2016" provides an overview of Hematological Tumor clinical trials scenario. This report provides top line data relating to the clinical trials on...
  • Market Report
  • Oncology
  • Global
  • $2,500.00
  • Report 05IC-GDHC3862CTIDB has a star rating of 4.9 out of 5
  • Go to More information on Report 05IC-GDHC3862CTIDB
  • View Report: Research and Experts Market Report: Renal Stones/Calculi Global Clinical Trials Review, H2, 2016

    Renal Stones/Calculi Global Clinical Trials Review, H2, 2016


    2016-10-30
    GlobalData's clinical trial report, “Renal Stones/Calculi Global Clinical Trials Review, H2, 2016" provides an overview of Renal Stones/Calculi clinical trials scenario. This report provides top line data relating to the clinical trials...
  • Market Report
  • Genitourinary Disorders
  • Global
  • $2,500.00
  • Report 05IC-GDHC3860CTIDB has a star rating of 4.5 out of 5
  • Go to More information on Report 05IC-GDHC3860CTIDB
  • View Report: Research and Experts Market Report: Renal Failure Global Clinical Trials Review, H2, 2016

    Renal Failure Global Clinical Trials Review, H2, 2016


    2016-10-30
    GlobalData's clinical trial report, “Renal Failure Global Clinical Trials Review, H2, 2016" provides an overview of Renal Failure clinical trials scenario. This report provides top line data relating to the clinical trials on Renal Failure....
  • Market Report
  • Genitourinary Disorders
  • Global
  • $2,500.00
  • Report 05IC-GDHC3859CTIDB has a star rating of 4.9 out of 5
  • Go to More information on Report 05IC-GDHC3859CTIDB
  • View Report: Research and Experts Market Report: End-Stage Kidney Disease (End-Stage Renal Disease or ESRD) Global Clinical Trials Review, H2, 2016

    End-Stage Kidney Disease (End-Stage Renal Disease or ESRD) Global Clinical Trials Review, H2, 2016


    2016-10-30
    GlobalData's clinical trial report, “End-Stage Kidney Disease (End-Stage Renal Disease or ESRD) Global Clinical Trials Review, H2, 2016" provides an overview of End-Stage Kidney Disease (End-Stage Renal Disease or ESRD) clinical trials...
  • Market Report
  • Genitourinary Disorders
  • Global
  • $2,500.00
  • Report 05IC-GDHC3858CTIDB has a star rating of 4.8 out of 5
  • Go to More information on Report 05IC-GDHC3858CTIDB
  • View Report: Research and Experts Market Report: US Market Report for Insulin Pumps 2017 - MedCore

    US Market Report for Insulin Pumps 2017 - MedCore


    2016-11-01
    The total U.S. market for insulin pumps can be segmented by pump type, yielding three segments: traditional insulin pumps, patch insulin pumps and simple insulin pumps. In 2016, the largest segment in the total insulin pump market was the traditional...
  • Market Report
  • Medical Devices
  • United States
  • $5,495.00
  • Report 01EK-iDATA_USDD17_MC_PUM has a star rating of 4.2 out of 5
  • Go to More information on Report 01EK-iDATA_USDD17_MC_PUM
  • View Report: Research and Experts Market Report: US Market Report for Insulin Syringes 2017 - MedCore

    US Market Report for Insulin Syringes 2017 - MedCore


    2016-11-01
    The U.S. insulin syringe market can be segmented by syringe type, yielding two segments: conventional insulin syringes and safety insulin syringes. In 2016, the largest segment in the total insulin syringe market was the conventional insulin syringe segme...
  • Market Report
  • Medical Devices
  • United States
  • $4,495.00
  • Report 01EK-iDATA_USDD17_MC_IS has a star rating of 4.2 out of 5
  • Go to More information on Report 01EK-iDATA_USDD17_MC_IS
  • View Report: Research and Experts Market Report: US Market Report for Insulin 2017 - MedCore

    US Market Report for Insulin 2017 - MedCore


    2016-11-01
    The U.S. insulin market can be segmented by insulin type, yielding four segments: long-acting insulin, rapid-acting insulin, premixed insulin and human insulin. In 2016, the largest segment in the total insulin market was long-acting insulin. Patent expir...
  • Market Report
  • Medical Devices
  • United States
  • $5,495.00
  • Report 01EK-iDATA_USDD17_MC_IM has a star rating of 4.3 out of 5
  • Go to More information on Report 01EK-iDATA_USDD17_MC_IM
  • View Report: Research and Experts Market Report: US Market Report for Continuous Glucose Monitoring 2017 - MedCore

    US Market Report for Continuous Glucose Monitoring 2017 - MedCore


    2016-11-01
    The U.S. continuous glucose monitoring (CGM) market can be segmented by setting, yielding two segments: professional CGM and personal CGM. In 2016, the largest segment in the total CGM market was the personal CGM segment. Growth is expected to continue...
  • Market Report
  • Medical Devices
  • United States
  • $5,495.00
  • Report 01EK-iDATA_USDD17_MC_CGM has a star rating of 4.2 out of 5
  • Go to More information on Report 01EK-iDATA_USDD17_MC_CGM
  • View Report: Research and Experts Market Report: US Market Report for Lancet and Lancing Devices 2017 - MedCore

    US Market Report for Lancet and Lancing Devices 2017 - MedCore


    2016-11-01
    The lancet and lancing device market can be segmented by setting, yielding two segments: personal and professional. In 2016, the largest segment in the total lancet and lancing device market was the personal segment. Personal lancets and lancing devices...
  • Market Report
  • Medical Devices
  • United States
  • $4,495.00
  • Report 01EK-iDATA_USDD17_MC_LL has a star rating of 4.2 out of 5
  • Go to More information on Report 01EK-iDATA_USDD17_MC_LL
  • View Report: Research and Experts Market Report: US Market Report for Blood Glucose Test Strips 2017 - MedCore

    US Market Report for Blood Glucose Test Strips 2017 - MedCore


    2016-11-01
    The U.S. blood glucose test strip market can be segmented by setting, yielding two segments: personal and professional. In 2016, the largest segment in the total blood glucose test strip market was the personal segment. Personal test strips are used by...
  • Market Report
  • Medical Devices
  • United States
  • $5,495.00
  • Report 01EK-iDATA_USDD17_MC_BGT has a star rating of 4.3 out of 5
  • Go to More information on Report 01EK-iDATA_USDD17_MC_BGT
  • View Report: Research and Experts Market Report: US Market Report for Blood Glucose Meters 2017 - MedCore

    US Market Report for Blood Glucose Meters 2017 - MedCore


    2016-11-01
    The U.S. blood glucose meter market can be segmented by setting, yielding two segments: personal and professional. In 2016, the largest segment in the total blood glucose meter market was the personal segment. Personal blood glucose meters are used by...
  • Market Report
  • Medical Devices
  • United States
  • $4,495.00
  • Report 01EK-iDATA_USDD17_MC_BGM has a star rating of 4.2 out of 5
  • Go to More information on Report 01EK-iDATA_USDD17_MC_BGM
  • View Report: Research and Experts Market Report: US Procedure Numbers for Diabetes Monitoring, Treatment and Drug Delivery 2017 - MedPro

    US Procedure Numbers for Diabetes Monitoring, Treatment and Drug Delivery 2017 - MedPro


    2016-11-01
    Diabetes mellitus is a multifaceted disease that yields various approaches in terms of diagnosis, treatment and drug delivery. Products for maintenance and treatment of diabetes can be of high volume and low cost or of relatively low volume and high cost....
  • Market Report
  • Medical Devices
  • United States
  • $1,995.00
  • Report 01EK-iDATA_USDD17_MP has a star rating of 4.2 out of 5
  • Go to More information on Report 01EK-iDATA_USDD17_MP
  • View Report: Research and Experts Market Report: US Market Overview for Diabetes Monitoring, Treatment and Drug Delivery 2017 - MedView

    US Market Overview for Diabetes Monitoring, Treatment and Drug Delivery 2017 - MedView


    2016-11-01
    Diabetes mellitus is a multifaceted disease that yields various approaches in terms of diagnosis, treatment and drug delivery. Products for maintenance and treatment of diabetes can be of high volume and low cost or of relatively low volume and high cost....
  • Market Report
  • Medical Devices
  • United States
  • $3,995.00
  • Report 01EK-iDATA_USDD17_MV has a star rating of 4.2 out of 5
  • Go to More information on Report 01EK-iDATA_USDD17_MV
  • View Report: Research and Experts Market Report: Canadian Market Report for Spinal Bone Graft Substitutes 2016 - MedCore

    Canadian Market Report for Spinal Bone Graft Substitutes 2016 - MedCore


    2016-11-01
    The vast majority of allograft materials utilized in spinal surgeries in Canada are supplied by large national tissue bank organizations and to a smaller extent, by provincial local tissue banks. In recent years, consolidation of tissue banks has become...
  • Market Report
  • Medical Devices
  • Canada
  • $5,495.00
  • Report 01EK-iDATA_CAOB16_CRPT_SBGS has a star rating of 4.2 out of 5
  • Go to More information on Report 01EK-iDATA_CAOB16_CRPT_SBGS
  • View Report: Research and Experts Market Report: Canadian Market Report for Bone Growth Stimulators 2016 - MedCore

    Canadian Market Report for Bone Growth Stimulators 2016 - MedCore


    2016-11-01
    Overall, the bone stimulator market in Canada is in the mature stage growing steady at a mid-single digit rate. The two segments of the market, ultrasonic and electrical, have similar unit growth profiles both positively contributing to the overall market...
  • Market Report
  • Medical Devices
  • Canada
  • $4,495.00
  • Report 01EK-iDATA_CAOB16_CRPT_BGS has a star rating of 4.3 out of 5
  • Go to More information on Report 01EK-iDATA_CAOB16_CRPT_BGS
  • View Report: Research and Experts Market Report: Canadian Market Report for Orthopedic Hyaluronic Acid 2016 - MedCore

    Canadian Market Report for Orthopedic Hyaluronic Acid 2016 - MedCore


    2016-11-01
    Hyaluronic acid viscosupplementation (HA) as a treatment for osteoarthritis has been available in Canada since the late 90’s with the major international brands receiving regulatory approval from Health Canada in 1999 and 2000. Unlike many other...
  • Market Report
  • Medical Devices
  • Canada
  • $4,995.00
  • Report 01EK-iDATA_CAOB16_CRPT_OHA has a star rating of 4.2 out of 5
  • Go to More information on Report 01EK-iDATA_CAOB16_CRPT_OHA
  • View Report: Research and Experts Market Report: Canadian Market Overview for Orthopedic Biomaterials 2016 - MedView

    Canadian Market Overview for Orthopedic Biomaterials 2016 - MedView


    2016-11-01
    Similarly, each market has its own set of limiters. For example, the growth in the bone graft substitute market is challenged by the lack of structure around tissue donation systems, which limits the supply side of the market. The viscosupplementation...
  • Market Report
  • Medical Devices
  • Canada
  • $3,995.00
  • Report 01EK-iDATA_CAOB16_CRPT_MV has a star rating of 4.2 out of 5
  • Go to More information on Report 01EK-iDATA_CAOB16_CRPT_MV
  • View Report: Research and Experts Market Report: Interleukin 13 (IL13) - Pipeline Review, H2 2016

    Interleukin 13 (IL13) - Pipeline Review, H2 2016


    2016-10-31
    Global Markets Direct’s, ‘Interleukin 13 (IL13) - Pipeline Review, H2 2016’, provides in depth analysis on Interleukin 13 (IL13) targeted pipeline therapeutics.

    The report provides comprehensive information on the Interleukin 13 (IL13)...

  • Market Report
  • Pharmaceuticals
  • Global
  • $3,500.00
  • Report 05IB-GMDHC0622TDB has a star rating of 4.2 out of 5
  • Go to More information on Report 05IB-GMDHC0622TDB
  • View Report: Research and Experts Market Report: Pontine Glioma - Pipeline Review, H2 2016

    Pontine Glioma - Pipeline Review, H2 2016


    2016-11-30
    Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Pontine Glioma – Pipeline Review, H2 2016, provides an overview of the Pontine Glioma (Oncology) pipeline landscape.

    Pontine gliomas are highly aggressive and...

  • Market Report
  • Oncology
  • Global
  • $2,000.00
  • Report 05IB-GMDHC8740IDB has a star rating of 4.4 out of 5
  • Go to More information on Report 05IB-GMDHC8740IDB
  • View Report: Research and Experts Market Report: Chronic Lymphocytic Leukemia (CLL) - Pipeline Review, H2 2016

    Chronic Lymphocytic Leukemia (CLL) - Pipeline Review, H2 2016


    2016-11-30
    Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Chronic Lymphocytic Leukemia (CLL) – Pipeline Review, H2 2016, provides an overview of the Chronic Lymphocytic Leukemia (CLL) (Oncology) pipeline landscape.

    Chronic...

  • Market Report
  • Oncology
  • Global
  • $2,000.00
  • Report 05IB-GMDHC8731IDB has a star rating of 4.9 out of 5
  • Go to More information on Report 05IB-GMDHC8731IDB
  • View Report: Research and Experts Market Report: Epithelial Ovarian Cancer - Pipeline Review, H2 2016

    Epithelial Ovarian Cancer - Pipeline Review, H2 2016


    2016-11-30
    Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Epithelial Ovarian Cancer – Pipeline Review, H2 2016, provides an overview of the Epithelial Ovarian Cancer (Oncology) pipeline landscape.

    Ovarian epithelial...

  • Market Report
  • Oncology
  • Global
  • $2,000.00
  • Report 05IB-GMDHC8712IDB has a star rating of 5.0 out of 5
  • Go to More information on Report 05IB-GMDHC8712IDB
  • View Report: Research and Experts Market Report: Becker Muscular Dystrophy Global Clinical Trials Review, H2, 2016

    Becker Muscular Dystrophy Global Clinical Trials Review, H2, 2016


    2016-10-31
    GlobalData's clinical trial report, “Becker Muscular Dystrophy Global Clinical Trials Review, H2, 2016" provides an overview of Becker Muscular Dystrophy clinical trials scenario. This report provides top line data relating to the clinical...
  • Market Report
  • Genetic Disorders
  • Global
  • $2,500.00
  • Report 05IC-GDHC3854CTIDB has a star rating of 4.2 out of 5
  • Go to More information on Report 05IC-GDHC3854CTIDB
  • View Report: Research and Experts Market Report: Reperfusion Injury Global Clinical Trials Review, H2, 2016

    Reperfusion Injury Global Clinical Trials Review, H2, 2016


    2016-10-31
    GlobalData's clinical trial report, “Reperfusion Injury Global Clinical Trials Review, H2, 2016" provides an overview of Reperfusion Injury clinical trials scenario. This report provides top line data relating to the clinical trials on...
  • Market Report
  • Cardiovascular
  • Global
  • $2,500.00
  • Report 05IC-GDHC3852CTIDB has a star rating of 4.6 out of 5
  • Go to More information on Report 05IC-GDHC3852CTIDB
  • View Report: Research and Experts Market Report: Prostaglandin E2 Receptor EP2 Subtype (Prostanoid EP2 Receptor or PTGER2) - Pipeline Review, H2 2016

    Prostaglandin E2 Receptor EP2 Subtype (Prostanoid EP2 Receptor or PTGER2) - Pipeline Review, H2 2016


    2016-10-26
    Global Markets Direct’s, ‘Prostaglandin E2 Receptor EP2 Subtype (Prostanoid EP2 Receptor or PTGER2) - Pipeline Review, H2 2016’, provides in depth analysis on Prostaglandin E2 Receptor EP2 Subtype (Prostanoid EP2 Receptor or PTGER2) targeted...
  • Market Report
  • Pharmaceuticals
  • Global
  • $3,500.00
  • Report 05IB-GMDHC0611TDB has a star rating of 4.2 out of 5
  • Go to More information on Report 05IB-GMDHC0611TDB
  • View Report: Research and Experts Market Report: Cervical Cancer - Pipeline Review, H2 2016

    Cervical Cancer - Pipeline Review, H2 2016


    2016-11-23
    Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Cervical Cancer – Pipeline Review, H2 2016, provides an overview of the Cervical Cancer (Oncology) pipeline landscape.

    Cervical cancer occurs when abnormal...

  • Market Report
  • Oncology
  • Global
  • $2,000.00
  • Report 05IB-GMDHC8700IDB has a star rating of 5.0 out of 5
  • Go to More information on Report 05IB-GMDHC8700IDB
  • View Report: Research and Experts Market Report: Endometrial Cancer - Pipeline Review, H2 2016

    Endometrial Cancer - Pipeline Review, H2 2016


    2016-11-23
    Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Endometrial Cancer – Pipeline Review, H2 2016, provides an overview of the Endometrial Cancer (Oncology) pipeline landscape.

    Endometrial cancer is cancer that...

  • Market Report
  • Oncology
  • Global
  • $2,000.00
  • Report 05IB-GMDHC8689IDB has a star rating of 4.9 out of 5
  • Go to More information on Report 05IB-GMDHC8689IDB
  • View Report: Research and Experts Market Report: Adenocarcinoma Of The Gastroesophageal Junction - Pipeline Review, H2 2016

    Adenocarcinoma Of The Gastroesophageal Junction - Pipeline Review, H2 2016


    2016-11-23
    Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Adenocarcinoma Of The Gastroesophageal Junction – Pipeline Review, H2 2016, provides an overview of the Adenocarcinoma Of The Gastroesophageal Junction (Oncology)...
  • Market Report
  • Oncology
  • Global
  • $2,000.00
  • Report 05IB-GMDHC8688IDB has a star rating of 4.9 out of 5
  • Go to More information on Report 05IB-GMDHC8688IDB
  • View Report: Research and Experts Market Report: Refractory Chronic Lymphocytic Leukemia (CLL) - Pipeline Review, H2 2016

    Refractory Chronic Lymphocytic Leukemia (CLL) - Pipeline Review, H2 2016


    2016-11-23
    Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Refractory Chronic Lymphocytic Leukemia (CLL) – Pipeline Review, H2 2016, provides an overview of the Refractory Chronic Lymphocytic Leukemia (CLL) (Oncology)...
  • Market Report
  • Oncology
  • Global
  • $2,000.00
  • Report 05IB-GMDHC8687IDB has a star rating of 4.9 out of 5
  • Go to More information on Report 05IB-GMDHC8687IDB
  • View Report: Research and Experts Market Report: Influenza A Virus, H1N1 Subtype Infections Global Clinical Trials Review, H2, 2016

    Influenza A Virus, H1N1 Subtype Infections Global Clinical Trials Review, H2, 2016


    2016-09-30
    GlobalData's clinical trial report, “Influenza A Virus, H1N1 Subtype Infections Global Clinical Trials Review, H2, 2016" provides an overview of Influenza A Virus, H1N1 Subtype Infections clinical trials scenario. This report provides top...
  • Market Report
  • Infectious Disease
  • Global
  • $2,500.00
  • Report 05IC-GDHC3832CTIDB has a star rating of 4.6 out of 5
  • Go to More information on Report 05IC-GDHC3832CTIDB
  • View Report: Research and Experts Market Report: Osteoarthritis Global Clinical Trials Review, H2, 2016

    Osteoarthritis Global Clinical Trials Review, H2, 2016


    2016-09-30
    GlobalData's clinical trial report, “Osteoarthritis Global Clinical Trials Review, H2, 2016" provides an overview of Osteoarthritis clinical trials scenario. This report provides top line data relating to the clinical trials on Osteoarthritis....
  • Market Report
  • Unassigned
  • Global
  • $2,500.00
  • Report 05IC-GDHC3830CTIDB has a star rating of 5.0 out of 5
  • Go to More information on Report 05IC-GDHC3830CTIDB
  • View Report: Research and Experts Market Report: Lung Transplant Rejection Global Clinical Trials Review, H2, 2016

    Lung Transplant Rejection Global Clinical Trials Review, H2, 2016


    2016-09-30
    GlobalData's clinical trial report, “Lung Transplant Rejection Global Clinical Trials Review, H2, 2016" provides an overview of Lung Transplant Rejection clinical trials scenario. This report provides top line data relating to the clinical...
  • Market Report
  • Immunology
  • Global
  • $2,500.00
  • Report 05IC-GDHC3825CTIDB has a star rating of 4.3 out of 5
  • Go to More information on Report 05IC-GDHC3825CTIDB
  • View Report: Research and Experts Market Report: Stem Cell Transplantation Global Clinical Trials Review, H2, 2016

    Stem Cell Transplantation Global Clinical Trials Review, H2, 2016


    2016-09-30
    GlobalData's clinical trial report, “Stem Cell Transplantation Global Clinical Trials Review, H2, 2016" provides an overview of Stem Cell Transplantation clinical trials scenario. This report provides top line data relating to the clinical...
  • Market Report
  • Immunology
  • Global
  • $2,500.00
  • Report 05IC-GDHC3824CTIDB has a star rating of 4.7 out of 5
  • Go to More information on Report 05IC-GDHC3824CTIDB
  • View Report: Research and Experts Market Report: Bone Marrow Transplant Rejection Global Clinical Trials Review, H2, 2016

    Bone Marrow Transplant Rejection Global Clinical Trials Review, H2, 2016


    2016-09-30
    GlobalData's clinical trial report, “Bone Marrow Transplant Rejection Global Clinical Trials Review, H2, 2016" provides an overview of Bone Marrow Transplant Rejection clinical trials scenario. This report provides top line data relating...
  • Market Report
  • Immunology
  • Global
  • $2,500.00
  • Report 05IC-GDHC3823CTIDB has a star rating of 4.9 out of 5
  • Go to More information on Report 05IC-GDHC3823CTIDB
  • View Report: Research and Experts Market Report: Kidney Transplant Rejection Global Clinical Trials Review, H2, 2016

    Kidney Transplant Rejection Global Clinical Trials Review, H2, 2016


    2016-09-30
    GlobalData's clinical trial report, “Kidney Transplant Rejection Global Clinical Trials Review, H2, 2016" provides an overview of Kidney Transplant Rejection clinical trials scenario. This report provides top line data relating to the clinical...
  • Market Report
  • Immunology
  • Global
  • $2,500.00
  • Report 05IC-GDHC3820CTIDB has a star rating of 5.0 out of 5
  • Go to More information on Report 05IC-GDHC3820CTIDB
  • View Report: Research and Experts Market Report: Corticosteroid 11 Beta Dehydrogenase Isozyme 1 (11 Beta Hydroxysteroid Dehydrogenase 1 or Short Chain Dehydrogenase/Reductase Family...

    Corticosteroid 11 Beta Dehydrogenase Isozyme 1 (11 Beta Hydroxysteroid Dehydrogenase 1 or Short Chain Dehydrogenase/Reductase Family 26C Member 1 or HSD11B1 or EC 1.1.1.146) - Pipeline Review, H2 2016


    2016-10-19
    Global Markets Direct’s, ‘Corticosteroid 11 Beta Dehydrogenase Isozyme 1 (11 Beta Hydroxysteroid Dehydrogenase 1 or Short Chain Dehydrogenase/Reductase Family 26C Member 1 or HSD11B1 or EC 1.1.1.146) - Pipeline Review, H2 2016’, provides...
  • Market Report
  • Pharmaceuticals
  • Global
  • $3,500.00
  • Report 05IB-GMDHC0593TDB has a star rating of 4.3 out of 5
  • Go to More information on Report 05IB-GMDHC0593TDB
  • View Report: Research and Experts Market Report: Aurora Kinase C (Aurora 3 or Aurora/IPL1 Related Kinase 3 or Aurora/IPL1/Eg2 Protein 2 or Serine/Threonine Protein Kinase 13 or Serine/Threonine...

    Aurora Kinase C (Aurora 3 or Aurora/IPL1 Related Kinase 3 or Aurora/IPL1/Eg2 Protein 2 or Serine/Threonine Protein Kinase 13 or Serine/Threonine Protein Kinase Aurora C or AURKC or EC 2.7.11.1) - Pipeline Review, H2 2016


    2016-10-19
    Global Markets Direct’s, ‘Aurora Kinase C (Aurora 3 or Aurora/IPL1 Related Kinase 3 or Aurora/IPL1/Eg2 Protein 2 or Serine/Threonine Protein Kinase 13 or Serine/Threonine Protein Kinase Aurora C or AURKC or EC 2.7.11.1) - Pipeline Review, H2...
  • Market Report
  • Pharmaceuticals
  • Global
  • $3,500.00
  • Report 05IB-GMDHC0589TDB has a star rating of 4.3 out of 5
  • Go to More information on Report 05IB-GMDHC0589TDB
  • View Report: Research and Experts Market Report: Type 1 Diabetes (Juvenile Diabetes) - Pipeline Review, H2 2016

    Type 1 Diabetes (Juvenile Diabetes) - Pipeline Review, H2 2016


    2016-11-16
    Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Type 1 Diabetes (Juvenile Diabetes) – Pipeline Review, H2 2016, provides an overview of the Type 1 Diabetes (Juvenile Diabetes) (Metabolic Disorders) pipeline...
  • Market Report
  • Metabolic Disorders
  • Global
  • $2,000.00
  • Report 05IB-GMDHC8770IDB has a star rating of 4.9 out of 5
  • Go to More information on Report 05IB-GMDHC8770IDB
  • View Report: Research and Experts Market Report: Tuberculosis - Pipeline Review, H2 2016

    Tuberculosis - Pipeline Review, H2 2016


    2016-11-16
    Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Tuberculosis – Pipeline Review, H2 2016, provides an overview of the Tuberculosis (Infectious Disease) pipeline landscape.

    Tuberculosis, commonly known as TB,...

  • Market Report
  • Infectious Disease
  • Global
  • $2,000.00
  • Report 05IB-GMDHC8686IDB has a star rating of 4.9 out of 5
  • Go to More information on Report 05IB-GMDHC8686IDB
  • View Report: Research and Experts Market Report: Relapsed Chronic Lymphocytic Leukemia (CLL) - Pipeline Review, H2 2016

    Relapsed Chronic Lymphocytic Leukemia (CLL) - Pipeline Review, H2 2016


    2016-11-16
    Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Relapsed Chronic Lymphocytic Leukemia (CLL) – Pipeline Review, H2 2016, provides an overview of the Relapsed Chronic Lymphocytic Leukemia (CLL) (Oncology) pipeline...
  • Market Report
  • Oncology
  • Global
  • $2,000.00
  • Report 05IB-GMDHC8673IDB has a star rating of 4.9 out of 5
  • Go to More information on Report 05IB-GMDHC8673IDB
  • View Report: Research and Experts Market Report: Malaria - Pipeline Review, H2 2016

    Malaria - Pipeline Review, H2 2016


    2016-11-16
    Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Malaria – Pipeline Review, H2 2016, provides an overview of the Malaria (Infectious Disease) pipeline landscape.

    Malaria is a life-threatening blood disease...

  • Market Report
  • Infectious Disease
  • Global
  • $2,000.00
  • Report 05IB-GMDHC8670IDB has a star rating of 4.9 out of 5
  • Go to More information on Report 05IB-GMDHC8670IDB
  • View Report: Research and Experts Market Report: Acute Lymphocytic Leukemia (ALL, Acute Lymphoblastic Leukemia) - Pipeline Review, H2 2016

    Acute Lymphocytic Leukemia (ALL, Acute Lymphoblastic Leukemia) - Pipeline Review, H2 2016


    2016-11-16
    Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Acute Lymphocytic Leukemia – Pipeline Review, H2 2016, provides an overview of the Acute Lymphocytic Leukemia (Oncology) pipeline landscape.

    Acute lymphocytic...

  • Market Report
  • Oncology
  • Global
  • $2,000.00
  • Report 05IB-GMDHC8640IDB has a star rating of 4.9 out of 5
  • Go to More information on Report 05IB-GMDHC8640IDB
  • View Report: Research and Experts Market Report: Systemic Lupus Erythematosus - Pipeline Review, H2 2016

    Systemic Lupus Erythematosus - Pipeline Review, H2 2016


    2016-11-16
    Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Systemic Lupus Erythematosus – Pipeline Review, H2 2016, provides an overview of the Systemic Lupus Erythematosus (Immunology) pipeline landscape.

    Systemic...

  • Market Report
  • Immunology
  • Global
  • $2,000.00
  • Report 05IB-GMDHC8637IDB has a star rating of 4.9 out of 5
  • Go to More information on Report 05IB-GMDHC8637IDB
  • View Report: Research and Experts Market Report: Non-Small Cell Lung Cancer Global Clinical Trials Review, H2, 2016

    Non-Small Cell Lung Cancer Global Clinical Trials Review, H2, 2016


    2016-09-30
    GlobalData's clinical trial report, “Non-Small Cell Lung Cancer Global Clinical Trials Review, H2, 2016" provides an overview of Non-Small Cell Lung Cancer clinical trials scenario. This report provides top line data relating to the clinical...
  • Market Report
  • Oncology
  • Global
  • $2,500.00
  • Report 05IC-GDHC3815CTIDB has a star rating of 4.9 out of 5
  • Go to More information on Report 05IC-GDHC3815CTIDB
  • View Report: Research and Experts Market Report: Hodgkin Lymphoma (B-Cell Hodgkin Lymphoma) Global Clinical Trials Review, H2, 2016

    Hodgkin Lymphoma (B-Cell Hodgkin Lymphoma) Global Clinical Trials Review, H2, 2016


    2016-09-30
    GlobalData's clinical trial report, “Hodgkin Lymphoma (B-Cell Hodgkin Lymphoma) Global Clinical Trials Review, H2, 2016" provides an overview of Hodgkin Lymphoma (B-Cell Hodgkin Lymphoma) clinical trials scenario. This report provides top...
  • Market Report
  • Oncology
  • Global
  • $2,500.00
  • Report 05IC-GDHC3814CTIDB has a star rating of 5.0 out of 5
  • Go to More information on Report 05IC-GDHC3814CTIDB
  • View Report: Research and Experts Market Report: Focal Segmental Glomerulosclerosis (FSGS) Global Clinical Trials Review, H2, 2016

    Focal Segmental Glomerulosclerosis (FSGS) Global Clinical Trials Review, H2, 2016


    2016-09-30
    GlobalData's clinical trial report, “Focal Segmental Glomerulosclerosis (FSGS) Global Clinical Trials Review, H2, 2016" provides an overview of Focal Segmental Glomerulosclerosis (FSGS) clinical trials scenario. This report provides top...
  • Market Report
  • Unassigned
  • Global
  • $2,500.00
  • Report 05IC-GDHC3803CTIDB has a star rating of 4.3 out of 5
  • Go to More information on Report 05IC-GDHC3803CTIDB
  • View Report: Research and Experts Market Report: Peripheral Arterial Disease (PAD)/ Peripheral Vascular Disease (PVD) Global Clinical Trials Review, H2, 2016

    Peripheral Arterial Disease (PAD)/ Peripheral Vascular Disease (PVD) Global Clinical Trials Review, H2, 2016


    2016-09-30
    GlobalData's clinical trial report, “Peripheral Arterial Disease (PAD)/ Peripheral Vascular Disease (PVD) Global Clinical Trials Review, H2, 2016" provides an overview of Peripheral Arterial Disease (PAD)/ Peripheral Vascular Disease (PVD)...
  • Market Report
  • Cardiovascular
  • Global
  • $2,500.00
  • Report 05IC-GDHC3802CTIDB has a star rating of 4.9 out of 5
  • Go to More information on Report 05IC-GDHC3802CTIDB
  • View Report: Research and Experts Market Report: Myopia Global Clinical Trials Review, H2, 2016

    Myopia Global Clinical Trials Review, H2, 2016


    2016-09-30
    GlobalData's clinical trial report, “Myopia Global Clinical Trials Review, H2, 2016" provides an overview of Myopia clinical trials scenario. This report provides top line data relating to the clinical trials on Myopia. Report includes...
  • Market Report
  • Healthcare
  • Global
  • $2,500.00
  • Report 05IC-GDHC3801CTIDB has a star rating of 4.3 out of 5
  • Go to More information on Report 05IC-GDHC3801CTIDB
  • View Report: Research and Experts Market Report: Tumor Lysis Syndrome Global Clinical Trials Review, H2, 2016

    Tumor Lysis Syndrome Global Clinical Trials Review, H2, 2016


    2016-09-30
    GlobalData's clinical trial report, “Tumor Lysis Syndrome Global Clinical Trials Review, H2, 2016" provides an overview of Tumor Lysis Syndrome clinical trials scenario. This report provides top line data relating to the clinical trials...
  • Market Report
  • Metabolic Disorders
  • Global
  • $2,500.00
  • Report 05IC-GDHC3800CTIDB has a star rating of 4.2 out of 5
  • Go to More information on Report 05IC-GDHC3800CTIDB
  • View Report: Research and Experts Market Report: Post Menopausal Osteoporosis Global Clinical Trials Review, H2, 2016

    Post Menopausal Osteoporosis Global Clinical Trials Review, H2, 2016


    2016-09-30
    GlobalData's clinical trial report, “Post Menopausal Osteoporosis Global Clinical Trials Review, H2, 2016" provides an overview of Post Menopausal Osteoporosis clinical trials scenario. This report provides top line data relating to the...
  • Market Report
  • Metabolic Disorders
  • Global
  • $2,500.00
  • Report 05IC-GDHC3794CTIDB has a star rating of 4.8 out of 5
  • Go to More information on Report 05IC-GDHC3794CTIDB
  • View Report: Research and Experts Market Report: Secondary Hyperparathyroidism Global Clinical Trials Review, H2, 2016

    Secondary Hyperparathyroidism Global Clinical Trials Review, H2, 2016


    2016-09-30
    GlobalData's clinical trial report, “Secondary Hyperparathyroidism Global Clinical Trials Review, H2, 2016" provides an overview of Secondary Hyperparathyroidism clinical trials scenario. This report provides top line data relating to the...
  • Market Report
  • Unassigned
  • Global
  • $2,500.00
  • Report 05IC-GDHC3792CTIDB has a star rating of 4.6 out of 5
  • Go to More information on Report 05IC-GDHC3792CTIDB
  • View Report: Research and Experts Market Report: Bordetella pertussis Infections Global Clinical Trials Review, H2, 2016

    Bordetella pertussis Infections Global Clinical Trials Review, H2, 2016


    2016-09-30
    GlobalData's clinical trial report, “Bordetella pertussis Infections Global Clinical Trials Review, H2, 2016" provides an overview of Bordetella pertussis Infections clinical trials scenario. This report provides top line data relating...
  • Market Report
  • Infectious Disease
  • Global
  • $2,500.00
  • Report 05IC-GDHC3790CTIDB has a star rating of 4.8 out of 5
  • Go to More information on Report 05IC-GDHC3790CTIDB
  • View Report: Research and Experts Market Report: Cathepsin S (CTSS or EC 3.4.22.27) - Pipeline Review, H2 2016

    Cathepsin S (CTSS or EC 3.4.22.27) - Pipeline Review, H2 2016


    2016-10-12
    Global Markets Direct’s, ‘Cathepsin S (CTSS or EC 3.4.22.27) - Pipeline Review, H2 2016’, provides in depth analysis on Cathepsin S (CTSS or EC 3.4.22.27) targeted pipeline therapeutics.

    The report provides comprehensive information on...

  • Market Report
  • Pharmaceuticals
  • Global
  • $3,500.00
  • Report 05IB-GMDHC0582TDB has a star rating of 4.2 out of 5
  • Go to More information on Report 05IB-GMDHC0582TDB
  • View Report: Research and Experts Market Report: Head And Neck Cancer Squamous Cell Carcinoma - Pipeline Review, H2 2016

    Head And Neck Cancer Squamous Cell Carcinoma - Pipeline Review, H2 2016


    2016-11-09
    Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Head And Neck Cancer Squamous Cell Carcinoma – Pipeline Review, H2 2016, provides an overview of the Head And Neck Cancer Squamous Cell Carcinoma (Oncology)...
  • Market Report
  • Oncology
  • Global
  • $2,000.00
  • Report 05IB-GMDHC8644IDB has a star rating of 5.0 out of 5
  • Go to More information on Report 05IB-GMDHC8644IDB
  • View Report: Research and Experts Market Report: Bladder Cancer - Pipeline Review, H2 2016

    Bladder Cancer - Pipeline Review, H2 2016


    2016-11-09
    Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Bladder Cancer – Pipeline Review, H2 2016, provides an overview of the Bladder Cancer (Oncology) pipeline landscape.

    Bladder cancer occurs in tissues of the...

  • Market Report
  • Oncology
  • Global
  • $2,000.00
  • Report 05IB-GMDHC8622IDB has a star rating of 5.0 out of 5
  • Go to More information on Report 05IB-GMDHC8622IDB
  • View Report: Research and Experts Market Report: Obesity - Pipeline Review, H2 2016

    Obesity - Pipeline Review, H2 2016


    2016-11-09
    Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Obesity – Pipeline Review, H2 2016, provides an overview of the Obesity (Metabolic Disorders) pipeline landscape.

    Obesity is defined as having an excessive...

  • Market Report
  • Metabolic Disorders
  • Global
  • $2,500.00
  • Report 05IB-GMDHC8621IDB has a star rating of 4.9 out of 5
  • Go to More information on Report 05IB-GMDHC8621IDB
  • View Report: Research and Experts Market Report: Type 2 Diabetes - Pipeline Review, H2 2016

    Type 2 Diabetes - Pipeline Review, H2 2016


    2016-11-09
    Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Type 2 Diabetes – Pipeline Review, H2 2016, provides an overview of the Type 2 Diabetes (Metabolic Disorders) pipeline landscape.

    Type 2 diabetes is a chronic...

  • Market Report
  • Metabolic Disorders
  • Global
  • $2,500.00
  • Report 05IB-GMDHC8585IDB has a star rating of 4.9 out of 5
  • Go to More information on Report 05IB-GMDHC8585IDB
  • View Report: Research and Experts Market Report: PharmaPoint: Acute Coronary Syndrome - Global Drug Forecast and Market Analysis to 2025

    PharmaPoint: Acute Coronary Syndrome - Global Drug Forecast and Market Analysis to 2025


    2016-08-08
    Cardiovascular diseases (CVD), including ischemic heart disease and stroke, are the leading causes of mortality in the world. The term acute coronary syndrome (ACS) applies to a spectrum of acute CVD states that are precipitated by coronary artery occlusi...
  • Market Report
  • Automotive
  • Global
  • $10,995.00
  • Report 05IC-GDHC131PIDR has a star rating of 4.4 out of 5
  • Go to More information on Report 05IC-GDHC131PIDR
  • View Report: Research and Experts Market Report: B-Cell Non-Hodgkin Lymphoma - Pipeline Review, H2 2016

    B-Cell Non-Hodgkin Lymphoma - Pipeline Review, H2 2016


    2016-10-29
    Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide B-Cell Non-Hodgkin Lymphoma – Pipeline Review, H2 2016, provides an overview of the B-Cell Non-Hodgkin Lymphoma (Oncology) pipeline landscape.

    Non-Hodgkin lymphoma...

  • Market Report
  • Oncology
  • Global
  • $2,500.00
  • Report 05IB-GMDHC8609IDB has a star rating of 4.9 out of 5
  • Go to More information on Report 05IB-GMDHC8609IDB
  • View Report: Research and Experts Market Report: Idiopathic Pulmonary Fibrosis - Pipeline Review, H2 2016

    Idiopathic Pulmonary Fibrosis - Pipeline Review, H2 2016


    2016-10-29
    Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Idiopathic Pulmonary Fibrosis – Pipeline Review, H2 2016, provides an overview of the Idiopathic Pulmonary Fibrosis (Respiratory) pipeline landscape.

    Idiopathic...

  • Market Report
  • Respiratory
  • Global
  • $2,000.00
  • Report 05IB-GMDHC8608IDB has a star rating of 4.8 out of 5
  • Go to More information on Report 05IB-GMDHC8608IDB
  • View Report: Research and Experts Market Report: Peanut Allergy - Pipeline Review, H2 2016

    Peanut Allergy - Pipeline Review, H2 2016


    2016-10-26
    Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Peanut Allergy – Pipeline Review, H2 2016, provides an overview of the Peanut Allergy (Immunology) pipeline landscape.

    Peanut allergy is common, especially...

  • Market Report
  • Immunology
  • Global
  • $2,000.00
  • Report 05IB-GMDHC8594IDB has a star rating of 4.6 out of 5
  • Go to More information on Report 05IB-GMDHC8594IDB
  • View Report: Research and Experts Market Report: Head And Neck Cancer - Pipeline Review, H2 2016

    Head And Neck Cancer - Pipeline Review, H2 2016


    2016-10-26
    Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Head And Neck Cancer – Pipeline Review, H2 2016, provides an overview of the Head And Neck Cancer (Oncology) pipeline landscape.

    Head and Neck Cancer is a cancer...

  • Market Report
  • Oncology
  • Global
  • $2,500.00
  • Report 05IB-GMDHC8588IDB has a star rating of 4.9 out of 5
  • Go to More information on Report 05IB-GMDHC8588IDB
  • View Report: Research and Experts Market Report: Gastric Cancer - Pipeline Review, H2 2016

    Gastric Cancer - Pipeline Review, H2 2016


    2016-10-26
    Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Gastric Cancer – Pipeline Review, H2 2016, provides an overview of the Gastric Cancer (Oncology) pipeline landscape.

    Gastric cancer, also called stomach cancer,...

  • Market Report
  • Oncology
  • Global
  • $2,000.00
  • Report 05IB-GMDHC8584IDB has a star rating of 4.9 out of 5
  • Go to More information on Report 05IB-GMDHC8584IDB
  • View Report: Research and Experts Market Report: Narcolepsy - Pipeline Review, H2 2016

    Narcolepsy - Pipeline Review, H2 2016


    2016-10-26
    Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Narcolepsy – Pipeline Review, H2 2016, provides an overview of the Narcolepsy (Central Nervous System) pipeline landscape.

    Narcolepsy is a sleep disorder that...

  • Market Report
  • Central Nervous System
  • Global
  • $2,000.00
  • Report 05IB-GMDHC8580IDB has a star rating of 4.4 out of 5
  • Go to More information on Report 05IB-GMDHC8580IDB
  • View Report: Research and Experts Market Report: Angina (Angina Pectoris) - Pipeline Review, H2 2016

    Angina (Angina Pectoris) - Pipeline Review, H2 2016


    2016-10-26
    Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Angina – Pipeline Review, H2 2016, provides an overview of the Angina (Cardiovascular) pipeline landscape.

    Angina pectoris is a term that describes chest pain...

  • Market Report
  • Cardiovascular
  • Global
  • $2,000.00
  • Report 05IB-GMDHC8578IDB has a star rating of 4.3 out of 5
  • Go to More information on Report 05IB-GMDHC8578IDB
  • View Report: Research and Experts Market Report: Overactive Bladder - Pipeline Review, H2 2016

    Overactive Bladder - Pipeline Review, H2 2016


    2016-10-12
    Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Overactive Bladder – Pipeline Review, H2 2016, provides an overview of the Overactive Bladder (Genito Urinary System And Sex Hormones) pipeline landscape.

    Overactive...

  • Market Report
  • Healthcare
  • Global
  • $2,000.00
  • Report 05IB-GMDHC8530IDB has a star rating of 4.8 out of 5
  • Go to More information on Report 05IB-GMDHC8530IDB
  • View Report: Research and Experts Market Report: Chagas Disease (American Trypanosomiasis) - Pipeline Review, H2 2016

    Chagas Disease (American Trypanosomiasis) - Pipeline Review, H2 2016


    2016-10-12
    Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Chagas Disease – Pipeline Review, H2 2016, provides an overview of the Chagas Disease (Infectious Disease) pipeline landscape.

    Chagas disease or American Trypanosomi...

  • Market Report
  • Infectious Disease
  • Global
  • $2,000.00
  • Report 05IB-GMDHC8523IDB has a star rating of 4.5 out of 5
  • Go to More information on Report 05IB-GMDHC8523IDB
  • View Report: Research and Experts Market Report: Malignant Pleural Effusion Global Clinical Trials Review, H2, 2016

    Malignant Pleural Effusion Global Clinical Trials Review, H2, 2016


    2016-09-30
    GlobalData's clinical trial report, “Malignant Pleural Effusion Global Clinical Trials Review, H2, 2016" provides an overview of Malignant Pleural Effusion clinical trials scenario. This report provides top line data relating to the clinical...
  • Market Report
  • Life Sciences
  • Global
  • $2,500.00
  • Report 05IC-GDHC3771CTIDB has a star rating of 4.4 out of 5
  • Go to More information on Report 05IC-GDHC3771CTIDB
  • View Report: Research and Experts Market Report: Pleural Effusion Global Clinical Trials Review, H2, 2016

    Pleural Effusion Global Clinical Trials Review, H2, 2016


    2016-09-30
    GlobalData's clinical trial report, “Pleural Effusion Global Clinical Trials Review, H2, 2016" provides an overview of Pleural Effusion clinical trials scenario. This report provides top line data relating to the clinical trials on Pleural...
  • Market Report
  • Life Sciences
  • Global
  • $2,500.00
  • Report 05IC-GDHC3770CTIDB has a star rating of 4.5 out of 5
  • Go to More information on Report 05IC-GDHC3770CTIDB
  • View Report: Research and Experts Market Report: Avian Influenza Global Clinical Trials Review, H2, 2016

    Avian Influenza Global Clinical Trials Review, H2, 2016


    2016-09-30
    GlobalData's clinical trial report, “Avian Influenza Global Clinical Trials Review, H2, 2016" provides an overview of Avian Influenza clinical trials scenario. This report provides top line data relating to the clinical trials on Avian...
  • Market Report
  • Life Sciences
  • Global
  • $2,500.00
  • Report 05IC-GDHC3769CTIDB has a star rating of 4.6 out of 5
  • Go to More information on Report 05IC-GDHC3769CTIDB
  • View Report: Research and Experts Market Report: Perennial Allergic Rhinitis Global Clinical Trials Review, H2, 2016

    Perennial Allergic Rhinitis Global Clinical Trials Review, H2, 2016


    2016-09-30
    GlobalData's clinical trial report, “Perennial Allergic Rhinitis Global Clinical Trials Review, H2, 2016" provides an overview of Perennial Allergic Rhinitis clinical trials scenario. This report provides top line data relating to the clinical...
  • Market Report
  • Life Sciences
  • Global
  • $2,500.00
  • Report 05IC-GDHC3764CTIDB has a star rating of 4.7 out of 5
  • Go to More information on Report 05IC-GDHC3764CTIDB
  • View Report: Research and Experts Market Report: Seasonal Allergic Rhinitis Global Clinical Trials Review, H2, 2016

    Seasonal Allergic Rhinitis Global Clinical Trials Review, H2, 2016


    2016-09-30
    GlobalData's clinical trial report, “Seasonal Allergic Rhinitis Global Clinical Trials Review, H2, 2016" provides an overview of Seasonal Allergic Rhinitis clinical trials scenario. This report provides top line data relating to the clinical...
  • Market Report
  • Life Sciences
  • Global
  • $2,500.00
  • Report 05IC-GDHC3763CTIDB has a star rating of 4.8 out of 5
  • Go to More information on Report 05IC-GDHC3763CTIDB
  • View Report: Research and Experts Market Report: Pneumocystis carinii Pneumonia Global Clinical Trials Review, H2, 2016

    Pneumocystis carinii Pneumonia Global Clinical Trials Review, H2, 2016


    2016-09-30
    GlobalData's clinical trial report, “Pneumocystis carinii Pneumonia Global Clinical Trials Review, H2, 2016" provides an overview of Pneumocystis carinii Pneumonia clinical trials scenario. This report provides top line data relating to...
  • Market Report
  • Life Sciences
  • Global
  • $2,500.00
  • Report 05IC-GDHC3762CTIDB has a star rating of 4.2 out of 5
  • Go to More information on Report 05IC-GDHC3762CTIDB
  • View Report: Research and Experts Market Report: Acute Ischemic Stroke Global Clinical Trials Review, H2, 2016

    Acute Ischemic Stroke Global Clinical Trials Review, H2, 2016


    2016-09-28
    GlobalData's clinical trial report, “Acute Ischemic Stroke Global Clinical Trials Review, H2, 2016" provides an overview of Acute Ischemic Stroke clinical trials scenario. This report provides top line data relating to the clinical trials...
  • Market Report
  • Cardiovascular
  • Global
  • $2,500.00
  • Report 05IC-GDHC3755CTIDB has a star rating of 4.8 out of 5
  • Go to More information on Report 05IC-GDHC3755CTIDB
  • View Report: Research and Experts Market Report: Atrial Fibrillation Global Clinical Trials Review, H2, 2016

    Atrial Fibrillation Global Clinical Trials Review, H2, 2016


    2016-09-28
    GlobalData's clinical trial report, “Atrial Fibrillation Global Clinical Trials Review, H2, 2016" provides an overview of Atrial Fibrillation clinical trials scenario. This report provides top line data relating to the clinical trials on...
  • Market Report
  • Cardiovascular
  • Global
  • $2,500.00
  • Report 05IC-GDHC3754CTIDB has a star rating of 4.9 out of 5
  • Go to More information on Report 05IC-GDHC3754CTIDB
  • View Report: Research and Experts Market Report: Ventricular Arrhythmia Global Clinical Trials Review, H2, 2016

    Ventricular Arrhythmia Global Clinical Trials Review, H2, 2016


    2016-09-28
    GlobalData's clinical trial report, “Ventricular Arrhythmia Global Clinical Trials Review, H2, 2016" provides an overview of Ventricular Arrhythmia clinical trials scenario. This report provides top line data relating to the clinical trials...
  • Market Report
  • Cardiovascular
  • Global
  • $2,500.00
  • Report 05IC-GDHC3752CTIDB has a star rating of 4.2 out of 5
  • Go to More information on Report 05IC-GDHC3752CTIDB
  • View Report: Research and Experts Market Report: Acute Coronary Syndrome Global Clinical Trials Review, H2, 2016

    Acute Coronary Syndrome Global Clinical Trials Review, H2, 2016


    2016-09-28
    GlobalData's clinical trial report, “Acute Coronary Syndrome Global Clinical Trials Review, H2, 2016" provides an overview of Acute Coronary Syndrome clinical trials scenario. This report provides top line data relating to the clinical...
  • Market Report
  • Cardiovascular
  • Global
  • $2,500.00
  • Report 05IC-GDHC3750CTIDB has a star rating of 4.9 out of 5
  • Go to More information on Report 05IC-GDHC3750CTIDB
  • View Report: Research and Experts Market Report: Pulmonary Fibrosis Global Clinical Trials Review, H2, 2016

    Pulmonary Fibrosis Global Clinical Trials Review, H2, 2016


    2016-09-28
    GlobalData's clinical trial report, “Pulmonary Fibrosis Global Clinical Trials Review, H2, 2016" provides an overview of Pulmonary Fibrosis clinical trials scenario. This report provides top line data relating to the clinical trials on...
  • Market Report
  • Respiratory
  • Global
  • $2,500.00
  • Report 05IC-GDHC3749CTIDB has a star rating of 4.9 out of 5
  • Go to More information on Report 05IC-GDHC3749CTIDB
  • View Report: Research and Experts Market Report: Tetanus Global Clinical Trials Review, H2, 2016

    Tetanus Global Clinical Trials Review, H2, 2016


    2016-09-28
    GlobalData's clinical trial report, “Tetanus Global Clinical Trials Review, H2, 2016" provides an overview of Tetanus clinical trials scenario. This report provides top line data relating to the clinical trials on Tetanus. Report includes...
  • Market Report
  • Infectious Disease
  • Global
  • $2,500.00
  • Report 05IC-GDHC3744CTIDB has a star rating of 4.8 out of 5
  • Go to More information on Report 05IC-GDHC3744CTIDB
  • View Report: Research and Experts Market Report: Diphtheria Global Clinical Trials Review, H2, 2016

    Diphtheria Global Clinical Trials Review, H2, 2016


    2016-09-28
    GlobalData's clinical trial report, “Diphtheria Global Clinical Trials Review, H2, 2016" provides an overview of Diphtheria clinical trials scenario. This report provides top line data relating to the clinical trials on Diphtheria. Report...
  • Market Report
  • Infectious Disease
  • Global
  • $2,500.00
  • Report 05IC-GDHC3743CTIDB has a star rating of 4.8 out of 5
  • Go to More information on Report 05IC-GDHC3743CTIDB
  • View Report: Research and Experts Market Report: Benign Prostatic Hyperplasia Global Clinical Trials Review, H2, 2016

    Benign Prostatic Hyperplasia Global Clinical Trials Review, H2, 2016


    2016-09-28
    GlobalData's clinical trial report, “Benign Prostatic Hyperplasia Global Clinical Trials Review, H2, 2016" provides an overview of Benign Prostatic Hyperplasia clinical trials scenario. This report provides top line data relating to the...
  • Market Report
  • Unassigned
  • Global
  • $2,500.00
  • Report 05IC-GDHC3740CTIDB has a star rating of 4.9 out of 5
  • Go to More information on Report 05IC-GDHC3740CTIDB
  • View Report: Research and Experts Market Report: Acyl CoA Desaturase (Fatty Acid Desaturase or Delta 9 Desaturase or Stearoyl CoA Desaturase or SCD or EC 1.14.19.1) - Pipeline Review,...

    Acyl CoA Desaturase (Fatty Acid Desaturase or Delta 9 Desaturase or Stearoyl CoA Desaturase or SCD or EC 1.14.19.1) - Pipeline Review, H2 2016


    2016-09-28
    Global Markets Direct’s, ‘Acyl CoA Desaturase (Fatty Acid Desaturase or Delta 9 Desaturase or Stearoyl CoA Desaturase or SCD or EC 1.14.19.1) - Pipeline Review, H2 2016’, provides in depth analysis on Acyl CoA Desaturase (Fatty Acid Desaturase...
  • Market Report
  • Pharmaceuticals
  • Global
  • $3,500.00
  • Report 05IB-GMDHC0550TDB has a star rating of 4.2 out of 5
  • Go to More information on Report 05IB-GMDHC0550TDB
  • View Report: Research and Experts Market Report: Lysophosphatidic Acid Receptor 1 (Lysophosphatidic Acid Receptor Edg 2 or LPAR1) - Pipeline Review, H2 2016

    Lysophosphatidic Acid Receptor 1 (Lysophosphatidic Acid Receptor Edg 2 or LPAR1) - Pipeline Review, H2 2016


    2016-09-28
    Global Markets Direct’s, ‘Lysophosphatidic Acid Receptor 1 (Lysophosphatidic Acid Receptor Edg 2 or LPAR1) - Pipeline Review, H2 2016’, provides in depth analysis on Lysophosphatidic Acid Receptor 1 (Lysophosphatidic Acid Receptor Edg 2...
  • Market Report
  • Pharmaceuticals
  • Global
  • $3,500.00
  • Report 05IB-GMDHC0541TDB has a star rating of 4.2 out of 5
  • Go to More information on Report 05IB-GMDHC0541TDB
  • View Report: Research and Experts Market Report: Hypersensitivity - Pipeline Review, H2 2016

    Hypersensitivity - Pipeline Review, H2 2016


    2016-09-28
    Global Markets Direct’s, ‘Hypersensitivity - Pipeline Review, H2 2016’, provides an overview of the Hypersensitivity pipeline landscape.

    The report provides comprehensive information on the therapeutics under development for Hypersensitivity,...

  • Market Report
  • Immunology
  • Global
  • $2,000.00
  • Report 05IB-GMDHC8499IDB has a star rating of 4.9 out of 5
  • Go to More information on Report 05IB-GMDHC8499IDB
  • View Report: Research and Experts Market Report: Pulmonary Fibrosis - Pipeline Review, H2 2016

    Pulmonary Fibrosis - Pipeline Review, H2 2016


    2016-09-28
    Global Markets Direct’s, ‘Pulmonary Fibrosis - Pipeline Review, H2 2016’, provides an overview of the Pulmonary Fibrosis pipeline landscape.

    The report provides comprehensive information on the therapeutics under development for Pulmonary...

  • Market Report
  • Respiratory
  • Global
  • $2,000.00
  • Report 05IB-GMDHC8475IDB has a star rating of 4.9 out of 5
  • Go to More information on Report 05IB-GMDHC8475IDB
  • View Report: Research and Experts Market Report: Articular Cartilage Defect Global Clinical Trials Review, H2, 2016

    Articular Cartilage Defect Global Clinical Trials Review, H2, 2016


    2016-09-21
    GlobalData's clinical trial report, “Articular Cartilage Defect Global Clinical Trials Review, H2, 2016" provides an overview of Articular Cartilage Defect clinical trials scenario. This report provides top line data relating to the clinical...
  • Market Report
  • Unassigned
  • Global
  • $2,500.00
  • Report 05IC-GDHC3739CTIDB has a star rating of 4.2 out of 5
  • Go to More information on Report 05IC-GDHC3739CTIDB
  • View Report: Research and Experts Market Report: Multiple Myeloma (Kahler Disease) Global Clinical Trials Review, H2, 2016

    Multiple Myeloma (Kahler Disease) Global Clinical Trials Review, H2, 2016


    2016-08-30
    GlobalData's clinical trial report, “Multiple Myeloma (Kahler Disease) Global Clinical Trials Review, H2, 2016" provides an overview of Multiple Myeloma (Kahler Disease) clinical trials scenario. This report provides top line data relating...
  • Market Report
  • Oncology
  • Global
  • $2,500.00
  • Report 05IC-GDHC3734CTIDB has a star rating of 5.0 out of 5
  • Go to More information on Report 05IC-GDHC3734CTIDB
  • View Report: Research and Experts Market Report: Lymphoblastic Lymphoma Global Clinical Trials Review, H2, 2016

    Lymphoblastic Lymphoma Global Clinical Trials Review, H2, 2016


    2016-08-30
    GlobalData's clinical trial report, “Lymphoblastic Lymphoma Global Clinical Trials Review, H2, 2016" provides an overview of Lymphoblastic Lymphoma clinical trials scenario. This report provides top line data relating to the clinical trials...
  • Market Report
  • Oncology
  • Global
  • $2,500.00
  • Report 05IC-GDHC3726CTIDB has a star rating of 4.8 out of 5
  • Go to More information on Report 05IC-GDHC3726CTIDB
  • View Report: Research and Experts Market Report: Malignant Ascites Global Clinical Trials Review, H2, 2016

    Malignant Ascites Global Clinical Trials Review, H2, 2016


    2016-08-30
    GlobalData's clinical trial report, “Malignant Ascites Global Clinical Trials Review, H2, 2016" provides an overview of Malignant Ascites clinical trials scenario. This report provides top line data relating to the clinical trials on Malignant...
  • Market Report
  • Oncology
  • Global
  • $2,500.00
  • Report 05IC-GDHC3720CTIDB has a star rating of 4.2 out of 5
  • Go to More information on Report 05IC-GDHC3720CTIDB
  • View Report: Research and Experts Market Report: Relapsed Chronic Lymphocytic Leukemia (CLL) Global Clinical Trials Review, H2, 2016

    Relapsed Chronic Lymphocytic Leukemia (CLL) Global Clinical Trials Review, H2, 2016


    2016-08-30
    GlobalData's clinical trial report, “Relapsed Chronic Lymphocytic Leukemia (CLL) Global Clinical Trials Review, H2, 2016" provides an overview of Relapsed Chronic Lymphocytic Leukemia (CLL) clinical trials scenario. This report provides...
  • Market Report
  • Oncology
  • Global
  • $2,500.00
  • Report 05IC-GDHC3719CTIDB has a star rating of 4.8 out of 5
  • Go to More information on Report 05IC-GDHC3719CTIDB
  • View Report: Research and Experts Market Report: Fanconi Anemia Global Clinical Trials Review, H2, 2016

    Fanconi Anemia Global Clinical Trials Review, H2, 2016


    2016-08-31
    GlobalData's clinical trial report, “Fanconi Anemia Global Clinical Trials Review, H2, 2016" provides an overview of Fanconi Anemia clinical trials scenario. This report provides top line data relating to the clinical trials on Fanconi...
  • Market Report
  • Unassigned
  • Global
  • $2,500.00
  • Report 05IC-GDHC3711CTIDB has a star rating of 4.2 out of 5
  • Go to More information on Report 05IC-GDHC3711CTIDB
  • View Report: Research and Experts Market Report: Thalassemia Global Clinical Trials Review, H2, 2016

    Thalassemia Global Clinical Trials Review, H2, 2016


    2016-08-31
    GlobalData's clinical trial report, “Thalassemia Global Clinical Trials Review, H2, 2016" provides an overview of Thalassemia clinical trials scenario. This report provides top line data relating to the clinical trials on Thalassemia. Report...
  • Market Report
  • Unassigned
  • Global
  • $2,500.00
  • Report 05IC-GDHC3706CTIDB has a star rating of 4.8 out of 5
  • Go to More information on Report 05IC-GDHC3706CTIDB
  • View Report: Research and Experts Market Report: Aplastic Anemia Global Clinical Trials Review, H2, 2016

    Aplastic Anemia Global Clinical Trials Review, H2, 2016


    2016-08-31
    GlobalData's clinical trial report, “Aplastic Anemia Global Clinical Trials Review, H2, 2016" provides an overview of Aplastic Anemia clinical trials scenario. This report provides top line data relating to the clinical trials on Aplastic...
  • Market Report
  • Unassigned
  • Global
  • $2,500.00
  • Report 05IC-GDHC3703CTIDB has a star rating of 4.8 out of 5
  • Go to More information on Report 05IC-GDHC3703CTIDB
  • View Report: Research and Experts Market Report: Graft Versus Host Disease (GVHD) Global Clinical Trials Review, H2, 2016

    Graft Versus Host Disease (GVHD) Global Clinical Trials Review, H2, 2016


    2016-08-31
    GlobalData's clinical trial report, “Graft Versus Host Disease (GVHD) Global Clinical Trials Review, H2, 2016" provides an overview of Graft Versus Host Disease (GVHD) clinical trials scenario. This report provides top line data relating...
  • Market Report
  • Immunology
  • Global
  • $2,500.00
  • Report 05IC-GDHC3697CTIDB has a star rating of 4.9 out of 5
  • Go to More information on Report 05IC-GDHC3697CTIDB
  • View Report: Research and Experts Market Report: Tonsillitis Global Clinical Trials Review, H2, 2016

    Tonsillitis Global Clinical Trials Review, H2, 2016


    2016-08-31
    GlobalData's clinical trial report, “Tonsillitis Global Clinical Trials Review, H2, 2016" provides an overview of Tonsillitis clinical trials scenario. This report provides top line data relating to the clinical trials on Tonsillitis. Report...
  • Market Report
  • Ear Nose Throat Disorders
  • Global
  • $2,500.00
  • Report 05IC-GDHC3691CTIDB has a star rating of 4.4 out of 5
  • Go to More information on Report 05IC-GDHC3691CTIDB
  • View Report: Research and Experts Market Report: Insomnia - Current and Future Players

    Insomnia - Current and Future Players


    2015-02-27
    GlobalData has released its pharma report, “Insomnia - Current and Future Players”. The report is a vital source of up-to-date information with in-depth analysis on the companies in the rapidly growing Insomnia Market. The report identifies...
  • Market Report
  • Central Nervous System
  • Global
  • $2,995.00
  • Report 05IC-GDHC1062FPR has a star rating of 3.9 out of 5
  • Go to More information on Report 05IC-GDHC1062FPR
  • View Report: Research and Experts Market Report: Type 1 Diabetes - Current and Future Players

    Type 1 Diabetes - Current and Future Players


    2015-03-01
    GlobalData has released its pharma report, “Type 1 Diabetes - Current and Future Players”. The report is a vital source of up-to-date information with in-depth analysis on the companies in the rapidly growing Insomnia Market. The report identifies...
  • Market Report
  • Metabolic Disorders
  • Global
  • $2,995.00
  • Report 05IC-GDHC1061FPR has a star rating of 3.7 out of 5
  • Go to More information on Report 05IC-GDHC1061FPR
  • View Report: Research and Experts Market Report: Gastric Inhibitory Polypeptide Receptor (Glucose Dependent Insulinotropic Polypeptide Receptor or GIPR) - Pipeline Review, H2 2016

    Gastric Inhibitory Polypeptide Receptor (Glucose Dependent Insulinotropic Polypeptide Receptor or GIPR) - Pipeline Review, H2 2016


    2016-09-14
    Global Markets Direct’s, ‘Gastric Inhibitory Polypeptide Receptor (Glucose Dependent Insulinotropic Polypeptide Receptor or GIPR) - Pipeline Review, H2 2016’, provides in depth analysis on Gastric Inhibitory Polypeptide Receptor (Glucose...
  • Market Report
  • Pharmaceuticals
  • Global
  • $3,500.00
  • Report 05IB-GMDHC0518TDB has a star rating of 4.2 out of 5
  • Go to More information on Report 05IB-GMDHC0518TDB
  • View Report: Research and Experts Market Report: Celiac Disease - Pipeline Review, H2 2016

    Celiac Disease - Pipeline Review, H2 2016


    2016-09-14
    Global Markets Direct’s, ‘Celiac Disease - Pipeline Review, H2 2016’, provides an overview of the Celiac Disease pipeline landscape.

    The report provides comprehensive information on the therapeutics under development for Celiac Disease,...

  • Market Report
  • Gastrointestinal
  • Global
  • $2,000.00
  • Report 05IB-GMDHC8529IDB has a star rating of 4.4 out of 5
  • Go to More information on Report 05IB-GMDHC8529IDB
  • View Report: Research and Experts Market Report: Allergic Rhinitis - Pipeline Review, H2 2016

    Allergic Rhinitis - Pipeline Review, H2 2016


    2016-09-14
    Global Markets Direct’s, ‘Allergic Rhinitis - Pipeline Review, H2 2016’, provides an overview of the Allergic Rhinitis pipeline landscape.

    The report provides comprehensive information on the therapeutics under development for Allergic...

  • Market Report
  • Respiratory
  • Global
  • $2,000.00
  • Report 05IB-GMDHC8463IDB has a star rating of 4.8 out of 5
  • Go to More information on Report 05IB-GMDHC8463IDB
  • View Report: Research and Experts Market Report: Arterial Thrombosis - Pipeline Review, H2 2016

    Arterial Thrombosis - Pipeline Review, H2 2016


    2016-09-14
    Global Markets Direct’s, ‘Arterial Thrombosis - Pipeline Review, H2 2016’, provides an overview of the Arterial Thrombosis pipeline landscape.

    The report provides comprehensive information on the therapeutics under development for Arterial...

  • Market Report
  • Cardiovascular
  • Global
  • $2,000.00
  • Report 05IB-GMDHC8444IDB has a star rating of 4.4 out of 5
  • Go to More information on Report 05IB-GMDHC8444IDB
  • View Report: Research and Experts Market Report: Swine Influenza Global Clinical Trials Review, H2, 2016

    Swine Influenza Global Clinical Trials Review, H2, 2016


    2016-08-31
    GlobalData's clinical trial report, “Swine Influenza Global Clinical Trials Review, H2, 2016" provides an overview of Swine Influenza clinical trials scenario. This report provides top line data relating to the clinical trials on Swine...
  • Market Report
  • Infectious Disease
  • Global
  • $2,500.00
  • Report 05IC-GDHC3685CTIDB has a star rating of 4.6 out of 5
  • Go to More information on Report 05IC-GDHC3685CTIDB
  • View Report: Research and Experts Market Report: Pediculosis (Head Lice Infestation) Global Clinical Trials Review, H2, 2016

    Pediculosis (Head Lice Infestation) Global Clinical Trials Review, H2, 2016


    2016-08-31
    GlobalData's clinical trial report, “Pediculosis (Head Lice Infestation) Global Clinical Trials Review, H2, 2016" provides an overview of Pediculosis (Head Lice Infestation) clinical trials scenario. This report provides top line data relating...
  • Market Report
  • Infectious Disease
  • Global
  • $2,500.00
  • Report 05IC-GDHC3684CTIDB has a star rating of 4.3 out of 5
  • Go to More information on Report 05IC-GDHC3684CTIDB
  • View Report: Research and Experts Market Report: Yellow Fever Global Clinical Trials Review, H2, 2016

    Yellow Fever Global Clinical Trials Review, H2, 2016


    2016-08-31
    GlobalData's clinical trial report, “Yellow Fever Global Clinical Trials Review, H2, 2016" provides an overview of Yellow Fever clinical trials scenario. This report provides top line data relating to the clinical trials on Yellow Fever....
  • Market Report
  • Infectious Disease
  • Global
  • $2,500.00
  • Report 05IC-GDHC3680CTIDB has a star rating of 4.2 out of 5
  • Go to More information on Report 05IC-GDHC3680CTIDB
  • View Report: Research and Experts Market Report: Pulmonary Tuberculosis Global Clinical Trials Review, H2, 2016

    Pulmonary Tuberculosis Global Clinical Trials Review, H2, 2016


    2016-08-31
    GlobalData's clinical trial report, “Pulmonary Tuberculosis Global Clinical Trials Review, H2, 2016" provides an overview of Pulmonary Tuberculosis clinical trials scenario. This report provides top line data relating to the clinical trials...
  • Market Report
  • Infectious Disease
  • Global
  • $2,500.00
  • Report 05IC-GDHC3679CTIDB has a star rating of 4.6 out of 5
  • Go to More information on Report 05IC-GDHC3679CTIDB
  • View Report: Research and Experts Market Report: Chronic Bronchitis Global Clinical Trials Review, H2, 2016

    Chronic Bronchitis Global Clinical Trials Review, H2, 2016


    2016-08-31
    GlobalData's clinical trial report, “Chronic Bronchitis Global Clinical Trials Review, H2, 2016" provides an overview of Chronic Bronchitis clinical trials scenario. This report provides top line data relating to the clinical trials on...
  • Market Report
  • Respiratory
  • Global
  • $2,500.00
  • Report 05IC-GDHC3673CTIDB has a star rating of 4.5 out of 5
  • Go to More information on Report 05IC-GDHC3673CTIDB
  • View Report: Research and Experts Market Report: Dyslipidemia - Current and Future Players

    Dyslipidemia - Current and Future Players


    2015-05-05
    GlobalData has released its pharma report, “Dyslipidemia - Current and Future Players”. The report is a vital source of up-to-date information with in-depth analysis on the companies in the rapidly growing Dyslipidemia Market. The report identifies...
  • Market Report
  • Metabolic Disorders
  • Global
  • $2,995.00
  • Report 05IC-GDHC1056FPR has a star rating of 4.2 out of 5
  • Go to More information on Report 05IC-GDHC1056FPR
  • View Report: Research and Experts Market Report: African Trypanosomiasis - Pipeline Review, H2 2016

    African Trypanosomiasis - Pipeline Review, H2 2016


    2016-08-31
    Global Markets Direct’s, ‘African Trypanosomiasis - Pipeline Review, H2 2016’, provides an overview of the African Trypanosomiasis pipeline landscape.

    The report provides comprehensive information on the therapeutics under development...

  • Market Report
  • Infectious Disease
  • Global
  • $2,000.00
  • Report 05IB-GMDHC8417IDB has a star rating of 4.3 out of 5
  • Go to More information on Report 05IB-GMDHC8417IDB
  • View Report: Research and Experts Market Report: Ocular Hypertension - Pipeline Review, H2 2016

    Ocular Hypertension - Pipeline Review, H2 2016


    2016-08-31
    Global Markets Direct’s, ‘Ocular Hypertension - Pipeline Review, H2 2016’, provides an overview of the Ocular Hypertension pipeline landscape.

    The report provides comprehensive information on the therapeutics under development for Ocular...

  • Market Report
  • Healthcare
  • Global
  • $2,000.00
  • Report 05IB-GMDHC8410IDB has a star rating of 4.8 out of 5
  • Go to More information on Report 05IB-GMDHC8410IDB
  • View Report: Research and Experts Market Report: Open-Angle Glaucoma - Pipeline Review, H2 2016

    Open-Angle Glaucoma - Pipeline Review, H2 2016


    2016-08-31
    Global Markets Direct’s, ‘Open-Angle Glaucoma - Pipeline Review, H2 2016’, provides an overview of the Open-Angle Glaucoma pipeline landscape.

    The report provides comprehensive information on the therapeutics under development for Open-Angle...

  • Market Report
  • Healthcare
  • Global
  • $2,000.00
  • Report 05IB-GMDHC8409IDB has a star rating of 4.8 out of 5
  • Go to More information on Report 05IB-GMDHC8409IDB
  • View Report: Research and Experts Market Report: European Market Overview for Diabetes Monitoring, Treatment and Drug Delivery 2016 - MedView

    European Market Overview for Diabetes Monitoring, Treatment and Drug Delivery 2016 - MedView


    2016-09-01
    The European diabetes diagnosis, treatment and drug delivery market increased in 2015 and growth is expected to persist over the forecast period. Market growth will be driven by the growing prevalence of diabetes in Europe and technological advancements...
  • Market Report
  • Medical Devices
  • Europe
  • $4,995.00
  • Report 01EK-iDATA_EUDD16_MV has a star rating of 4.3 out of 5
  • Go to More information on Report 01EK-iDATA_EUDD16_MV
  • View Report: Research and Experts Market Report: European Market Report for Insulin Syringes 2016 - MedCore

    European Market Report for Insulin Syringes 2016 - MedCore


    2016-09-01
    The insulin syringe market is a fast declining segment. Although the product was once a popular method of injecting insulin, patients have transitioned towards new technologies such as insulin pens and pumps, thereby cannibalizing the insulin syringe...
  • Market Report
  • Medical Devices
  • Europe
  • $4,995.00
  • Report 01EK-iDATA_EUDD16_MC_IS has a star rating of 4.2 out of 5
  • Go to More information on Report 01EK-iDATA_EUDD16_MC_IS
  • View Report: Research and Experts Market Report: European Market Report for Insulin Pumps 2016 - MedCore

    European Market Report for Insulin Pumps 2016 - MedCore


    2016-09-01
    The total European market for insulin pumps comprises the traditional insulin pump segment and the insulin patch pump market. In 2015, the largest segment in the total insulin pump market was the traditional pump segment, representing over 80% of the...
  • Market Report
  • Medical Devices
  • Europe
  • $6,495.00
  • Report 01EK-iDATA_EUDD16_MC_PUM has a star rating of 4.2 out of 5
  • Go to More information on Report 01EK-iDATA_EUDD16_MC_PUM
  • View Report: Research and Experts Market Report: European Market Report for Insulin Pens 2016 - MedCore

    European Market Report for Insulin Pens 2016 - MedCore


    2016-09-01
    The total European market for insulin pens comprises the prefilled pen segment, the pen cartridge segment, the pen needle segment and the safety pen needle segment. In 2015, the largest segment in the total insulin pen market was the prefilled pen segment...
  • Market Report
  • Medical Devices
  • Europe
  • $6,495.00
  • Report 01EK-iDATA_EUDD16_MC_PEN has a star rating of 4.2 out of 5
  • Go to More information on Report 01EK-iDATA_EUDD16_MC_PEN
  • View Report: Research and Experts Market Report: European Market Report for Modern Insulin 2016 - MedCore

    European Market Report for Modern Insulin 2016 - MedCore


    2016-09-01
    The European modern insulin market can be segmented by insulin type, yielding three segments: long-acting insulin, rapid-acting insulin and premixed insulin. In 2015, the largest segment in the total modern insulin market was the long-acting insulin segme...
  • Market Report
  • Medical Devices
  • Europe
  • $5,995.00
  • Report 01EK-iDATA_EUDD16_MC_IM has a star rating of 4.2 out of 5
  • Go to More information on Report 01EK-iDATA_EUDD16_MC_IM
  • View Report: Research and Experts Market Report: European Market Report for Flash Glucose Monitoring 2016 - MedCore

    European Market Report for Flash Glucose Monitoring 2016 - MedCore


    2016-09-01
    The European FGM market comprises the FGM reader segment and the FGM sensor segment. The business model for FGM is similar to traditional blood glucose meters and CGM, where the reader is the base equipment and the majority of sales are made from the...
  • Market Report
  • Medical Devices
  • Europe
  • $5,495.00
  • Report 01EK-iDATA_EUDD16_MC_FGM has a star rating of 4.2 out of 5
  • Go to More information on Report 01EK-iDATA_EUDD16_MC_FGM
  • View Report: Research and Experts Market Report: European Market Report for Continuous Glucose Monitoring 2016 - MedCore

    European Market Report for Continuous Glucose Monitoring 2016 - MedCore


    2016-09-01
    The European CGM market comprises the CGM system segment and the CGM sensor segment. The business model for CGM is similar to traditional blood glucose meters, where the CGM system is the base equipment and the majority of sales are made from the disposab...
  • Market Report
  • Medical Devices
  • Europe
  • $5,495.00
  • Report 01EK-iDATA_EUDD16_MC_CGM has a star rating of 4.2 out of 5
  • Go to More information on Report 01EK-iDATA_EUDD16_MC_CGM
  • View Report: Research and Experts Market Report: European Market Report for Lancet and Lancing Devices 2016 - MedCore

    European Market Report for Lancet and Lancing Devices 2016 - MedCore


    2016-09-01
    The value of the lancet and lancing device increased in 2015 and modest growth is expected to continue over the forecast period, driven by increasing unit sales and limited by ASP erosion. Unit sales growth will be driven by the increasing patient populat...
  • Market Report
  • Medical Devices
  • Europe
  • $4,995.00
  • Report 01EK-iDATA_EUDD16_MC_LL has a star rating of 4.3 out of 5
  • Go to More information on Report 01EK-iDATA_EUDD16_MC_LL
  • View Report: Research and Experts Market Report: European Market Report for Blood Glucose Test Strips 2016 - MedCore

    European Market Report for Blood Glucose Test Strips 2016 - MedCore


    2016-09-01
    The value of the blood glucose test strip market increased in 2015 and modest growth is expected to continue over the forecast period, driven by increasing unit sales and limited by ASP erosion. Unit sales growth will be driven by the increasing patient...
  • Market Report
  • Medical Devices
  • Europe
  • $4,995.00
  • Report 01EK-iDATA_EUDD16_MC_BGT has a star rating of 4.3 out of 5
  • Go to More information on Report 01EK-iDATA_EUDD16_MC_BGT
  • View Report: Research and Experts Market Report: European Market Report for Blood Glucose Meters 2016 - MedCore

    European Market Report for Blood Glucose Meters 2016 - MedCore


    2016-09-01
    The value of the blood glucose meter market increased in 2015 and modest growth is expected to continue over the forecast period, driven by increasing unit sales and limited by ASP erosion. Unit sales growth will be driven by the increasing patient popula...
  • Market Report
  • Medical Devices
  • Europe
  • $4,995.00
  • Report 01EK-iDATA_EUDD16_MC_BGM has a star rating of 4.2 out of 5
  • Go to More information on Report 01EK-iDATA_EUDD16_MC_BGM
  • View Report: Research and Experts Market Report: European Market Report for Traditional Blood Glucose Monitoring 2016 - MedCore

    European Market Report for Traditional Blood Glucose Monitoring 2016 - MedCore


    2016-09-01
    The European traditional blood glucose monitoring market is comprised of the blood glucose meter segment, the blood glucose test strip segment, and the lancet and lancing device segment. In 2015, the largest segment in the traditional blood glucose monito...
  • Market Report
  • Medical Devices
  • Europe
  • $4,995.00
  • Report 01EK-iDATA_EUDD16_MC_TBG has a star rating of 4.3 out of 5
  • Go to More information on Report 01EK-iDATA_EUDD16_MC_TBG
  • View Report: Research and Experts Market Report: Hepatitis B Global Clinical Trials Review, H2, 2016

    Hepatitis B Global Clinical Trials Review, H2, 2016


    2016-08-24
    GlobalData's clinical trial report, “Hepatitis B Global Clinical Trials Review, H2, 2016" provides an overview of Hepatitis B clinical trials scenario. This report provides top line data relating to the clinical trials on Hepatitis B. Report...
  • Market Report
  • Infectious Disease
  • Global
  • $2,500.00
  • Report 05IC-GDHC3663CTIDB has a star rating of 4.9 out of 5
  • Go to More information on Report 05IC-GDHC3663CTIDB
  • View Report: Research and Experts Market Report: Chagas Disease (American Trypanosomiasis) Global Clinical Trials Review, H2, 2016

    Chagas Disease (American Trypanosomiasis) Global Clinical Trials Review, H2, 2016


    2016-08-24
    GlobalData's clinical trial report, “Chagas Disease (American Trypanosomiasis) Global Clinical Trials Review, H2, 2016" provides an overview of Chagas Disease (American Trypanosomiasis) clinical trials scenario. This report provides top...
  • Market Report
  • Infectious Disease
  • Global
  • $2,500.00
  • Report 05IC-GDHC3659CTIDB has a star rating of 4.2 out of 5
  • Go to More information on Report 05IC-GDHC3659CTIDB
  • View Report: Research and Experts Market Report: Allergic Rhinitis - Current and Future Players

    Allergic Rhinitis - Current and Future Players


    2015-09-01
    GlobalData has released its pharma report, “Allergic Rhinitis - Current and Future Players”. The report is a vital source of up-to-date information with in-depth analysis on the companies in the rapidly growing Allergic Rhinitis Market. The...
  • Market Report
  • Respiratory
  • Global
  • $2,995.00
  • Report 05IC-GDHC1054FPR has a star rating of 4.1 out of 5
  • Go to More information on Report 05IC-GDHC1054FPR
  • View Report: Research and Experts Market Report: Juvenile Macular Degeneration (Stargardt Disease) - Pipeline Review, H2 2016

    Juvenile Macular Degeneration (Stargardt Disease) - Pipeline Review, H2 2016


    2016-08-24
    Global Markets Direct’s, ‘Juvenile Macular Degeneration (Stargardt Disease) - Pipeline Review, H2 2016’, provides an overview of the Juvenile Macular Degeneration (Stargardt Disease) pipeline landscape.

    The report provides comprehensive...

  • Market Report
  • Life Sciences
  • Global
  • $2,000.00
  • Report 05IB-GMDHC8396IDB has a star rating of 4.4 out of 5
  • Go to More information on Report 05IB-GMDHC8396IDB
  • View Report: Research and Experts Market Report: Tumor Necrosis Factor Receptor Superfamily Member 16 (Low Affinity Neurotrophin Receptor p75NTR or Low Affinity Nerve Growth Factor...

    Tumor Necrosis Factor Receptor Superfamily Member 16 (Low Affinity Neurotrophin Receptor p75NTR or Low Affinity Nerve Growth Factor Receptor or Gp80 LNGFR or p75 ICD or TNFRSF16 or CD271 or NGFR) - Pipeline Review, H2 2016


    2016-08-17
    Global Markets Direct’s, ‘Tumor Necrosis Factor Receptor Superfamily Member 16 (Low Affinity Neurotrophin Receptor p75NTR or Low Affinity Nerve Growth Factor Receptor or Gp80 LNGFR or p75 ICD or TNFRSF16 or CD271 or NGFR) - Pipeline Review,...
  • Market Report
  • Pharmaceuticals
  • Global
  • $3,500.00
  • Report 05IB-GMDHC0468TDB has a star rating of 4.2 out of 5
  • Go to More information on Report 05IB-GMDHC0468TDB
  • View Report: Research and Experts Market Report: Alzheimer

    Alzheimer's Disease - Pipeline Review, H2 2016


    2016-08-10
    Global Markets Direct’s, ‘Alzheimer's Disease - Pipeline Review, H2 2016’, provides an overview of the Alzheimer's Disease pipeline landscape.

    The report provides comprehensive information on the therapeutics under development...

  • Market Report
  • Central Nervous System
  • Global
  • $2,500.00
  • Report 05IB-GMDHC8356IDB has a star rating of 4.9 out of 5
  • Go to More information on Report 05IB-GMDHC8356IDB
  • View Report: Research and Experts Market Report: Unstable Angina Global Clinical Trials Review, H2, 2016

    Unstable Angina Global Clinical Trials Review, H2, 2016


    2016-07-29
    Clinical trial report, “Unstable Angina Global Clinical Trials Review, H2, 2016" provides an overview of Unstable Angina clinical trials scenario. This report provides top line data relating to the clinical trials on Unstable Angina. Report...
  • Market Report
  • Cardiovascular
  • Global
  • $2,500.00
  • Report 05IC-GDHC3611CTIDB has a star rating of 4.7 out of 5
  • Go to More information on Report 05IC-GDHC3611CTIDB
  • View Report: Research and Experts Market Report: Vascular Calcification Global Clinical Trials Review, H2, 2016

    Vascular Calcification Global Clinical Trials Review, H2, 2016


    2016-07-29
    Clinical trial report, “Vascular Calcification Global Clinical Trials Review, H2, 2016" provides an overview of Vascular Calcification clinical trials scenario. This report provides top line data relating to the clinical trials on Vascular Calcificat...
  • Market Report
  • Cardiovascular
  • Global
  • $2,500.00
  • Report 05IC-GDHC3609CTIDB has a star rating of 4.2 out of 5
  • Go to More information on Report 05IC-GDHC3609CTIDB
  • View Report: Research and Experts Market Report: Systolic Hypertension Global Clinical Trials Review, H2, 2016

    Systolic Hypertension Global Clinical Trials Review, H2, 2016


    2016-07-29
    Clinical trial report, “Systolic Hypertension Global Clinical Trials Review, H2, 2016" provides an overview of Systolic Hypertension clinical trials scenario. This report provides top line data relating to the clinical trials on Systolic Hypertension...
  • Market Report
  • Cardiovascular
  • Global
  • $2,500.00
  • Report 05IC-GDHC3608CTIDB has a star rating of 4.2 out of 5
  • Go to More information on Report 05IC-GDHC3608CTIDB
  • View Report: Research and Experts Market Report: Pericarditis Global Clinical Trials Review, H2, 2016

    Pericarditis Global Clinical Trials Review, H2, 2016


    2016-07-29
    Clinical trial report, “Pericarditis Global Clinical Trials Review, H2, 2016" provides an overview of Pericarditis clinical trials scenario. This report provides top line data relating to the clinical trials on Pericarditis. Report includes...
  • Market Report
  • Cardiovascular
  • Global
  • $2,500.00
  • Report 05IC-GDHC3606CTIDB has a star rating of 4.2 out of 5
  • Go to More information on Report 05IC-GDHC3606CTIDB
  • View Report: Research and Experts Market Report: Peripheral Artery Occlusive Disease (PAOD) Global Clinical Trials Review, H2, 2016

    Peripheral Artery Occlusive Disease (PAOD) Global Clinical Trials Review, H2, 2016


    2016-07-29
    Clinical trial report, “Peripheral Artery Occlusive Disease (PAOD) Global Clinical Trials Review, H2, 2016" provides an overview of Peripheral Artery Occlusive Disease (PAOD) clinical trials scenario. This report provides top line data relating...
  • Market Report
  • Cardiovascular
  • Global
  • $2,500.00
  • Report 05IC-GDHC3603CTIDB has a star rating of 4.9 out of 5
  • Go to More information on Report 05IC-GDHC3603CTIDB
  • View Report: Research and Experts Market Report: Occlusive Arterial Disease (OAD) Global Clinical Trials Review, H2, 2016

    Occlusive Arterial Disease (OAD) Global Clinical Trials Review, H2, 2016


    2016-07-29
    Clinical trial report, “Occlusive Arterial Disease (OAD) Global Clinical Trials Review, H2, 2016" provides an overview of Occlusive Arterial Disease (OAD) clinical trials scenario. This report provides top line data relating to the clinical...
  • Market Report
  • Cardiovascular
  • Global
  • $2,500.00
  • Report 05IC-GDHC3601CTIDB has a star rating of 4.9 out of 5
  • Go to More information on Report 05IC-GDHC3601CTIDB
  • View Report: Research and Experts Market Report: Intermittent Claudication Global Clinical Trials Review, H2, 2016

    Intermittent Claudication Global Clinical Trials Review, H2, 2016


    2016-07-29
    Clinical trial report, “Intermittent Claudication Global Clinical Trials Review, H2, 2016" provides an overview of Intermittent Claudication clinical trials scenario. This report provides top line data relating to the clinical trials on Intermittent...
  • Market Report
  • Cardiovascular
  • Global
  • $2,500.00
  • Report 05IC-GDHC3597CTIDB has a star rating of 4.4 out of 5
  • Go to More information on Report 05IC-GDHC3597CTIDB
  • View Report: Research and Experts Market Report: Critical Limb Ischemia Global Clinical Trials Review, H2, 2016

    Critical Limb Ischemia Global Clinical Trials Review, H2, 2016


    2016-07-29
    Clinical trial report, “Critical Limb Ischemia Global Clinical Trials Review, H2, 2016" provides an overview of Critical Limb Ischemia clinical trials scenario. This report provides top line data relating to the clinical trials on Critical Limb...
  • Market Report
  • Cardiovascular
  • Global
  • $2,500.00
  • Report 05IC-GDHC3588CTIDB has a star rating of 4.5 out of 5
  • Go to More information on Report 05IC-GDHC3588CTIDB
  • View Report: Research and Experts Market Report: Atherosclerosis Global Clinical Trials Review, H2, 2016

    Atherosclerosis Global Clinical Trials Review, H2, 2016


    2016-07-29
    Clinical trial report, “Atherosclerosis Global Clinical Trials Review, H2, 2016" provides an overview of Atherosclerosis clinical trials scenario. This report provides top line data relating to the clinical trials on Atherosclerosis. Report...
  • Market Report
  • Cardiovascular
  • Global
  • $2,500.00
  • Report 05IC-GDHC3587CTIDB has a star rating of 4.9 out of 5
  • Go to More information on Report 05IC-GDHC3587CTIDB
  • View Report: Research and Experts Market Report: Arterial Calcification Global Clinical Trials Review, H2, 2016

    Arterial Calcification Global Clinical Trials Review, H2, 2016


    2016-07-29
    Clinical trial report, “Arterial Calcification Global Clinical Trials Review, H2, 2016" provides an overview of Arterial Calcification clinical trials scenario. This report provides top line data relating to the clinical trials on Arterial Calcificat...
  • Market Report
  • Cardiovascular
  • Global
  • $2,500.00
  • Report 05IC-GDHC3586CTIDB has a star rating of 4.3 out of 5
  • Go to More information on Report 05IC-GDHC3586CTIDB
  • View Report: Research and Experts Market Report: Arteriosclerosis Global Clinical Trials Review, H2, 2016

    Arteriosclerosis Global Clinical Trials Review, H2, 2016


    2016-07-29
    Clinical trial report, “Arteriosclerosis Global Clinical Trials Review, H2, 2016" provides an overview of Arteriosclerosis clinical trials scenario. This report provides top line data relating to the clinical trials on Arteriosclerosis. Report...
  • Market Report
  • Cardiovascular
  • Global
  • $2,500.00
  • Report 05IC-GDHC3583CTIDB has a star rating of 4.9 out of 5
  • Go to More information on Report 05IC-GDHC3583CTIDB
  • View Report: Research and Experts Market Report: Aortic Valve Stenosis Global Clinical Trials Review, H2, 2016

    Aortic Valve Stenosis Global Clinical Trials Review, H2, 2016


    2016-07-29
    Clinical trial report, “Aortic Valve Stenosis Global Clinical Trials Review, H2, 2016" provides an overview of Aortic Valve Stenosis clinical trials scenario. This report provides top line data relating to the clinical trials on Aortic Valve...
  • Market Report
  • Cardiovascular
  • Global
  • $2,500.00
  • Report 05IC-GDHC3582CTIDB has a star rating of 4.3 out of 5
  • Go to More information on Report 05IC-GDHC3582CTIDB
  • View Report: Research and Experts Market Report: Wrinkles Global Clinical Trials Review, H2, 2016

    Wrinkles Global Clinical Trials Review, H2, 2016


    2016-07-27
    Clinical trial report, “Wrinkles Global Clinical Trials Review, H2, 2016" provides an overview of Wrinkles clinical trials scenario. This report provides top line data relating to the clinical trials on Wrinkles. Report includes an overview...
  • Market Report
  • Dermatology
  • Global
  • $2,500.00
  • Report 05IC-GDHC3570CTIDB has a star rating of 4.5 out of 5
  • Go to More information on Report 05IC-GDHC3570CTIDB
  • View Report: Research and Experts Market Report: Sciatic Pain Global Clinical Trials Review, H2, 2016

    Sciatic Pain Global Clinical Trials Review, H2, 2016


    2016-07-27
    Clinical trial report, “Sciatic Pain Global Clinical Trials Review, H2, 2016" provides an overview of Sciatic Pain clinical trials scenario. This report provides top line data relating to the clinical trials on Sciatic Pain. Report includes...
  • Market Report
  • Central Nervous System
  • Global
  • $2,500.00
  • Report 05IC-GDHC3566CTIDB has a star rating of 4.2 out of 5
  • Go to More information on Report 05IC-GDHC3566CTIDB
  • View Report: Research and Experts Market Report: Relapsing Remitting Multiple Sclerosis (RRMS) Global Clinical Trials Review, H2, 2016

    Relapsing Remitting Multiple Sclerosis (RRMS) Global Clinical Trials Review, H2, 2016


    2016-07-27
    Clinical trial report, “Relapsing Remitting Multiple Sclerosis (RRMS) Global Clinical Trials Review, H2, 2016" provides an overview of Relapsing Remitting Multiple Sclerosis (RRMS) clinical trials scenario. This report provides top line data...
  • Market Report
  • Central Nervous System
  • Global
  • $2,500.00
  • Report 05IC-GDHC3559CTIDB has a star rating of 4.9 out of 5
  • Go to More information on Report 05IC-GDHC3559CTIDB
  • View Report: Research and Experts Market Report: Relapsing Multiple Sclerosis (RMS) Global Clinical Trials Review, H2, 2016

    Relapsing Multiple Sclerosis (RMS) Global Clinical Trials Review, H2, 2016


    2016-07-27
    Clinical trial report, “Relapsing Multiple Sclerosis (RMS) Global Clinical Trials Review, H2, 2016" provides an overview of Relapsing Multiple Sclerosis (RMS) clinical trials scenario. This report provides top line data relating to the clinical...
  • Market Report
  • Central Nervous System
  • Global
  • $2,500.00
  • Report 05IC-GDHC3558CTIDB has a star rating of 4.8 out of 5
  • Go to More information on Report 05IC-GDHC3558CTIDB
  • View Report: Research and Experts Market Report: Multiple Sclerosis Global Clinical Trials Review, H2, 2016

    Multiple Sclerosis Global Clinical Trials Review, H2, 2016


    2016-07-27
    Clinical trial report, “Multiple Sclerosis Global Clinical Trials Review, H2, 2016" provides an overview of Multiple Sclerosis clinical trials scenario. This report provides top line data relating to the clinical trials on Multiple Sclerosis....
  • Market Report
  • Central Nervous System
  • Global
  • $2,500.00
  • Report 05IC-GDHC3549CTIDB has a star rating of 4.9 out of 5
  • Go to More information on Report 05IC-GDHC3549CTIDB
  • View Report: Research and Experts Market Report: Hypoglycemia - Pipeline Review, H2 2016

    Hypoglycemia - Pipeline Review, H2 2016


    2016-07-20
    ‘Hypoglycemia - Pipeline Review, H2 2016’, provides an overview of the Hypoglycemia pipeline landscape.

    The report provides comprehensive information on the therapeutics under development for Hypoglycemia, complete with analysis by stage of...

  • Market Report
  • Metabolic Disorders
  • Global
  • $2,000.00
  • Report 05IB-GMDHC8287IDB has a star rating of 4.5 out of 5
  • Go to More information on Report 05IB-GMDHC8287IDB
  • View Report: Research and Experts Market Report: Insulin Resistance - Pipeline Review, H2 2016

    Insulin Resistance - Pipeline Review, H2 2016


    2016-07-20
    ‘Insulin Resistance - Pipeline Review, H2 2016’, provides an overview of the Insulin Resistance pipeline landscape.

    The report provides comprehensive information on the therapeutics under development for Insulin Resistance, complete with analysis...

  • Market Report
  • Metabolic Disorders
  • Global
  • $2,000.00
  • Report 05IB-GMDHC8267IDB has a star rating of 4.2 out of 5
  • Go to More information on Report 05IB-GMDHC8267IDB
  • View Report: Research and Experts Market Report: Systemic Sclerosis (Scleroderma) - Pipeline Review, H2 2016

    Systemic Sclerosis (Scleroderma) - Pipeline Review, H2 2016


    2016-07-27
    ‘Systemic Sclerosis (Scleroderma) - Pipeline Review, H2 2016’, provides an overview of the Systemic Sclerosis (Scleroderma) pipeline landscape.

    The report provides comprehensive information on the therapeutics under development for Systemic...

  • Market Report
  • Healthcare
  • Global
  • $2,000.00
  • Report 05IB-GMDHC8302IDB has a star rating of 4.8 out of 5
  • Go to More information on Report 05IB-GMDHC8302IDB
  • View Report: Research and Experts Market Report: Peripheral Neuropathy (Sensory Neuropathy) - Pipeline Review, H2 2016

    Peripheral Neuropathy (Sensory Neuropathy) - Pipeline Review, H2 2016


    2016-07-20
    ‘Peripheral Neuropathy (Sensory Neuropathy) - Pipeline Review, H2 2016’, provides an overview of the Peripheral Neuropathy (Sensory Neuropathy) pipeline landscape.

    The report provides comprehensive information on the therapeutics under development...

  • Market Report
  • Central Nervous System
  • Global
  • $2,000.00
  • Report 05IB-GMDHC8291IDB has a star rating of 4.5 out of 5
  • Go to More information on Report 05IB-GMDHC8291IDB
  • View Report: Research and Experts Market Report: Dilated Cardiomyopathy - Pipeline Review, H2 2016

    Dilated Cardiomyopathy - Pipeline Review, H2 2016


    2016-07-20
    ‘Dilated Cardiomyopathy - Pipeline Review, H2 2016’, provides an overview of the Dilated Cardiomyopathy pipeline landscape.

    The report provides comprehensive information on the therapeutics under development for Dilated Cardiomyopathy, complete...

  • Market Report
  • Cardiovascular
  • Global
  • $2,000.00
  • Report 05IB-GMDHC8247IDB has a star rating of 4.3 out of 5
  • Go to More information on Report 05IB-GMDHC8247IDB
  • View Report: Research and Experts Company Report: Biogen Inc (BIIB) - Financial and Strategic SWOT Analysis Review

    Biogen Inc (BIIB) - Financial and Strategic SWOT Analysis Review


    2016-08-17
    Biogen Inc (Biogen) is a global biotechnology company that discovers, develops, manufactures and commercializes therapies for treating neurodegenerative diseases, hematologic conditions and autoimmune disorders. The company’s marketed product portfolio...
  • Company Report
  • Life Sciences
  • United States
  • $125.00
  • Report 01B4-GDPH1307FSA has a star rating of 4.2 out of 5
  • Go to More information on Report 01B4-GDPH1307FSA
  • View Report: Research and Experts Market Report: Insomnia Global Clinical Trials Review, H1, 2016

    Insomnia Global Clinical Trials Review, H1, 2016


    2016-06-30
    Clinical trial report, “Insomnia Global Clinical Trials Review, H1, 2016" provides an overview of Insomnia clinical trials scenario. This report provides top line data relating to the clinical trials on Insomnia. Report includes an overview...
  • Market Report
  • Healthcare
  • Global
  • $2,500.00
  • Report 05IC-GDHC3533CTIDB has a star rating of 4.8 out of 5
  • Go to More information on Report 05IC-GDHC3533CTIDB
  • View Report: Research and Experts Market Report: Japanese Encephalitis Global Clinical Trials Review, H1, 2016

    Japanese Encephalitis Global Clinical Trials Review, H1, 2016


    2016-06-30
    Clinical trial report, “Japanese Encephalitis Global Clinical Trials Review, H1, 2016" provides an overview of Japanese Encephalitis clinical trials scenario. This report provides top line data relating to the clinical trials on Japanese Encephalitis...
  • Market Report
  • Healthcare
  • Global
  • $2,500.00
  • Report 05IC-GDHC3531CTIDB has a star rating of 4.2 out of 5
  • Go to More information on Report 05IC-GDHC3531CTIDB
  • View Report: Research and Experts Market Report: Infantile Spasm (West Syndrome) Global Clinical Trials Review, H1, 2016

    Infantile Spasm (West Syndrome) Global Clinical Trials Review, H1, 2016


    2016-06-30
    Clinical trial report, “Infantile Spasm (West Syndrome) Global Clinical Trials Review, H1, 2016" provides an overview of Infantile Spasm (West Syndrome) clinical trials scenario. This report provides top line data relating to the clinical trials...
  • Market Report
  • Healthcare
  • Global
  • $2,500.00
  • Report 05IC-GDHC3526CTIDB has a star rating of 4.2 out of 5
  • Go to More information on Report 05IC-GDHC3526CTIDB
  • View Report: Research and Experts Market Report: Angiopoietin 1 Receptor (Endothelial Tyrosine Kinase or Tunica Interna Endothelial Cell Kinase or Tyrosine Kinase With Ig And EGF...

    Angiopoietin 1 Receptor (Endothelial Tyrosine Kinase or Tunica Interna Endothelial Cell Kinase or Tyrosine Kinase With Ig And EGF Homology Domains 2 or Tyrosine Protein Kinase Receptor TEK or Tyrosine Protein Kinase Receptor TIE 2 or p140 TEK or CD202b or


    2016-06-30
    Global Markets Direct’s, ‘Angiopoietin 1 Receptor (Endothelial Tyrosine Kinase or Tunica Interna Endothelial Cell Kinase or Tyrosine Kinase With Ig And EGF Homology Domains 2 or Tyrosine Protein Kinase Receptor TEK or Tyrosine Protein Kinase...
  • Market Report
  • Life Sciences
  • Global
  • $3,500.00
  • Report 05IB-GMDHC0227TDB has a star rating of 4.3 out of 5
  • Go to More information on Report 05IB-GMDHC0227TDB
  • View Report: Research and Experts Market Report: Aurora Kinase C (Aurora 3 or Serine/Threonine-Protein Kinase 13 or Serine/Threonine-Protein Kinase Aurora-C or EC 2.7.11.1) - Pipeline...

    Aurora Kinase C (Aurora 3 or Serine/Threonine-Protein Kinase 13 or Serine/Threonine-Protein Kinase Aurora-C or EC 2.7.11.1) - Pipeline Review, H1 2016


    2016-06-30
    Global Markets Direct’s, ‘Aurora Kinase C (Aurora 3 or Serine/Threonine-Protein Kinase 13 or Serine/Threonine-Protein Kinase Aurora-C or EC 2.7.11.1) - Pipeline Review, H1 2016’, provides in depth analysis on Aurora Kinase C (Aurora 3 or...
  • Market Report
  • Life Sciences
  • Global
  • $3,500.00
  • Report 05IB-GMDHC0214TDB has a star rating of 4.2 out of 5
  • Go to More information on Report 05IB-GMDHC0214TDB
  • View Report: Research and Experts Market Report: Aurora Kinase B (Aurora 1 or Aurora- and IPL1-Like Midbody-Associated Protein 1 or Serine/Threonine-Protein Kinase 12 or EC 2.7.11.1)...

    Aurora Kinase B (Aurora 1 or Aurora- and IPL1-Like Midbody-Associated Protein 1 or Serine/Threonine-Protein Kinase 12 or EC 2.7.11.1) - Pipeline Review, H1 2016


    2016-06-30
    Global Markets Direct’s, ‘Aurora Kinase B (Aurora 1 or Aurora- and IPL1-Like Midbody-Associated Protein 1 or Serine/Threonine-Protein Kinase 12 or EC 2.7.11.1) - Pipeline Review, H1 2016’, provides in depth analysis on Aurora Kinase B (Aurora...
  • Market Report
  • Life Sciences
  • Global
  • $3,500.00
  • Report 05IB-GMDHC0213TDB has a star rating of 4.2 out of 5
  • Go to More information on Report 05IB-GMDHC0213TDB
  • View Report: Research and Experts Market Report: Aurora Kinase A (Serine/Threonine-Protein Kinase 15 or Aurora/IPL1-Related Kinase 1 or Aurora 2 or EC 2.7.11.1) - Pipeline Review,...

    Aurora Kinase A (Serine/Threonine-Protein Kinase 15 or Aurora/IPL1-Related Kinase 1 or Aurora 2 or EC 2.7.11.1) - Pipeline Review, H1 2016


    2016-06-30
    Global Markets Direct’s, ‘Aurora Kinase A (Serine/Threonine-Protein Kinase 15 or Aurora/IPL1-Related Kinase 1 or Aurora 2 or EC 2.7.11.1) - Pipeline Review, H1 2016’, provides in depth analysis on Aurora Kinase A (Serine/Threonine-Protein...
  • Market Report
  • Life Sciences
  • Global
  • $3,500.00
  • Report 05IB-GMDHC0212TDB has a star rating of 4.2 out of 5
  • Go to More information on Report 05IB-GMDHC0212TDB
  • View Report: Research and Experts Market Report: Acute Myelocytic Leukemia (AML, Acute Myeloblastic Leukemia) - Pipeline Review, H1 2016

    Acute Myelocytic Leukemia (AML, Acute Myeloblastic Leukemia) - Pipeline Review, H1 2016


    2016-06-30
    Global Markets Direct’s, ‘Acute Myelocytic Leukemia (AML, Acute Myeloblastic Leukemia) - Pipeline Review, H1 2016’, provides an overview of the Acute Myelocytic Leukemia (AML, Acute Myeloblastic Leukemia) pipeline landscape.

    The report...

  • Market Report
  • Life Sciences
  • Global
  • $2,500.00
  • Report 05IB-GMDHC7960IDB has a star rating of 4.9 out of 5
  • Go to More information on Report 05IB-GMDHC7960IDB
  • View Report: Research and Experts Market Report: Colorectal Cancer - Pipeline Review, H1 2016

    Colorectal Cancer - Pipeline Review, H1 2016


    2016-06-30
    Global Markets Direct’s, ‘Colorectal Cancer - Pipeline Review, H1 2016’, provides an overview of the Colorectal Cancer pipeline landscape.

    The report provides comprehensive information on the therapeutics under development for Colorectal...

  • Market Report
  • Life Sciences
  • Global
  • $2,500.00
  • Report 05IB-GMDHC7959IDB has a star rating of 4.9 out of 5
  • Go to More information on Report 05IB-GMDHC7959IDB
  • View Report: Research and Experts Market Report: HIV / AIDS - Pipeline Review, H1 2016

    HIV / AIDS - Pipeline Review, H1 2016


    2016-06-30
    Global Markets Direct’s, ‘HIV / AIDS - Pipeline Review, H1 2016’, provides an overview of the HIV / AIDS pipeline landscape.

    The report provides comprehensive information on the therapeutics under development for HIV / AIDS, complete...

  • Market Report
  • Life Sciences
  • Global
  • $2,500.00
  • Report 05IB-GMDHC7958IDB has a star rating of 4.9 out of 5
  • Go to More information on Report 05IB-GMDHC7958IDB
  • View Report: Research and Experts Market Report: Breast Cancer - Pipeline Review, H1 2016

    Breast Cancer - Pipeline Review, H1 2016


    2016-06-30
    Global Markets Direct’s, ‘Breast Cancer - Pipeline Review, H1 2016’, provides an overview of the Breast Cancer pipeline landscape.

    The report provides comprehensive information on the therapeutics under development for Breast Cancer,...

  • Market Report
  • Life Sciences
  • Global
  • $2,500.00
  • Report 05IB-GMDHC7666IDB has a star rating of 4.9 out of 5
  • Go to More information on Report 05IB-GMDHC7666IDB
  • View Report: Research and Experts Market Report: Mucopolysaccharidosis I (MPS I) (Hurler Syndrome ) Global Clinical Trials Review, H1, 2016

    Mucopolysaccharidosis I (MPS I) (Hurler Syndrome ) Global Clinical Trials Review, H1, 2016


    2016-06-30
    GlobalData's clinical trial report, “Mucopolysaccharidosis I (MPS I) (Hurler Syndrome ) Global Clinical Trials Review, H1, 2016" provides an overview of Mucopolysaccharidosis I (MPS I) (Hurler Syndrome ) clinical trials scenario. This report...
  • Market Report
  • Life Sciences
  • Global
  • $2,500.00
  • Report 05IC-GDHC3509CTIDB has a star rating of 4.3 out of 5
  • Go to More information on Report 05IC-GDHC3509CTIDB
  • View Report: Research and Experts Market Report: Dysbetalipoproteinemia (Type III Hyperlipoproteinemia) Global Clinical Trials Review, H1, 2016

    Dysbetalipoproteinemia (Type III Hyperlipoproteinemia) Global Clinical Trials Review, H1, 2016


    2016-06-30
    GlobalData's clinical trial report, “Dysbetalipoproteinemia (Type III Hyperlipoproteinemia) Global Clinical Trials Review, H1, 2016" provides an overview of Dysbetalipoproteinemia (Type III Hyperlipoproteinemia) clinical trials scenario....
  • Market Report
  • Life Sciences
  • Global
  • $2,500.00
  • Report 05IC-GDHC3507CTIDB has a star rating of 4.2 out of 5
  • Go to More information on Report 05IC-GDHC3507CTIDB
  • View Report: Research and Experts Market Report: Familial Hypercholesterolemia (Type II Hyperlipoproteinemia) Global Clinical Trials Review, H1, 2016

    Familial Hypercholesterolemia (Type II Hyperlipoproteinemia) Global Clinical Trials Review, H1, 2016


    2016-06-30
    GlobalData's clinical trial report, “Familial Hypercholesterolemia (Type II Hyperlipoproteinemia) Global Clinical Trials Review, H1, 2016" provides an overview of Familial Hypercholesterolemia (Type II Hyperlipoproteinemia) clinical trials...
  • Market Report
  • Life Sciences
  • Global
  • $2,500.00
  • Report 05IC-GDHC3504CTIDB has a star rating of 4.8 out of 5
  • Go to More information on Report 05IC-GDHC3504CTIDB
  • View Report: Research and Experts Market Report: OpportunityAnalyzer: Huntington

    OpportunityAnalyzer: Huntington's Disease - Opportunity Analysis and Forecast to 2024


    2016-05-03
    Huntington’s Disease (HD) is a rare, autosomal-dominant, neurodegenerative disorder, characterized by impaired motor control, cognitive dysfunction, behavioral changes, and mood disorders. Approved treatments for HD across the 7MM are extremely limited,...
  • Market Report
  • Life Sciences
  • Global
  • $10,995.00
  • Report 05IC-GDHC056POA has a star rating of 4.2 out of 5
  • Go to More information on Report 05IC-GDHC056POA
  • View Report: Research and Experts Company Report: Johnson & Johnson (JNJ) - Financial and Strategic SWOT Analysis Review

    Johnson & Johnson (JNJ) - Financial and Strategic SWOT Analysis Review


    2016-08-02
    Johnson & Johnson (J&J) is a holding company that manufactures and sells a broad range of products in pharmaceutical, consumer and medical fields. Its product offerings include drugs to treat immune disorders, neurological diseases, cancer, cardio...
  • Company Report
  • Life Sciences
  • United States
  • $125.00
  • Report 05IC-GDPH659FSA has a star rating of 4.2 out of 5
  • Go to More information on Report 05IC-GDPH659FSA
  • View Report: Research and Experts Market Report: Interleukin 13 (IL13) - Pipeline Review, H1 2016

    Interleukin 13 (IL13) - Pipeline Review, H1 2016


    2016-06-28
    Global Markets Direct’s, ‘Interleukin 13 (IL13) - Pipeline Review, H1 2016’, provides in depth analysis on Interleukin 13 (IL13) targeted pipeline therapeutics.

    The report provides comprehensive information on the Interleukin 13 (IL13),...

  • Market Report
  • Pharmaceuticals
  • Global
  • $3,500.00
  • Report 05IB-GMDHC0124TDB has a star rating of 4.2 out of 5
  • Go to More information on Report 05IB-GMDHC0124TDB
  • View Report: Research and Experts Market Report: Ovarian Cancer - Pipeline Review, H1 2016

    Ovarian Cancer - Pipeline Review, H1 2016


    2016-06-28
    Global Markets Direct’s, ‘Ovarian Cancer - Pipeline Review, H1 2016’, provides an overview of the Ovarian Cancer pipeline landscape.

    The report provides comprehensive information on the therapeutics under development for Ovarian Cancer,...

  • Market Report
  • Oncology
  • Global
  • $2,500.00
  • Report 05IB-GMDHC7956IDB has a star rating of 5.0 out of 5
  • Go to More information on Report 05IB-GMDHC7956IDB
  • View Report: Research and Experts Market Report: Non-Small Cell Lung Cancer - Pipeline Review, H1 2016

    Non-Small Cell Lung Cancer - Pipeline Review, H1 2016


    2016-06-28
    Global Markets Direct’s, ‘Non-Small Cell Lung Cancer - Pipeline Review, H1 2016’, provides an overview of the Non-Small Cell Lung Cancer pipeline landscape.

    The report provides comprehensive information on the therapeutics under development...

  • Market Report
  • Oncology
  • Global
  • $2,500.00
  • Report 05IB-GMDHC7954IDB has a star rating of 4.9 out of 5
  • Go to More information on Report 05IB-GMDHC7954IDB
  • View Report: Research and Experts Market Report: Pancreatic Cancer - Pipeline Review, H1 2016

    Pancreatic Cancer - Pipeline Review, H1 2016


    2016-06-28
    Global Markets Direct’s, ‘Pancreatic Cancer - Pipeline Review, H1 2016’, provides an overview of the Pancreatic Cancer pipeline landscape.

    The report provides comprehensive information on the therapeutics under development for Pancreatic...

  • Market Report
  • Oncology
  • Global
  • $2,500.00
  • Report 05IB-GMDHC7953IDB has a star rating of 4.9 out of 5
  • Go to More information on Report 05IB-GMDHC7953IDB
  • View Report: Research and Experts Market Report: Prostate Cancer - Pipeline Review, H1 2016

    Prostate Cancer - Pipeline Review, H1 2016


    2016-06-28
    Global Markets Direct’s, ‘Prostate Cancer - Pipeline Review, H1 2016’, provides an overview of the Prostate Cancer pipeline landscape.

    The report provides comprehensive information on the therapeutics under development for Prostate Cancer,...

  • Market Report
  • Oncology
  • Global
  • $2,500.00
  • Report 05IB-GMDHC7952IDB has a star rating of 5.0 out of 5
  • Go to More information on Report 05IB-GMDHC7952IDB
  • View Report: Research and Experts Market Report: AIDS - Related Cancer Global Clinical Trials Review, H1, 2016

    AIDS - Related Cancer Global Clinical Trials Review, H1, 2016


    2016-06-29
    GlobalData's clinical trial report, “AIDS - Related Cancer Global Clinical Trials Review, H1, 2016" provides an overview of AIDS - Related Cancer clinical trials scenario. This report provides top line data relating to the clinical trials...
  • Market Report
  • Oncology
  • Global
  • $2,500.00
  • Report 05IC-GDHC3498CTIDB has a star rating of 4.3 out of 5
  • Go to More information on Report 05IC-GDHC3498CTIDB
  • View Report: Research and Experts Market Report: B-Cell Chronic Lymphocytic Leukemia Global Clinical Trials Review, H1, 2016

    B-Cell Chronic Lymphocytic Leukemia Global Clinical Trials Review, H1, 2016


    2016-06-29
    GlobalData's clinical trial report, “B-Cell Chronic Lymphocytic Leukemia Global Clinical Trials Review, H1, 2016" provides an overview of B-Cell Chronic Lymphocytic Leukemia clinical trials scenario. This report provides top line data relating...
  • Market Report
  • Oncology
  • Global
  • $2,500.00
  • Report 05IC-GDHC3497CTIDB has a star rating of 4.8 out of 5
  • Go to More information on Report 05IC-GDHC3497CTIDB
  • View Report: Research and Experts Market Report: AIDS - Related Lymphoma Global Clinical Trials Review, H1, 2016

    AIDS - Related Lymphoma Global Clinical Trials Review, H1, 2016


    2016-06-29
    GlobalData's clinical trial report, “AIDS - Related Lymphoma Global Clinical Trials Review, H1, 2016" provides an overview of AIDS - Related Lymphoma clinical trials scenario. This report provides top line data relating to the clinical...
  • Market Report
  • Oncology
  • Global
  • $2,500.00
  • Report 05IC-GDHC3496CTIDB has a star rating of 4.2 out of 5
  • Go to More information on Report 05IC-GDHC3496CTIDB
  • View Report: Research and Experts Market Report: Acute Myelocytic Leukemia (AML, Acute Myeloblastic Leukemia) Global Clinical Trials Review, H1, 2016

    Acute Myelocytic Leukemia (AML, Acute Myeloblastic Leukemia) Global Clinical Trials Review, H1, 2016


    2016-06-29
    GlobalData's clinical trial report, “Acute Myelocytic Leukemia (AML, Acute Myeloblastic Leukemia) Global Clinical Trials Review, H1, 2016" provides an overview of Acute Myelocytic Leukemia (AML, Acute Myeloblastic Leukemia) clinical trials...
  • Market Report
  • Oncology
  • Global
  • $2,500.00
  • Report 05IC-GDHC3492CTIDB has a star rating of 4.9 out of 5
  • Go to More information on Report 05IC-GDHC3492CTIDB
  • View Report: Research and Experts Market Report: Acute Lymphocytic Leukemia (ALL, Acute Lymphoblastic Leukemia) Global Clinical Trials Review, H1, 2016

    Acute Lymphocytic Leukemia (ALL, Acute Lymphoblastic Leukemia) Global Clinical Trials Review, H1, 2016


    2016-06-29
    GlobalData's clinical trial report, “Acute Lymphocytic Leukemia (ALL, Acute Lymphoblastic Leukemia) Global Clinical Trials Review, H1, 2016" provides an overview of Acute Lymphocytic Leukemia (ALL, Acute Lymphoblastic Leukemia) clinical...
  • Market Report
  • Oncology
  • Global
  • $2,500.00
  • Report 05IC-GDHC3491CTIDB has a star rating of 4.9 out of 5
  • Go to More information on Report 05IC-GDHC3491CTIDB
  • View Report: Research and Experts Market Report: Hormone-Sensitive Prostate Cancer Global Clinical Trials Review, H1, 2016

    Hormone-Sensitive Prostate Cancer Global Clinical Trials Review, H1, 2016


    2016-06-29
    GlobalData's clinical trial report, “Hormone-Sensitive Prostate Cancer Global Clinical Trials Review, H1, 2016" provides an overview of Hormone-Sensitive Prostate Cancer clinical trials scenario. This report provides top line data relating...
  • Market Report
  • Oncology
  • Global
  • $2,500.00
  • Report 05IC-GDHC3483CTIDB has a star rating of 4.3 out of 5
  • Go to More information on Report 05IC-GDHC3483CTIDB
  • View Report: Research and Experts Market Report: C-X-C Chemokine Receptor Type 4 (Fusin or Leukocyte-Derived Seven Transmembrane Domain Receptor or Lipopolysaccharide-Associated...

    C-X-C Chemokine Receptor Type 4 (Fusin or Leukocyte-Derived Seven Transmembrane Domain Receptor or Lipopolysaccharide-Associated Protein 3 or Stromal Cell-Derived Factor 1 Receptor or CD184 or CXCR4) - Pipeline Review, H1 2016


    2016-06-22
    Global Markets Direct’s, ‘C-X-C Chemokine Receptor Type 4 (Fusin or Leukocyte-Derived Seven Transmembrane Domain Receptor or Lipopolysaccharide-Associated Protein 3 or Stromal Cell-Derived Factor 1 Receptor or CD184 or CXCR4) - Pipeline Review,...
  • Market Report
  • Pharmaceuticals
  • Global
  • $3,500.00
  • Report 05IB-GMDHC0085TDB has a star rating of 4.3 out of 5
  • Go to More information on Report 05IB-GMDHC0085TDB
  • View Report: Research and Experts Market Report: Chemotherapy Induced Peripheral Neuropathy Global Clinical Trials Review, H1, 2016

    Chemotherapy Induced Peripheral Neuropathy Global Clinical Trials Review, H1, 2016


    2016-06-15
    GlobalData's clinical trial report, “Chemotherapy Induced Peripheral Neuropathy Global Clinical Trials Review, H1, 2016" provides an overview of Chemotherapy Induced Peripheral Neuropathy clinical trials scenario. This report provides top...
  • Market Report
  • Life Sciences
  • Global
  • $2,500.00
  • Report 05IC-GDHC3479CTIDB has a star rating of 4.4 out of 5
  • Go to More information on Report 05IC-GDHC3479CTIDB
  • View Report: Research and Experts Market Report: Hormone Refractory (Castration Resistant, Androgen-Independent) Prostate Cancer Global Clinical Trials Review, H1, 2016

    Hormone Refractory (Castration Resistant, Androgen-Independent) Prostate Cancer Global Clinical Trials Review, H1, 2016


    2016-06-15
    GlobalData's clinical trial report, “Hormone Refractory (Castration Resistant, Androgen-Independent) Prostate Cancer Global Clinical Trials Review, H1, 2016" provides an overview of Hormone Refractory (Castration Resistant, Androgen-Independent)...
  • Market Report
  • Life Sciences
  • Global
  • $2,500.00
  • Report 05IC-GDHC3478CTIDB has a star rating of 4.9 out of 5
  • Go to More information on Report 05IC-GDHC3478CTIDB
  • View Report: Research and Experts Market Report: Chronic Lymphocytic Leukemia (CLL) Global Clinical Trials Review, H1, 2016

    Chronic Lymphocytic Leukemia (CLL) Global Clinical Trials Review, H1, 2016


    2016-06-15
    GlobalData's clinical trial report, “Chronic Lymphocytic Leukemia (CLL) Global Clinical Trials Review, H1, 2016" provides an overview of Chronic Lymphocytic Leukemia (CLL) clinical trials scenario. This report provides top line data relating...
  • Market Report
  • Life Sciences
  • Global
  • $2,500.00
  • Report 05IC-GDHC3477CTIDB has a star rating of 4.9 out of 5
  • Go to More information on Report 05IC-GDHC3477CTIDB
  • View Report: Research and Experts Market Report: High-Grade Glioma Global Clinical Trials Review, H1, 2016

    High-Grade Glioma Global Clinical Trials Review, H1, 2016


    2016-06-15
    GlobalData's clinical trial report, “High-Grade Glioma Global Clinical Trials Review, H1, 2016" provides an overview of High-Grade Glioma clinical trials scenario. This report provides top line data relating to the clinical trials on High-Grade...
  • Market Report
  • Life Sciences
  • Global
  • $2,500.00
  • Report 05IC-GDHC3476CTIDB has a star rating of 4.7 out of 5
  • Go to More information on Report 05IC-GDHC3476CTIDB
  • View Report: Research and Experts Market Report: Chronic Myelocytic Leukemia (CML, Chronic Myeloid Leukemia) Global Clinical Trials Review, H1, 2016

    Chronic Myelocytic Leukemia (CML, Chronic Myeloid Leukemia) Global Clinical Trials Review, H1, 2016


    2016-06-15
    GlobalData's clinical trial report, “Chronic Myelocytic Leukemia (CML, Chronic Myeloid Leukemia) Global Clinical Trials Review, H1, 2016" provides an overview of Chronic Myelocytic Leukemia (CML, Chronic Myeloid Leukemia) clinical trials...
  • Market Report
  • Life Sciences
  • Global
  • $2,500.00
  • Report 05IC-GDHC3473CTIDB has a star rating of 5.0 out of 5
  • Go to More information on Report 05IC-GDHC3473CTIDB
  • View Report: Research and Experts Market Report: Methicillin-Resistant Staphylococcus aureus (MRSA) - Current and Future Players

    Methicillin-Resistant Staphylococcus aureus (MRSA) - Current and Future Players


    2015-12-16
    GlobalData has released its pharma report, “Methicillin-Resistant Staphylococcus aureus (MRSA) - Current and Future Players”. The report is a vital source of up-to-date information with in-depth analysis on the companies in the rapidly growing...
  • Market Report
  • Life Sciences
  • Global
  • $2,995.00
  • Report 05IC-GDHC1046FPR has a star rating of 4.5 out of 5
  • Go to More information on Report 05IC-GDHC1046FPR
  • View Report: Research and Experts Market Report: Hyperuricemia Global Clinical Trials Review, H1, 2016

    Hyperuricemia Global Clinical Trials Review, H1, 2016


    2016-05-31
    GlobalData's clinical trial report, “Hyperuricemia Global Clinical Trials Review, H1, 2016" provides an overview of Hyperuricemia clinical trials scenario. This report provides top line data relating to the clinical trials on Hyperuricemia....
  • Market Report
  • Life Sciences
  • Global
  • $2,500.00
  • Report 05IC-GDHC3469CTIDB has a star rating of 4.7 out of 5
  • Go to More information on Report 05IC-GDHC3469CTIDB
  • View Report: Research and Experts Market Report: Hyperphenylalaninemia Global Clinical Trials Review, H1, 2016

    Hyperphenylalaninemia Global Clinical Trials Review, H1, 2016


    2016-05-31
    GlobalData's clinical trial report, “Hyperphenylalaninemia Global Clinical Trials Review, H1, 2016" provides an overview of Hyperphenylalaninemia clinical trials scenario. This report provides top line data relating to the clinical trials...
  • Market Report
  • Life Sciences
  • Global
  • $2,500.00
  • Report 05IC-GDHC3464CTIDB has a star rating of 4.7 out of 5
  • Go to More information on Report 05IC-GDHC3464CTIDB
  • View Report: Research and Experts Company Report: Stallergenes Greer plc (STAGR) - Financial and Strategic SWOT Analysis Review

    Stallergenes Greer plc (STAGR) - Financial and Strategic SWOT Analysis Review


    2016-07-19
    Stallergenes Greer plc (Stallergenes Greer), formerly Ares Allergy Holdings plc is a biopharmaceutical company, which provides treatments for allergy-related respiratory diseases. The company develops diagnostic tests and products with principal focus...
  • Company Report
  • Life Sciences
  • United Kingdom
  • $125.00
  • Report 05IC-GDPH2508812FSA has a star rating of 4.2 out of 5
  • Go to More information on Report 05IC-GDPH2508812FSA
  • View Report: Research and Experts Market Report: Bile Duct Cancer (Cholangiocarcinoma) Global Clinical Trials Review, H1, 2016

    Bile Duct Cancer (Cholangiocarcinoma) Global Clinical Trials Review, H1, 2016


    2016-05-31
    GlobalData's clinical trial report, “Bile Duct Cancer (Cholangiocarcinoma) Global Clinical Trials Review, H1, 2016" provides an overview of Bile Duct Cancer (Cholangiocarcinoma) clinical trials scenario. This report provides top line data...
  • Market Report
  • Life Sciences
  • Global
  • $2,500.00
  • Report 05IC-GDHC3449CTIDB has a star rating of 5.0 out of 5
  • Go to More information on Report 05IC-GDHC3449CTIDB
  • View Report: Research and Experts Market Report: B-Cell Leukemia Global Clinical Trials Review, H1, 2016

    B-Cell Leukemia Global Clinical Trials Review, H1, 2016


    2016-05-31
    GlobalData's clinical trial report, “B-Cell Leukemia Global Clinical Trials Review, H1, 2016" provides an overview of B-Cell Leukemia clinical trials scenario. This report provides top line data relating to the clinical trials on B-Cell...
  • Market Report
  • Life Sciences
  • Global
  • $2,500.00
  • Report 05IC-GDHC3442CTIDB has a star rating of 4.9 out of 5
  • Go to More information on Report 05IC-GDHC3442CTIDB
  • View Report: Research and Experts Market Report: Hypercholesterolemia Global Clinical Trials Review, H1, 2016

    Hypercholesterolemia Global Clinical Trials Review, H1, 2016


    2016-05-31
    GlobalData's clinical trial report, “Hypercholesterolemia Global Clinical Trials Review, H1, 2016" provides an overview of Hypercholesterolemia clinical trials scenario. This report provides top line data relating to the clinical trials...
  • Market Report
  • Life Sciences
  • Global
  • $2,500.00
  • Report 05IC-GDHC3436CTIDB has a star rating of 4.9 out of 5
  • Go to More information on Report 05IC-GDHC3436CTIDB
  • View Report: Research and Experts Market Report: Hyperglycemia Global Clinical Trials Review, H1, 2016

    Hyperglycemia Global Clinical Trials Review, H1, 2016


    2016-05-31
    GlobalData's clinical trial report, “Hyperglycemia Global Clinical Trials Review, H1, 2016" provides an overview of Hyperglycemia clinical trials scenario. This report provides top line data relating to the clinical trials on Hyperglycemia....
  • Market Report
  • Life Sciences
  • Global
  • $2,500.00
  • Report 05IC-GDHC3435CTIDB has a star rating of 4.7 out of 5
  • Go to More information on Report 05IC-GDHC3435CTIDB
  • View Report: Research and Experts Market Report: Diabetic Ketoacidosis Global Clinical Trials Review, H1, 2016

    Diabetic Ketoacidosis Global Clinical Trials Review, H1, 2016


    2016-05-31
    GlobalData's clinical trial report, “Diabetic Ketoacidosis Global Clinical Trials Review, H1, 2016" provides an overview of Diabetic Ketoacidosis clinical trials scenario. This report provides top line data relating to the clinical trials...
  • Market Report
  • Life Sciences
  • Global
  • $2,500.00
  • Report 05IC-GDHC3432CTIDB has a star rating of 4.2 out of 5
  • Go to More information on Report 05IC-GDHC3432CTIDB
  • View Report: Research and Experts Market Report: Pharyngitis Global Clinical Trials Review, H1, 2016

    Pharyngitis Global Clinical Trials Review, H1, 2016


    2016-05-31
    GlobalData's clinical trial report, “Pharyngitis Global Clinical Trials Review, H1, 2016" provides an overview of Pharyngitis clinical trials scenario. This report provides top line data relating to the clinical trials on Pharyngitis. Report...
  • Market Report
  • Life Sciences
  • Global
  • $2,500.00
  • Report 05IC-GDHC3424CTIDB has a star rating of 4.5 out of 5
  • Go to More information on Report 05IC-GDHC3424CTIDB
  • View Report: Research and Experts Market Report: Bronchitis Global Clinical Trials Review, H1, 2016

    Bronchitis Global Clinical Trials Review, H1, 2016


    2016-05-31
    GlobalData's clinical trial report, “Bronchitis Global Clinical Trials Review, H1, 2016" provides an overview of Bronchitis clinical trials scenario. This report provides top line data relating to the clinical trials on Bronchitis. Report...
  • Market Report
  • Life Sciences
  • Global
  • $2,500.00
  • Report 05IC-GDHC3422CTIDB has a star rating of 4.8 out of 5
  • Go to More information on Report 05IC-GDHC3422CTIDB
  • View Report: Research and Experts Market Report: Allergic Rhinitis Global Clinical Trials Review, H1, 2016

    Allergic Rhinitis Global Clinical Trials Review, H1, 2016


    2016-05-31
    GlobalData's clinical trial report, “Allergic Rhinitis Global Clinical Trials Review, H1, 2016" provides an overview of Allergic Rhinitis clinical trials scenario. This report provides top line data relating to the clinical trials on Allergic...
  • Market Report
  • Life Sciences
  • Global
  • $2,500.00
  • Report 05IC-GDHC3421CTIDB has a star rating of 4.9 out of 5
  • Go to More information on Report 05IC-GDHC3421CTIDB
  • View Report: Research and Experts Market Report: Oligodendroglioma Global Clinical Trials Review, H1, 2016

    Oligodendroglioma Global Clinical Trials Review, H1, 2016


    2016-05-31
    GlobalData's clinical trial report, “Oligodendroglioma Global Clinical Trials Review, H1, 2016" provides an overview of Oligodendroglioma clinical trials scenario. This report provides top line data relating to the clinical trials on Oligodendro...
  • Market Report
  • Life Sciences
  • Global
  • $2,500.00
  • Report 05IC-GDHC3419CTIDB has a star rating of 4.7 out of 5
  • Go to More information on Report 05IC-GDHC3419CTIDB
  • View Report: Research and Experts Market Report: Non-Hodgkin Lymphoma Global Clinical Trials Review, H1, 2016

    Non-Hodgkin Lymphoma Global Clinical Trials Review, H1, 2016


    2016-05-31
    GlobalData's clinical trial report, “Non-Hodgkin Lymphoma Global Clinical Trials Review, H1, 2016" provides an overview of Non-Hodgkin Lymphoma clinical trials scenario. This report provides top line data relating to the clinical trials...
  • Market Report
  • Life Sciences
  • Global
  • $2,500.00
  • Report 05IC-GDHC3417CTIDB has a star rating of 4.9 out of 5
  • Go to More information on Report 05IC-GDHC3417CTIDB
  • View Report: Research and Experts Market Report: Pancreatic Cancer Global Clinical Trials Review, H1, 2016

    Pancreatic Cancer Global Clinical Trials Review, H1, 2016


    2016-05-31
    GlobalData's clinical trial report, “Pancreatic Cancer Global Clinical Trials Review, H1, 2016" provides an overview of Pancreatic Cancer clinical trials scenario. This report provides top line data relating to the clinical trials on Pancreatic...
  • Market Report
  • Life Sciences
  • Global
  • $2,500.00
  • Report 05IC-GDHC3415CTIDB has a star rating of 4.9 out of 5
  • Go to More information on Report 05IC-GDHC3415CTIDB
  • View Report: Research and Experts Market Report: Hodgkin Lymphoma Global Clinical Trials Review, H1, 2016

    Hodgkin Lymphoma Global Clinical Trials Review, H1, 2016


    2016-05-31
    GlobalData's clinical trial report, “Hodgkin Lymphoma Global Clinical Trials Review, H1, 2016" provides an overview of Hodgkin Lymphoma clinical trials scenario. This report provides top line data relating to the clinical trials on Hodgkin...
  • Market Report
  • Life Sciences
  • Global
  • $2,500.00
  • Report 05IC-GDHC3414CTIDB has a star rating of 4.9 out of 5
  • Go to More information on Report 05IC-GDHC3414CTIDB
  • View Report: Research and Experts Market Report: Head And Neck Cancer Global Clinical Trials Review, H1, 2016

    Head And Neck Cancer Global Clinical Trials Review, H1, 2016


    2016-05-31
    GlobalData's clinical trial report, “Head And Neck Cancer Global Clinical Trials Review, H1, 2016" provides an overview of Head And Neck Cancer clinical trials scenario. This report provides top line data relating to the clinical trials...
  • Market Report
  • Life Sciences
  • Global
  • $2,500.00
  • Report 05IC-GDHC3413CTIDB has a star rating of 5.0 out of 5
  • Go to More information on Report 05IC-GDHC3413CTIDB
  • View Report: Research and Experts Market Report: Anaplastic Astrocytoma Global Clinical Trials Review, H1, 2016

    Anaplastic Astrocytoma Global Clinical Trials Review, H1, 2016


    2016-05-31
    GlobalData's clinical trial report, “Anaplastic Astrocytoma Global Clinical Trials Review, H1, 2016" provides an overview of Anaplastic Astrocytoma clinical trials scenario. This report provides top line data relating to the clinical trials...
  • Market Report
  • Life Sciences
  • Global
  • $2,500.00
  • Report 05IC-GDHC3412CTIDB has a star rating of 4.9 out of 5
  • Go to More information on Report 05IC-GDHC3412CTIDB
  • View Report: Research and Experts Market Report: Corticosteroid 11-Beta-Dehydrogenase Isozyme 1 (11-Beta-Hydroxysteroid Dehydrogenase 1 or Short Chain Dehydrogenase/Reductase Family...

    Corticosteroid 11-Beta-Dehydrogenase Isozyme 1 (11-Beta-Hydroxysteroid Dehydrogenase 1 or Short Chain Dehydrogenase/Reductase Family 26C Member 1 or 11-DH or 11-beta-HSD1 or HSD11B1 or EC 1.1.1.146) - Pipeline Review, H1 2016


    2016-06-15
    Global Markets Direct’s, ‘Corticosteroid 11-Beta-Dehydrogenase Isozyme 1 (11-Beta-Hydroxysteroid Dehydrogenase 1 or Short Chain Dehydrogenase/Reductase Family 26C Member 1 or 11-DH or 11-beta-HSD1 or HSD11B1 or EC 1.1.1.146) - Pipeline Review,...
  • Market Report
  • Life Sciences
  • Global
  • $3,500.00
  • Report 05IB-GMDHC0098TDB has a star rating of 4.2 out of 5
  • Go to More information on Report 05IB-GMDHC0098TDB
  • View Report: Research and Experts Market Report: Multiple Myeloma (Kahler Disease) - Pipeline Review, H1 2016

    Multiple Myeloma (Kahler Disease) - Pipeline Review, H1 2016


    2016-06-15
    Global Markets Direct’s, ‘Multiple Myeloma (Kahler Disease) - Pipeline Review, H1 2016’, provides an overview of the Multiple Myeloma (Kahler Disease) pipeline landscape.

    The report provides comprehensive information on the therapeutics...

  • Market Report
  • Life Sciences
  • Global
  • $2,500.00
  • Report 05IB-GMDHC8160IDB has a star rating of 4.9 out of 5
  • Go to More information on Report 05IB-GMDHC8160IDB
  • View Report: Research and Experts Market Report: Retinitis Pigmentosa (Retinitis) - Pipeline Review, H1 2016

    Retinitis Pigmentosa (Retinitis) - Pipeline Review, H1 2016


    2016-06-08
    Global Markets Direct’s, ‘Retinitis Pigmentosa (Retinitis) - Pipeline Review, H1 2016’, provides an overview of the Retinitis Pigmentosa (Retinitis) pipeline landscape.

    The report provides comprehensive information on the therapeutics...

  • Market Report
  • Life Sciences
  • Global
  • $2,000.00
  • Report 05IB-GMDHC8168IDB has a star rating of 4.8 out of 5
  • Go to More information on Report 05IB-GMDHC8168IDB
  • View Report: Research and Experts Market Report: Bile Duct Cancer (Cholangiocarcinoma) - Pipeline Review, H1 2016

    Bile Duct Cancer (Cholangiocarcinoma) - Pipeline Review, H1 2016


    2016-05-31
    Global Markets Direct’s, ‘Bile Duct Cancer (Cholangiocarcinoma) - Pipeline Review, H1 2016’, provides an overview of the Bile Duct Cancer (Cholangiocarcinoma) pipeline landscape.

    The report provides comprehensive information on the therapeutics...

  • Market Report
  • Life Sciences
  • Global
  • $2,000.00
  • Report 05IB-GMDHC8167IDB has a star rating of 4.9 out of 5
  • Go to More information on Report 05IB-GMDHC8167IDB
  • View Report: Research and Experts Market Report: Herpes Simplex Virus (HSV) Infections - Pipeline Review, H1 2016

    Herpes Simplex Virus (HSV) Infections - Pipeline Review, H1 2016


    2016-06-08
    Global Markets Direct’s, ‘Herpes Simplex Virus (HSV) Infections - Pipeline Review, H1 2016’, provides an overview of the Herpes Simplex Virus (HSV) Infections pipeline landscape.

    The report provides comprehensive information on the therapeutics...

  • Market Report
  • Life Sciences
  • Global
  • $2,000.00
  • Report 05IB-GMDHC8166IDB has a star rating of 4.8 out of 5
  • Go to More information on Report 05IB-GMDHC8166IDB
  • View Report: Research and Experts Market Report: Kidney Cancer (Renal Cell Cancer) - Pipeline Review, H1 2016

    Kidney Cancer (Renal Cell Cancer) - Pipeline Review, H1 2016


    2016-06-08
    Global Markets Direct’s, ‘Kidney Cancer (Renal Cell Cancer) - Pipeline Review, H1 2016’, provides an overview of the Kidney Cancer (Renal Cell Cancer) pipeline landscape.

    The report provides comprehensive information on the therapeutics...

  • Market Report
  • Life Sciences
  • Global
  • $2,500.00
  • Report 05IB-GMDHC8161IDB has a star rating of 4.9 out of 5
  • Go to More information on Report 05IB-GMDHC8161IDB
  • View Report: Research and Experts Market Report: Arterial Calcification - Pipeline Review, H1 2016

    Arterial Calcification - Pipeline Review, H1 2016


    2016-05-31
    Global Markets Direct’s, ‘Arterial Calcification - Pipeline Review, H1 2016’, provides an overview of the Arterial Calcification pipeline landscape.

    The report provides comprehensive information on the therapeutics under development for...

  • Market Report
  • Life Sciences
  • Global
  • $2,000.00
  • Report 05IB-GMDHC8149IDB has a star rating of 4.2 out of 5
  • Go to More information on Report 05IB-GMDHC8149IDB
  • View Report: Research and Experts Market Report: Hypertension - Pipeline Review, H1 2016

    Hypertension - Pipeline Review, H1 2016


    2016-06-08
    Global Markets Direct’s, ‘Hypertension - Pipeline Review, H1 2016’, provides an overview of the Hypertension pipeline landscape.

    The report provides comprehensive information on the therapeutics under development for Hypertension, complete...

  • Market Report
  • Life Sciences
  • Global
  • $2,000.00
  • Report 05IB-GMDHC7972IDB has a star rating of 4.9 out of 5
  • Go to More information on Report 05IB-GMDHC7972IDB
  • View Report: Research and Experts Market Report: Metastatic Breast Cancer - Pipeline Review, H1 2016

    Metastatic Breast Cancer - Pipeline Review, H1 2016


    2016-05-31
    Global Markets Direct’s, ‘Metastatic Breast Cancer - Pipeline Review, H1 2016’, provides an overview of the Metastatic Breast Cancer pipeline landscape.

    The report provides comprehensive information on the therapeutics under development...

  • Market Report
  • Life Sciences
  • Global
  • $2,000.00
  • Report 05IB-GMDHC7968IDB has a star rating of 4.9 out of 5
  • Go to More information on Report 05IB-GMDHC7968IDB
  • View Report: Research and Experts Market Report: Type 1 diabetes (Juvenile Diabetes) - Pipeline Review, H1 2016

    Type 1 diabetes (Juvenile Diabetes) - Pipeline Review, H1 2016


    2016-06-08
    Global Markets Direct’s, ‘Type 1 Diabetes (Juvenile Diabetes) - Pipeline Review, H1 2016’, provides an overview of the Type 1 Diabetes (Juvenile Diabetes) pipeline landscape.

    The report provides comprehensive information on the therapeutics...

  • Market Report
  • Life Sciences
  • Global
  • $2,000.00
  • Report 05IB-GMDHC7967IDB has a star rating of 4.9 out of 5
  • Go to More information on Report 05IB-GMDHC7967IDB
  • View Report: Research and Experts Market Report: Prostaglandin E2 Receptor EP2 Subtype (Prostanoid EP2 Receptor or PTGER2) - Pipeline Review, H1 2016

    Prostaglandin E2 Receptor EP2 Subtype (Prostanoid EP2 Receptor or PTGER2) - Pipeline Review, H1 2016


    2016-05-31
    Global Markets Direct’s, ‘Prostaglandin E2 Receptor EP2 Subtype (Prostanoid EP2 Receptor or PTGER2) - Pipeline Review, H1 2016’, provides in depth analysis on Prostaglandin E2 Receptor EP2 Subtype (Prostanoid EP2 Receptor or PTGER2) targeted...
  • Market Report
  • Life Sciences
  • Global
  • $3,500.00
  • Report 05IB-GMDHC0093TDB has a star rating of 4.2 out of 5
  • Go to More information on Report 05IB-GMDHC0093TDB
  • View Report: Research and Experts Market Report: Pontine Glioma - Pipeline Review, H1 2016

    Pontine Glioma - Pipeline Review, H1 2016


    2016-05-31
    Global Markets Direct’s, ‘Pontine Glioma - Pipeline Review, H1 2016’, provides an overview of the Pontine Glioma pipeline landscape.

    The report provides comprehensive information on the therapeutics under development for Pontine Glioma,...

  • Market Report
  • Life Sciences
  • Global
  • $2,000.00
  • Report 05IB-GMDHC8116IDB has a star rating of 4.3 out of 5
  • Go to More information on Report 05IB-GMDHC8116IDB
  • View Report: Research and Experts Market Report: Chronic Lymphocytic Leukemia (CLL) - Pipeline Review, H1 2016

    Chronic Lymphocytic Leukemia (CLL) - Pipeline Review, H1 2016


    2016-05-31
    Global Markets Direct’s, ‘Chronic Lymphocytic Leukemia (CLL) - Pipeline Review, H1 2016’, provides an overview of the Chronic Lymphocytic Leukemia (CLL) pipeline landscape.

    The report provides comprehensive information on the therapeutics...

  • Market Report
  • Life Sciences
  • Global
  • $2,000.00
  • Report 05IB-GMDHC7977IDB has a star rating of 5.0 out of 5
  • Go to More information on Report 05IB-GMDHC7977IDB
  • View Report: Research and Experts Market Report: Non-Hodgkin Lymphoma - Pipeline Review, H1 2016

    Non-Hodgkin Lymphoma - Pipeline Review, H1 2016


    2016-05-31
    Global Markets Direct’s, ‘Non-Hodgkin Lymphoma - Pipeline Review, H1 2016’, provides an overview of the Non-Hodgkin Lymphoma pipeline landscape.

    The report provides comprehensive information on the therapeutics under development for Non-Hodgkin...

  • Market Report
  • Life Sciences
  • Global
  • $2,000.00
  • Report 05IB-GMDHC7970IDB has a star rating of 5.0 out of 5
  • Go to More information on Report 05IB-GMDHC7970IDB
  • View Report: Research and Experts Market Report: Testicular Cancer Global Clinical Trials Review, H1, 2016

    Testicular Cancer Global Clinical Trials Review, H1, 2016


    2016-05-19
    GlobalData's clinical trial report, “Testicular Cancer Global Clinical Trials Review, H1, 2016" provides an overview of Testicular Cancer clinical trials scenario. This report provides top line data relating to the clinical trials on Testicular...
  • Market Report
  • Life Sciences
  • Global
  • $2,500.00
  • Report 05IC-GDHC3408CTIDB has a star rating of 4.6 out of 5
  • Go to More information on Report 05IC-GDHC3408CTIDB
  • View Report: Research and Experts Market Report: Fallopian Tube Cancer Global Clinical Trials Review, H1, 2016

    Fallopian Tube Cancer Global Clinical Trials Review, H1, 2016


    2016-05-19
    GlobalData's clinical trial report, “Fallopian Tube Cancer Global Clinical Trials Review, H1, 2016" provides an overview of Fallopian Tube Cancer clinical trials scenario. This report provides top line data relating to the clinical trials...
  • Market Report
  • Life Sciences
  • Global
  • $2,500.00
  • Report 05IC-GDHC3407CTIDB has a star rating of 4.9 out of 5
  • Go to More information on Report 05IC-GDHC3407CTIDB
  • View Report: Research and Experts Market Report: Gallbladder Cancer Global Clinical Trials Review, H1, 2016

    Gallbladder Cancer Global Clinical Trials Review, H1, 2016


    2016-05-19
    GlobalData's clinical trial report, “Gallbladder Cancer Global Clinical Trials Review, H1, 2016" provides an overview of Gallbladder Cancer clinical trials scenario. This report provides top line data relating to the clinical trials on...
  • Market Report
  • Life Sciences
  • Global
  • $2,500.00
  • Report 05IC-GDHC3406CTIDB has a star rating of 4.7 out of 5
  • Go to More information on Report 05IC-GDHC3406CTIDB
  • View Report: Research and Experts Market Report: Esophageal Cancer Global Clinical Trials Review, H1, 2016

    Esophageal Cancer Global Clinical Trials Review, H1, 2016


    2016-05-19
    GlobalData's clinical trial report, “Esophageal Cancer Global Clinical Trials Review, H1, 2016" provides an overview of Esophageal Cancer clinical trials scenario. This report provides top line data relating to the clinical trials on Esophageal...
  • Market Report
  • Life Sciences
  • Global
  • $2,500.00
  • Report 05IC-GDHC3405CTIDB has a star rating of 4.9 out of 5
  • Go to More information on Report 05IC-GDHC3405CTIDB
  • View Report: Research and Experts Market Report: Ovarian Cancer Global Clinical Trials Review, H1, 2016

    Ovarian Cancer Global Clinical Trials Review, H1, 2016


    2016-05-19
    GlobalData's clinical trial report, “Ovarian Cancer Global Clinical Trials Review, H1, 2016" provides an overview of Ovarian Cancer clinical trials scenario. This report provides top line data relating to the clinical trials on Ovarian...
  • Market Report
  • Life Sciences
  • Global
  • $2,500.00
  • Report 05IC-GDHC3404CTIDB has a star rating of 4.9 out of 5
  • Go to More information on Report 05IC-GDHC3404CTIDB
  • View Report: Research and Experts Market Report: Uterine Cancer Global Clinical Trials Review, H1, 2016

    Uterine Cancer Global Clinical Trials Review, H1, 2016


    2016-05-19
    GlobalData's clinical trial report, “Uterine Cancer Global Clinical Trials Review, H1, 2016" provides an overview of Uterine Cancer clinical trials scenario. This report provides top line data relating to the clinical trials on Uterine...
  • Market Report
  • Life Sciences
  • Global
  • $2,500.00
  • Report 05IC-GDHC3403CTIDB has a star rating of 4.9 out of 5
  • Go to More information on Report 05IC-GDHC3403CTIDB
  • View Report: Research and Experts Market Report: Gastric Cancer Global Clinical Trials Review, H1, 2016

    Gastric Cancer Global Clinical Trials Review, H1, 2016


    2016-05-19
    GlobalData's clinical trial report, “Gastric Cancer Global Clinical Trials Review, H1, 2016" provides an overview of Gastric Cancer clinical trials scenario. This report provides top line data relating to the clinical trials on Gastric...
  • Market Report
  • Life Sciences
  • Global
  • $2,500.00
  • Report 05IC-GDHC3402CTIDB has a star rating of 4.9 out of 5
  • Go to More information on Report 05IC-GDHC3402CTIDB
  • View Report: Research and Experts Market Report: Cervical Cancer Global Clinical Trials Review, H1, 2016

    Cervical Cancer Global Clinical Trials Review, H1, 2016


    2016-05-19
    GlobalData's clinical trial report, “Cervical Cancer Global Clinical Trials Review, H1, 2016" provides an overview of Cervical Cancer clinical trials scenario. This report provides top line data relating to the clinical trials on Cervical...
  • Market Report
  • Life Sciences
  • Global
  • $2,500.00
  • Report 05IC-GDHC3401CTIDB has a star rating of 4.9 out of 5
  • Go to More information on Report 05IC-GDHC3401CTIDB
  • View Report: Research and Experts Market Report: Peritoneal Cancer Global Clinical Trials Review, H1, 2016

    Peritoneal Cancer Global Clinical Trials Review, H1, 2016


    2016-05-19
    GlobalData's clinical trial report, “Peritoneal Cancer Global Clinical Trials Review, H1, 2016" provides an overview of Peritoneal Cancer clinical trials scenario. This report provides top line data relating to the clinical trials on Peritoneal...
  • Market Report
  • Life Sciences
  • Global
  • $2,500.00
  • Report 05IC-GDHC3400CTIDB has a star rating of 4.9 out of 5
  • Go to More information on Report 05IC-GDHC3400CTIDB
  • View Report: Research and Experts Market Report: Endometrial Cancer Global Clinical Trials Review, H1, 2016

    Endometrial Cancer Global Clinical Trials Review, H1, 2016


    2016-05-19
    GlobalData's clinical trial report, “Endometrial Cancer Global Clinical Trials Review, H1, 2016" provides an overview of Endometrial Cancer clinical trials scenario. This report provides top line data relating to the clinical trials on...
  • Market Report
  • Life Sciences
  • Global
  • $2,500.00
  • Report 05IC-GDHC3399CTIDB has a star rating of 4.9 out of 5
  • Go to More information on Report 05IC-GDHC3399CTIDB
  • View Report: Research and Experts Market Report: Burkitt Lymphoma Global Clinical Trials Review, H1, 2016

    Burkitt Lymphoma Global Clinical Trials Review, H1, 2016


    2016-05-19
    GlobalData's clinical trial report, “Burkitt Lymphoma Global Clinical Trials Review, H1, 2016" provides an overview of Burkitt Lymphoma clinical trials scenario. This report provides top line data relating to the clinical trials on Burkitt...
  • Market Report
  • Life Sciences
  • Global
  • $2,500.00
  • Report 05IC-GDHC3397CTIDB has a star rating of 4.8 out of 5
  • Go to More information on Report 05IC-GDHC3397CTIDB
  • View Report: Research and Experts Market Report: Thyroid Cancer Global Clinical Trials Review, H1, 2016

    Thyroid Cancer Global Clinical Trials Review, H1, 2016


    2016-05-19
    GlobalData's clinical trial report, “Thyroid Cancer Global Clinical Trials Review, H1, 2016" provides an overview of Thyroid Cancer clinical trials scenario. This report provides top line data relating to the clinical trials on Thyroid...
  • Market Report
  • Life Sciences
  • Global
  • $2,500.00
  • Report 05IC-GDHC3396CTIDB has a star rating of 4.9 out of 5
  • Go to More information on Report 05IC-GDHC3396CTIDB
  • View Report: Research and Experts Market Report: Hyperparathyroidism Global Clinical Trials Review, H1, 2016

    Hyperparathyroidism Global Clinical Trials Review, H1, 2016


    2016-05-19
    GlobalData's clinical trial report, “Hyperparathyroidism Global Clinical Trials Review, H1, 2016" provides an overview of Hyperparathyroidism clinical trials scenario. This report provides top line data relating to the clinical trials on...
  • Market Report
  • Life Sciences
  • Global
  • $2,500.00
  • Report 05IC-GDHC3391CTIDB has a star rating of 4.8 out of 5
  • Go to More information on Report 05IC-GDHC3391CTIDB
  • View Report: Research and Experts Market Report: Diabetic Foot Ulcers - Pipeline Review, H1 2016

    Diabetic Foot Ulcers - Pipeline Review, H1 2016


    2016-05-25
    Global Markets Direct’s, ‘Diabetic Foot Ulcers - Pipeline Review, H1 2016’, provides an overview of the Diabetic Foot Ulcers pipeline landscape.

    The report provides comprehensive information on the therapeutics under development for Diabetic...

  • Market Report
  • Life Sciences
  • Global
  • $2,000.00
  • Report 05IB-GMDHC8021IDB has a star rating of 4.8 out of 5
  • Go to More information on Report 05IB-GMDHC8021IDB
  • View Report: Research and Experts Market Report: Metastatic Hormone Refractory (Castration Resistant, Androgen-Independent) Prostate Cancer - Pipeline Review, H1 2016

    Metastatic Hormone Refractory (Castration Resistant, Androgen-Independent) Prostate Cancer - Pipeline Review, H1 2016


    2016-05-25
    Global Markets Direct’s, ‘Metastatic Hormone Refractory (Castration Resistant, Androgen-Independent) Prostate Cancer - Pipeline Review, H1 2016’, provides an overview of the Metastatic Hormone Refractory (Castration Resistant, Androgen-Independent)...
  • Market Report
  • Life Sciences
  • Global
  • $2,000.00
  • Report 05IB-GMDHC8003IDB has a star rating of 4.9 out of 5
  • Go to More information on Report 05IB-GMDHC8003IDB
  • View Report: Research and Experts Market Report: Epithelial Ovarian Cancer - Pipeline Review, H1 2016

    Epithelial Ovarian Cancer - Pipeline Review, H1 2016


    2016-05-25
    Global Markets Direct’s, ‘Epithelial Ovarian Cancer - Pipeline Review, H1 2016’, provides an overview of the Epithelial Ovarian Cancer pipeline landscape.

    The report provides comprehensive information on the therapeutics under development...

  • Market Report
  • Life Sciences
  • Global
  • $2,000.00
  • Report 05IB-GMDHC8000IDB has a star rating of 5.0 out of 5
  • Go to More information on Report 05IB-GMDHC8000IDB
  • View Report: Research and Experts Market Report: Chronic Myelocytic Leukemia (CML, Chronic Myeloid Leukemia) - Pipeline Review, H1 2016

    Chronic Myelocytic Leukemia (CML, Chronic Myeloid Leukemia) - Pipeline Review, H1 2016


    2016-05-25
    Global Markets Direct’s, ‘Chronic Myelocytic Leukemia (CML, Chronic Myeloid Leukemia) - Pipeline Review, H1 2016’, provides an overview of the Chronic Myelocytic Leukemia (CML, Chronic Myeloid Leukemia) pipeline landscape.

    The report...

  • Market Report
  • Life Sciences
  • Global
  • $2,000.00
  • Report 05IB-GMDHC7997IDB has a star rating of 4.9 out of 5
  • Go to More information on Report 05IB-GMDHC7997IDB
  • View Report: Research and Experts Market Report: Cervical Cancer - Pipeline Review, H1 2016

    Cervical Cancer - Pipeline Review, H1 2016


    2016-05-25
    Global Markets Direct’s, ‘Cervical Cancer - Pipeline Review, H1 2016’, provides an overview of the Cervical Cancer pipeline landscape.

    The report provides comprehensive information on the therapeutics under development for Cervical Cancer,...

  • Market Report
  • Life Sciences
  • Global
  • $2,000.00
  • Report 05IB-GMDHC7994IDB has a star rating of 4.9 out of 5
  • Go to More information on Report 05IB-GMDHC7994IDB
  • View Report: Research and Experts Company Report: Midatech Pharma US Inc - Strategic SWOT Analysis Review

    Midatech Pharma US Inc - Strategic SWOT Analysis Review


    2017-02-08
    Midatech Pharma US Inc (Midatech Pharma), formerly DARA BioSciences, Inc., is a pharmaceutical company which focuses on the development and commercialization of cancer treatment and supportive care products. The company’s product portfolio includes...
  • Company Report
  • Life Sciences
  • United States
  • $125.00
  • Report 05IC-GDPH82132SA has a star rating of 4.1 out of 5
  • Go to More information on Report 05IC-GDPH82132SA
  • View Report: Research and Experts Market Report: Stearoyl-CoA Desaturase 1 (SCD-1 or EC1.14.19.1) - Pipeline Review, H1 2016

    Stearoyl-CoA Desaturase 1 (SCD-1 or EC1.14.19.1) - Pipeline Review, H1 2016


    2016-05-18
    Global Markets Direct’s, ‘Stearoyl-CoA Desaturase 1 (SCD-1 or EC1.14.19.1) - Pipeline Review, H1 2016’, provides in depth analysis on Stearoyl-CoA Desaturase 1 (SCD-1 or EC1.14.19.1) targeted pipeline therapeutics.

    The report provides...

  • Market Report
  • Life Sciences
  • Global
  • $3,500.00
  • Report 05IB-GMDHC0038TDB has a star rating of 4.2 out of 5
  • Go to More information on Report 05IB-GMDHC0038TDB
  • View Report: Research and Experts Market Report: Lysophosphatidic Acid Receptor 1 (Lysophosphatidic Acid Receptor Edg-2 or LPAR1 or EDG2 or LPA1) - Pipeline Review, H1 2016

    Lysophosphatidic Acid Receptor 1 (Lysophosphatidic Acid Receptor Edg-2 or LPAR1 or EDG2 or LPA1) - Pipeline Review, H1 2016


    2016-05-18
    Global Markets Direct’s, ‘Lysophosphatidic Acid Receptor 1 (Lysophosphatidic Acid Receptor Edg-2 or LPAR1 or EDG2 or LPA1) - Pipeline Review, H1 2016’, provides in depth analysis on Lysophosphatidic Acid Receptor 1 (Lysophosphatidic Acid...
  • Market Report
  • Life Sciences
  • Global
  • $3,500.00
  • Report 05IB-GMDHC0029TDB has a star rating of 4.3 out of 5
  • Go to More information on Report 05IB-GMDHC0029TDB
  • View Report: Research and Experts Market Report: Adenocarcinoma Of The Gastroesophageal Junction - Pipeline Review, H1 2016

    Adenocarcinoma Of The Gastroesophageal Junction - Pipeline Review, H1 2016


    2016-05-18
    Global Markets Direct’s, ‘Adenocarcinoma Of The Gastroesophageal Junction - Pipeline Review, H1 2016’, provides an overview of the Adenocarcinoma Of The Gastroesophageal Junction pipeline landscape.

    The report provides comprehensive information...

  • Market Report
  • Life Sciences
  • Global
  • $2,000.00
  • Report 05IB-GMDHC8024IDB has a star rating of 4.8 out of 5
  • Go to More information on Report 05IB-GMDHC8024IDB
  • View Report: Research and Experts Market Report: Refractory Chronic Lymphocytic Leukemia (CLL) - Pipeline Review, H1 2016

    Refractory Chronic Lymphocytic Leukemia (CLL) - Pipeline Review, H1 2016


    2016-05-18
    Global Markets Direct’s, ‘Refractory Chronic Lymphocytic Leukemia (CLL) - Pipeline Review, H1 2016’, provides an overview of the Refractory Chronic Lymphocytic Leukemia (CLL) pipeline landscape.

    The report provides comprehensive information...

  • Market Report
  • Life Sciences
  • Global
  • $2,000.00
  • Report 05IB-GMDHC8019IDB has a star rating of 4.8 out of 5
  • Go to More information on Report 05IB-GMDHC8019IDB
  • View Report: Research and Experts Market Report: Relapsed Chronic Lymphocytic Leukemia (CLL) - Pipeline Review, H1 2016

    Relapsed Chronic Lymphocytic Leukemia (CLL) - Pipeline Review, H1 2016


    2016-05-18
    Global Markets Direct’s, ‘Relapsed Chronic Lymphocytic Leukemia (CLL) - Pipeline Review, H1 2016’, provides an overview of the Relapsed Chronic Lymphocytic Leukemia (CLL) pipeline landscape.

    The report provides comprehensive information...

  • Market Report
  • Life Sciences
  • Global
  • $2,000.00
  • Report 05IB-GMDHC8017IDB has a star rating of 4.8 out of 5
  • Go to More information on Report 05IB-GMDHC8017IDB
  • View Report: Research and Experts Market Report: Endometrial Cancer - Pipeline Review, H1 2016

    Endometrial Cancer - Pipeline Review, H1 2016


    2016-05-18
    Global Markets Direct’s, ‘Endometrial Cancer - Pipeline Review, H1 2016’, provides an overview of the Endometrial Cancer pipeline landscape.

    The report provides comprehensive information on the therapeutics under development for Endometrial...

  • Market Report
  • Life Sciences
  • Global
  • $2,000.00
  • Report 05IB-GMDHC8014IDB has a star rating of 4.9 out of 5
  • Go to More information on Report 05IB-GMDHC8014IDB
  • View Report: Research and Experts Market Report: Tuberculosis - Pipeline Review, H1 2016

    Tuberculosis - Pipeline Review, H1 2016


    2016-05-18
    Global Markets Direct’s, ‘Tuberculosis - Pipeline Review, H1 2016’, provides an overview of the Tuberculosis pipeline landscape.

    The report provides comprehensive information on the therapeutics under development for Tuberculosis, complete...

  • Market Report
  • Life Sciences
  • Global
  • $2,000.00
  • Report 05IB-GMDHC7976IDB has a star rating of 4.9 out of 5
  • Go to More information on Report 05IB-GMDHC7976IDB
  • View Report: Research and Experts Market Report: Malaria - Pipeline Review, H1 2016

    Malaria - Pipeline Review, H1 2016


    2016-05-18
    Global Markets Direct’s, ‘Malaria - Pipeline Review, H1 2016’, provides an overview of the Malaria pipeline landscape.

    The report provides comprehensive information on the therapeutics under development for Malaria, complete with analysis...

  • Market Report
  • Life Sciences
  • Global
  • $2,000.00
  • Report 05IB-GMDHC7969IDB has a star rating of 4.9 out of 5
  • Go to More information on Report 05IB-GMDHC7969IDB
  • View Report: Research and Experts Market Report: Systemic Lupus Erythematosus - Pipeline Review, H1 2016

    Systemic Lupus Erythematosus - Pipeline Review, H1 2016


    2016-05-11
    Global Markets Direct’s, ‘Systemic Lupus Erythematosus - Pipeline Review, H1 2016’, provides an overview of the Systemic Lupus Erythematosus pipeline landscape.

    The report provides comprehensive information on the therapeutics under development...

  • Market Report
  • Life Sciences
  • Global
  • $2,000.00
  • Report 05IB-GMDHC7998IDB has a star rating of 4.9 out of 5
  • Go to More information on Report 05IB-GMDHC7998IDB
  • View Report: Research and Experts Market Report: Head And Neck Cancer Squamous Cell Carcinoma - Pipeline Review, H1 2016

    Head And Neck Cancer Squamous Cell Carcinoma - Pipeline Review, H1 2016


    2016-05-11
    Global Markets Direct’s, ‘Head And Neck Cancer Squamous Cell Carcinoma - Pipeline Review, H1 2016’, provides an overview of the Head And Neck Cancer Squamous Cell Carcinoma pipeline landscape.

    The report provides comprehensive information...

  • Market Report
  • Life Sciences
  • Global
  • $2,000.00
  • Report 05IB-GMDHC7988IDB has a star rating of 4.9 out of 5
  • Go to More information on Report 05IB-GMDHC7988IDB
  • View Report: Research and Experts Market Report: Acute Lymphocytic Leukemia (ALL, Acute Lymphoblastic Leukemia) - Pipeline Review, H1 2016

    Acute Lymphocytic Leukemia (ALL, Acute Lymphoblastic Leukemia) - Pipeline Review, H1 2016


    2016-05-11
    Global Markets Direct’s, ‘Acute Lymphocytic Leukemia (ALL, Acute Lymphoblastic Leukemia) - Pipeline Review, H1 2016’, provides an overview of the Acute Lymphocytic Leukemia (ALL, Acute Lymphoblastic Leukemia) pipeline landscape.

    The report...

  • Market Report
  • Life Sciences
  • Global
  • $2,000.00
  • Report 05IB-GMDHC7978IDB has a star rating of 4.9 out of 5
  • Go to More information on Report 05IB-GMDHC7978IDB
  • View Report: Research and Experts Market Report: B-Cell Non-Hodgkin Lymphoma - Pipeline Review, H1 2016

    B-Cell Non-Hodgkin Lymphoma - Pipeline Review, H1 2016


    2016-04-30
    Global Markets Direct’s, ‘B-Cell Non-Hodgkin Lymphoma - Pipeline Review, H1 2016’, provides an overview of the B-Cell Non-Hodgkin Lymphoma pipeline landscape.

    The report provides comprehensive information on the therapeutics under development...

  • Market Report
  • Life Sciences
  • Global
  • $2,000.00
  • Report 05IB-GMDHC7687IDB has a star rating of 4.9 out of 5
  • Go to More information on Report 05IB-GMDHC7687IDB
  • View Report: Research and Experts Market Report: Myelofibrosis Global Clinical Trials Review, H1, 2016

    Myelofibrosis Global Clinical Trials Review, H1, 2016


    2016-04-30
    GlobalData's clinical trial report, “Myelofibrosis Global Clinical Trials Review, H1, 2016" provides an overview of Myelofibrosis clinical trials scenario. This report provides top line data relating to the clinical trials on Myelofibrosis....
  • Market Report
  • Life Sciences
  • Global
  • $2,500.00
  • Report 05IC-GDHC3385CTIDB has a star rating of 4.9 out of 5
  • Go to More information on Report 05IC-GDHC3385CTIDB
  • View Report: Research and Experts Market Report: Encephalitis Global Clinical Trials Review, H1, 2016

    Encephalitis Global Clinical Trials Review, H1, 2016


    2016-04-30
    GlobalData's clinical trial report, “Encephalitis Global Clinical Trials Review, H1, 2016" provides an overview of Encephalitis clinical trials scenario. This report provides top line data relating to the clinical trials on Encephalitis....
  • Market Report
  • Life Sciences
  • Global
  • $2,500.00
  • Report 05IC-GDHC3382CTIDB has a star rating of 4.6 out of 5
  • Go to More information on Report 05IC-GDHC3382CTIDB
  • View Report: Research and Experts Market Report: Osteopenia Global Clinical Trials Review, H1, 2016

    Osteopenia Global Clinical Trials Review, H1, 2016


    2016-04-30
    GlobalData's clinical trial report, “Osteopenia Global Clinical Trials Review, H1, 2016" provides an overview of Osteopenia clinical trials scenario. This report provides top line data relating to the clinical trials on Osteopenia. Report...
  • Market Report
  • Life Sciences
  • Global
  • $2,500.00
  • Report 05IC-GDHC3379CTIDB has a star rating of 4.6 out of 5
  • Go to More information on Report 05IC-GDHC3379CTIDB
  • View Report: Research and Experts Market Report: Osteoporosis Global Clinical Trials Review, H1, 2016

    Osteoporosis Global Clinical Trials Review, H1, 2016


    2016-04-30
    GlobalData's clinical trial report, “Osteoporosis Global Clinical Trials Review, H1, 2016" provides an overview of Osteoporosis clinical trials scenario. This report provides top line data relating to the clinical trials on Osteoporosis....
  • Market Report
  • Life Sciences
  • Global
  • $2,500.00
  • Report 05IC-GDHC3378CTIDB has a star rating of 4.9 out of 5
  • Go to More information on Report 05IC-GDHC3378CTIDB
  • View Report: Research and Experts Market Report: Urinary Retention Global Clinical Trials Review, H1, 2016

    Urinary Retention Global Clinical Trials Review, H1, 2016


    2016-04-30
    GlobalData's clinical trial report, “Urinary Retention Global Clinical Trials Review, H1, 2016" provides an overview of Urinary Retention clinical trials scenario. This report provides top line data relating to the clinical trials on Urinary...
  • Market Report
  • Life Sciences
  • Global
  • $2,500.00
  • Report 05IC-GDHC3376CTIDB has a star rating of 4.2 out of 5
  • Go to More information on Report 05IC-GDHC3376CTIDB
  • View Report: Research and Experts Market Report: Duchenne Muscular Dystrophy Global Clinical Trials Review, H1, 2016

    Duchenne Muscular Dystrophy Global Clinical Trials Review, H1, 2016


    2016-04-30
    GlobalData's clinical trial report, “Duchenne Muscular Dystrophy Global Clinical Trials Review, H1, 2016" provides an overview of Duchenne Muscular Dystrophy clinical trials scenario. This report provides top line data relating to the clinical...
  • Market Report
  • Life Sciences
  • Global
  • $2,500.00
  • Report 05IC-GDHC3373CTIDB has a star rating of 4.6 out of 5
  • Go to More information on Report 05IC-GDHC3373CTIDB
  • View Report: Research and Experts Market Report: Bladder Cancer - Pipeline Review, H1 2016

    Bladder Cancer - Pipeline Review, H1 2016


    2016-04-30
    Global Markets Direct’s, ‘Bladder Cancer - Pipeline Review, H1 2016’, provides an overview of the Bladder Cancer pipeline landscape.

    The report provides comprehensive information on the therapeutics under development for Bladder Cancer,...

  • Market Report
  • Life Sciences
  • Global
  • $2,000.00
  • Report 05IB-GMDHC7982IDB has a star rating of 4.9 out of 5
  • Go to More information on Report 05IB-GMDHC7982IDB
  • View Report: Research and Experts Market Report: Obesity - Pipeline Review, H1 2016

    Obesity - Pipeline Review, H1 2016


    2016-04-30
    Global Markets Direct’s, ‘Obesity - Pipeline Review, H1 2016’, provides an overview of the Obesity pipeline landscape.

    The report provides comprehensive information on the therapeutics under development for Obesity, complete with analysis...

  • Market Report
  • Life Sciences
  • Global
  • $2,000.00
  • Report 05IB-GMDHC7684IDB has a star rating of 5.0 out of 5
  • Go to More information on Report 05IB-GMDHC7684IDB
  • View Report: Research and Experts Market Report: Gastric Inhibitory Polypeptide Receptor (GIP-R or Glucose-Dependent Insulinotropic Polypeptide Receptor or GIPR) - Pipeline Review,...

    Gastric Inhibitory Polypeptide Receptor (GIP-R or Glucose-Dependent Insulinotropic Polypeptide Receptor or GIPR) - Pipeline Review, H1 2016


    2016-04-27
    Global Markets Direct’s, ‘Gastric Inhibitory Polypeptide Receptor (GIP-R or Glucose-Dependent Insulinotropic Polypeptide Receptor or GIPR) - Pipeline Review, H1 2016’, provides in depth analysis on Gastric Inhibitory Polypeptide Receptor...
  • Market Report
  • Life Sciences
  • Global
  • $3,500.00
  • Report 05IB-GMDHC0004TDB has a star rating of 4.2 out of 5
  • Go to More information on Report 05IB-GMDHC0004TDB
  • View Report: Research and Experts Market Report: Narcolepsy - Pipeline Review, H1 2016

    Narcolepsy - Pipeline Review, H1 2016


    2016-04-27
    Global Markets Direct’s, ‘Narcolepsy - Pipeline Review, H1 2016’, provides an overview of the Narcolepsy pipeline landscape.

    The report provides comprehensive information on the therapeutics under development for Narcolepsy, complete...

  • Market Report
  • Life Sciences
  • Global
  • $2,000.00
  • Report 05IB-GMDHC7878IDB has a star rating of 4.3 out of 5
  • Go to More information on Report 05IB-GMDHC7878IDB
  • View Report: Research and Experts Market Report: Angina (Angina Pectoris) - Pipeline Review, H1 2016

    Angina (Angina Pectoris) - Pipeline Review, H1 2016


    2016-04-27
    Global Markets Direct’s, ‘Angina (Angina Pectoris) - Pipeline Review, H1 2016’, provides an overview of the Angina (Angina Pectoris) pipeline landscape.

    The report provides comprehensive information on the therapeutics under development...

  • Market Report
  • Life Sciences
  • Global
  • $2,000.00
  • Report 05IB-GMDHC7876IDB has a star rating of 4.5 out of 5
  • Go to More information on Report 05IB-GMDHC7876IDB
  • View Report: Research and Experts Market Report: Sickle Cell Disease - Pipeline Review, H1 2016

    Sickle Cell Disease - Pipeline Review, H1 2016


    2016-04-27
    Global Markets Direct’s, ‘Sickle Cell Disease - Pipeline Review, H1 2016’, provides an overview of the Sickle Cell Disease pipeline landscape.

    The report provides comprehensive information on the therapeutics under development for Sickle...

  • Market Report
  • Life Sciences
  • Global
  • $2,000.00
  • Report 05IB-GMDHC7824IDB has a star rating of 4.8 out of 5
  • Go to More information on Report 05IB-GMDHC7824IDB
  • View Report: Research and Experts Market Report: Idiopathic Pulmonary Fibrosis - Pipeline Review, H1 2016

    Idiopathic Pulmonary Fibrosis - Pipeline Review, H1 2016


    2016-04-27
    Global Markets Direct’s, ‘Idiopathic Pulmonary Fibrosis - Pipeline Review, H1 2016’, provides an overview of the Idiopathic Pulmonary Fibrosis pipeline landscape.

    The report provides comprehensive information on the therapeutics under...

  • Market Report
  • Life Sciences
  • Global
  • $2,000.00
  • Report 05IB-GMDHC7818IDB has a star rating of 4.9 out of 5
  • Go to More information on Report 05IB-GMDHC7818IDB
  • View Report: Research and Experts Market Report: Gastric Cancer - Pipeline Review, H1 2016

    Gastric Cancer - Pipeline Review, H1 2016


    2016-04-27
    Global Markets Direct’s, ‘Gastric Cancer - Pipeline Review, H1 2016’, provides an overview of the Gastric Cancer pipeline landscape.

    The report provides comprehensive information on the therapeutics under development for Gastric Cancer,...

  • Market Report
  • Life Sciences
  • Global
  • $2,000.00
  • Report 05IB-GMDHC7815IDB has a star rating of 4.9 out of 5
  • Go to More information on Report 05IB-GMDHC7815IDB
  • View Report: Research and Experts Market Report: Head and neck Cancer - Pipeline Review, H1 2016

    Head and neck Cancer - Pipeline Review, H1 2016


    2016-04-27
    Global Markets Direct’s, ‘Head And Neck Cancer - Pipeline Review, H1 2016’, provides an overview of the Head And Neck Cancer pipeline landscape.

    The report provides comprehensive information on the therapeutics under development for Head...

  • Market Report
  • Life Sciences
  • Global
  • $2,500.00
  • Report 05IB-GMDHC7685IDB has a star rating of 4.9 out of 5
  • Go to More information on Report 05IB-GMDHC7685IDB
  • View Report: Research and Experts Market Report: Type 2 Diabetes - Pipeline Review, H1 2016

    Type 2 Diabetes - Pipeline Review, H1 2016


    2016-04-27
    Global Markets Direct’s, ‘Type 2 Diabetes - Pipeline Review, H1 2016’, provides an overview of the Type 2 Diabetes pipeline landscape.

    The report provides comprehensive information on the therapeutics under development for Type 2 Diabetes,...

  • Market Report
  • Life Sciences
  • Global
  • $2,500.00
  • Report 05IB-GMDHC7682IDB has a star rating of 5.0 out of 5
  • Go to More information on Report 05IB-GMDHC7682IDB
  • View Report: Research and Experts Market Report: Gaucher Disease Global Clinical Trials Review, H1, 2016

    Gaucher Disease Global Clinical Trials Review, H1, 2016


    2016-04-20
    GlobalData's clinical trial report, “Gaucher Disease Global Clinical Trials Review, H1, 2016" provides an overview of Gaucher Disease clinical trials scenario. This report provides top line data relating to the clinical trials on Gaucher...
  • Market Report
  • Life Sciences
  • Global
  • $2,500.00
  • Report 05IC-GDHC3368CTIDB has a star rating of 4.3 out of 5
  • Go to More information on Report 05IC-GDHC3368CTIDB
  • View Report: Research and Experts Market Report: Typhoid Fever Global Clinical Trials Review, H1, 2016

    Typhoid Fever Global Clinical Trials Review, H1, 2016


    2016-04-20
    GlobalData's clinical trial report, “Typhoid Fever Global Clinical Trials Review, H1, 2016" provides an overview of Typhoid Fever clinical trials scenario. This report provides top line data relating to the clinical trials on Typhoid Fever....
  • Market Report
  • Life Sciences
  • Global
  • $2,500.00
  • Report 05IC-GDHC3367CTIDB has a star rating of 4.2 out of 5
  • Go to More information on Report 05IC-GDHC3367CTIDB
  • View Report: Research and Experts Market Report: Rabies Global Clinical Trials Review, H1, 2016

    Rabies Global Clinical Trials Review, H1, 2016


    2016-04-20
    GlobalData's clinical trial report, “Rabies Global Clinical Trials Review, H1, 2016" provides an overview of Rabies clinical trials scenario. This report provides top line data relating to the clinical trials on Rabies. Report includes...
  • Market Report
  • Life Sciences
  • Global
  • $2,500.00
  • Report 05IC-GDHC3356CTIDB has a star rating of 4.2 out of 5
  • Go to More information on Report 05IC-GDHC3356CTIDB
  • View Report: Research and Experts Market Report: Gastroenteritis Global Clinical Trials Review, H1, 2016

    Gastroenteritis Global Clinical Trials Review, H1, 2016


    2016-04-20
    GlobalData's clinical trial report, “Gastroenteritis Global Clinical Trials Review, H1, 2016" provides an overview of Gastroenteritis clinical trials scenario. This report provides top line data relating to the clinical trials on Gastroenteritis...
  • Market Report
  • Life Sciences
  • Global
  • $2,500.00
  • Report 05IC-GDHC3355CTIDB has a star rating of 4.6 out of 5
  • Go to More information on Report 05IC-GDHC3355CTIDB
  • View Report: Research and Experts Market Report: Hyponatremia Global Clinical Trials Review, H1, 2016

    Hyponatremia Global Clinical Trials Review, H1, 2016


    2016-04-20
    GlobalData's clinical trial report, “Hyponatremia Global Clinical Trials Review, H1, 2016" provides an overview of Hyponatremia clinical trials scenario. This report provides top line data relating to the clinical trials on Hyponatremia....
  • Market Report
  • Life Sciences
  • Global
  • $2,500.00
  • Report 05IC-GDHC3354CTIDB has a star rating of 4.4 out of 5
  • Go to More information on Report 05IC-GDHC3354CTIDB
  • View Report: Research and Experts Market Report: Pulmonary Embolism Global Clinical Trials Review, H1, 2016

    Pulmonary Embolism Global Clinical Trials Review, H1, 2016


    2016-04-15
    GlobalData's clinical trial report, “Pulmonary Embolism Global Clinical Trials Review, H1, 2016" provides an overview of Pulmonary Embolism clinical trials scenario. This report provides top line data relating to the clinical trials on...
  • Market Report
  • Life Sciences
  • Global
  • $2,500.00
  • Report 05IC-GDHC3347CTIDB has a star rating of 4.7 out of 5
  • Go to More information on Report 05IC-GDHC3347CTIDB
  • View Report: Research and Experts Market Report: Congenital Heart Disease Global Clinical Trials Review, H1, 2016

    Congenital Heart Disease Global Clinical Trials Review, H1, 2016


    2016-04-15
    GlobalData's clinical trial report, “Congenital Heart Disease Global Clinical Trials Review, H1, 2016" provides an overview of Congenital Heart Disease clinical trials scenario. This report provides top line data relating to the clinical...
  • Market Report
  • Life Sciences
  • Global
  • $2,500.00
  • Report 05IC-GDHC3345CTIDB has a star rating of 4.7 out of 5
  • Go to More information on Report 05IC-GDHC3345CTIDB
  • View Report: Research and Experts Market Report: Otitis Media Global Clinical Trials Review, H1, 2016

    Otitis Media Global Clinical Trials Review, H1, 2016


    2016-04-15
    GlobalData's clinical trial report, “Otitis Media Global Clinical Trials Review, H1, 2016" provides an overview of Otitis Media clinical trials scenario. This report provides top line data relating to the clinical trials on Otitis Media....
  • Market Report
  • Life Sciences
  • Global
  • $2,500.00
  • Report 05IC-GDHC3343CTIDB has a star rating of 4.6 out of 5
  • Go to More information on Report 05IC-GDHC3343CTIDB
  • View Report: Research and Experts Market Report: Smallpox Global Clinical Trials Review, H1, 2016

    Smallpox Global Clinical Trials Review, H1, 2016


    2016-04-15
    GlobalData's clinical trial report, “Smallpox Global Clinical Trials Review, H1, 2016" provides an overview of Smallpox clinical trials scenario. This report provides top line data relating to the clinical trials on Smallpox. Report includes...
  • Market Report
  • Life Sciences
  • Global
  • $2,500.00
  • Report 05IC-GDHC3338CTIDB has a star rating of 4.3 out of 5
  • Go to More information on Report 05IC-GDHC3338CTIDB
  • View Report: Research and Experts Market Report: Poliomyelitis Global Clinical Trials Review, H1, 2016

    Poliomyelitis Global Clinical Trials Review, H1, 2016


    2016-04-15
    GlobalData's clinical trial report, “Poliomyelitis Global Clinical Trials Review, H1, 2016" provides an overview of Poliomyelitis clinical trials scenario. This report provides top line data relating to the clinical trials on Poliomyelitis....
  • Market Report
  • Life Sciences
  • Global
  • $2,500.00
  • Report 05IC-GDHC3336CTIDB has a star rating of 4.7 out of 5
  • Go to More information on Report 05IC-GDHC3336CTIDB
  • View Report: Research and Experts Market Report: Top Trends in Healthcare and OTC; Exploring the over-the-counter medication; vitamins, minerals and supplements; functional food...

    Top Trends in Healthcare and OTC; Exploring the over-the-counter medication; vitamins, minerals and supplements; functional food and drink; and sports nutrition categories


    2016-05-19
    The market for healthcare and OTC is primarily driven by the Health & Wellness megatrend, but manufacturers must look beyond health functionality alone to remain relevant in an ever-evolving category. Pharmaceutical, sports nutrition, and healthcare...
  • Market Report
  • Pharmaceuticals
  • Global
  • $3,450.00
  • Report 01GZ-CS0008CT has a star rating of 4.2 out of 5
  • Go to More information on Report 01GZ-CS0008CT
  • View Report: Research and Experts Market Report: Celiac Disease - Pipeline Review, H1 2016

    Celiac Disease - Pipeline Review, H1 2016


    2016-04-20
    Global Markets Direct’s, ‘Celiac Disease - Pipeline Review, H1 2016’, provides an overview of the Celiac Disease pipeline landscape.

    The report provides comprehensive information on the therapeutics under development for Celiac Disease,...

  • Market Report
  • Life Sciences
  • Global
  • $2,000.00
  • Report 05IB-GMDHC7846IDB has a star rating of 4.4 out of 5
  • Go to More information on Report 05IB-GMDHC7846IDB
  • View Report: Research and Experts Market Report: Chronic Heart Failure - Pipeline Review, H1 2016

    Chronic Heart Failure - Pipeline Review, H1 2016


    2016-04-20
    Global Markets Direct’s, ‘Chronic Heart Failure - Pipeline Review, H1 2016’, provides an overview of the Chronic Heart Failure pipeline landscape.

    The report provides comprehensive information on the therapeutics under development for...

  • Market Report
  • Life Sciences
  • Global
  • $2,000.00
  • Report 05IB-GMDHC7839IDB has a star rating of 4.7 out of 5
  • Go to More information on Report 05IB-GMDHC7839IDB
  • View Report: Research and Experts Market Report: Chagas Disease (American Trypanosomiasis) - Pipeline Review, H1 2016

    Chagas Disease (American Trypanosomiasis) - Pipeline Review, H1 2016


    2016-04-20
    Global Markets Direct’s, ‘Chagas Disease (American Trypanosomiasis) - Pipeline Review, H1 2016’, provides an overview of the Chagas Disease (American Trypanosomiasis) pipeline landscape.

    The report provides comprehensive information on...

  • Market Report
  • Life Sciences
  • Global
  • $2,000.00
  • Report 05IB-GMDHC7838IDB has a star rating of 4.5 out of 5
  • Go to More information on Report 05IB-GMDHC7838IDB
  • View Report: Research and Experts Market Report: Overactive Bladder - Pipeline Review, H1 2016

    Overactive Bladder - Pipeline Review, H1 2016


    2016-04-20
    Global Markets Direct’s, ‘Overactive Bladder - Pipeline Review, H1 2016’, provides an overview of the Overactive Bladder pipeline landscape.

    The report provides comprehensive information on the therapeutics under development for Overactive...

  • Market Report
  • Life Sciences
  • Global
  • $2,000.00
  • Report 05IB-GMDHC7835IDB has a star rating of 4.6 out of 5
  • Go to More information on Report 05IB-GMDHC7835IDB
  • View Report: Research and Experts Market Report: Insulin Pens - Medical Devices Pipeline Assessment, 2016

    Insulin Pens - Medical Devices Pipeline Assessment, 2016


    2016-05-01
    GlobalData's Medical Devices sector report, “Insulin Pens - Medical Devices Pipeline Assessment, 2016" provides an overview of Insulin Pens currently in pipeline stage.

    The report provides comprehensive information on the pipeline products...

  • Market Report
  • Medical Devices
  • Global
  • $2,500.00
  • Report 05IC-GDME0176EPD has a star rating of 4.4 out of 5
  • Go to More information on Report 05IC-GDME0176EPD
  • View Report: Research and Experts Market Report: Pulmonary Fibrosis - Pipeline Review, H1 2016

    Pulmonary Fibrosis - Pipeline Review, H1 2016


    2016-04-13
    Global Markets Direct’s, ‘Pulmonary Fibrosis - Pipeline Review, H1 2016’, provides an overview of the Pulmonary Fibrosis pipeline landscape.

    The report provides comprehensive information on the therapeutics under development for Pulmonary...

  • Market Report
  • Life Sciences
  • Global
  • $2,000.00
  • Report 05IB-GMDHC7692IDB has a star rating of 4.9 out of 5
  • Go to More information on Report 05IB-GMDHC7692IDB
  • View Report: Research and Experts Market Report: Hormone Refractory (Castration Resistant, Androgen-Independent) Prostate Cancer - Pipeline Review, H1 2016

    Hormone Refractory (Castration Resistant, Androgen-Independent) Prostate Cancer - Pipeline Review, H1 2016


    2016-04-13
    Global Markets Direct’s, ‘Hormone Refractory (Castration Resistant, Androgen-Independent) Prostate Cancer - Pipeline Review, H1 2016’, provides an overview of the Hormone Refractory (Castration Resistant, Androgen-Independent) Prostate...
  • Market Report
  • Life Sciences
  • Global
  • $2,000.00
  • Report 05IB-GMDHC7689IDB has a star rating of 4.9 out of 5
  • Go to More information on Report 05IB-GMDHC7689IDB
  • View Report: Research and Experts Market Report: Allergic Rhinitis - Pipeline Review, H1 2016

    Allergic Rhinitis - Pipeline Review, H1 2016


    2016-03-31
    Global Markets Direct’s, ‘Allergic Rhinitis - Pipeline Review, H1 2016’, provides an overview of the Allergic Rhinitis pipeline landscape.

    The report provides comprehensive information on the therapeutics under development for Allergic...

  • Market Report
  • Life Sciences
  • Global
  • $2,000.00
  • Report 05IB-GMDHC7703IDB has a star rating of 4.8 out of 5
  • Go to More information on Report 05IB-GMDHC7703IDB
  • View Report: Research and Experts Market Report: Metastatic Pancreatic Cancer - Pipeline Review, H1 2016

    Metastatic Pancreatic Cancer - Pipeline Review, H1 2016


    2016-03-31
    Global Markets Direct’s, ‘Metastatic Pancreatic Cancer - Pipeline Review, H1 2016’, provides an overview of the Metastatic Pancreatic Cancer pipeline landscape.

    The report provides comprehensive information on the therapeutics under development...

  • Market Report
  • Life Sciences
  • Global
  • $2,000.00
  • Report 05IB-GMDHC7699IDB has a star rating of 4.8 out of 5
  • Go to More information on Report 05IB-GMDHC7699IDB
  • View Report: Research and Experts Market Report: Glaucoma - Pipeline Review, H1 2016

    Glaucoma - Pipeline Review, H1 2016


    2016-03-31
    Global Markets Direct’s, ‘Glaucoma - Pipeline Review, H1 2016’, provides an overview of the Glaucoma pipeline landscape.

    The report provides comprehensive information on the therapeutics under development for Glaucoma, complete with analysis...

  • Market Report
  • Life Sciences
  • Global
  • $2,000.00
  • Report 05IB-GMDHC7695IDB has a star rating of 4.9 out of 5
  • Go to More information on Report 05IB-GMDHC7695IDB
  • View Report: Research and Experts Market Report: Arterial Thrombosis - Pipeline Review, H1 2016

    Arterial Thrombosis - Pipeline Review, H1 2016


    2016-03-30
    Global Markets Direct’s, ‘Arterial Thrombosis - Pipeline Review, H1 2016’, provides an overview of the Arterial Thrombosis pipeline landscape.

    The report provides comprehensive information on the therapeutics under development for Arterial...

  • Market Report
  • Life Sciences
  • Global
  • $2,000.00
  • Report 05IB-GMDHC7739IDB has a star rating of 4.3 out of 5
  • Go to More information on Report 05IB-GMDHC7739IDB
  • View Report: Research and Experts Market Report: Myelodysplastic Syndrome Global Clinical Trials Review, H1, 2016

    Myelodysplastic Syndrome Global Clinical Trials Review, H1, 2016


    2016-03-31
    GlobalData's clinical trial report, “Myelodysplastic Syndrome Global Clinical Trials Review, H1, 2016" provides an overview of Myelodysplastic Syndrome clinical trials scenario. This report provides top line data relating to the clinical...
  • Market Report
  • Life Sciences
  • Global
  • $2,500.00
  • Report 05IC-GDHC3328CTIDB has a star rating of 4.9 out of 5
  • Go to More information on Report 05IC-GDHC3328CTIDB
  • View Report: Research and Experts Market Report: Deep Vein Thrombosis (DVT) Global Clinical Trials Review, H1, 2016

    Deep Vein Thrombosis (DVT) Global Clinical Trials Review, H1, 2016


    2016-03-31
    GlobalData's clinical trial report, “Deep Vein Thrombosis (DVT) Global Clinical Trials Review, H1, 2016" provides an overview of Deep Vein Thrombosis (DVT) clinical trials scenario. This report provides top line data relating to the clinical...
  • Market Report
  • Life Sciences
  • Global
  • $2,500.00
  • Report 05IC-GDHC3326CTIDB has a star rating of 4.7 out of 5
  • Go to More information on Report 05IC-GDHC3326CTIDB
  • View Report: Research and Experts Market Report: Hepatitis A Global Clinical Trials Review, H1, 2016

    Hepatitis A Global Clinical Trials Review, H1, 2016


    2016-03-31
    GlobalData's clinical trial report, “Hepatitis A Global Clinical Trials Review, H1, 2016" provides an overview of Hepatitis A clinical trials scenario. This report provides top line data relating to the clinical trials on Hepatitis A. Report...
  • Market Report
  • Life Sciences
  • Global
  • $2,500.00
  • Report 05IC-GDHC3322CTIDB has a star rating of 4.2 out of 5
  • Go to More information on Report 05IC-GDHC3322CTIDB
  • View Report: Research and Experts Market Report: Fabry Disease Global Clinical Trials Review, H1, 2016

    Fabry Disease Global Clinical Trials Review, H1, 2016


    2016-03-31
    GlobalData's clinical trial report, “Fabry Disease Global Clinical Trials Review, H1, 2016" provides an overview of Fabry Disease clinical trials scenario. This report provides top line data relating to the clinical trials on Fabry Disease....
  • Market Report
  • Life Sciences
  • Global
  • $2,500.00
  • Report 05IC-GDHC3315CTIDB has a star rating of 4.4 out of 5
  • Go to More information on Report 05IC-GDHC3315CTIDB
  • View Report: Research and Experts Industry Report: Sanofi - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report

    Sanofi - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report


    2016-06-30
    Marketline's Company Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive...
  • Industry Report
  • Biotechnology
  • France
  • $350.00
  • Report 05IK-27D2359F-E314-4731-8846-80 has a star rating of 4.3 out of 5
  • Go to More information on Report 05IK-27D2359F-E314-4731-8846-80
  • View Report: Research and Experts Market Report: Osteoarthritis - Pipeline Review, H1 2016

    Osteoarthritis - Pipeline Review, H1 2016


    2016-03-22
    Global Markets Direct’s, ‘Osteoarthritis - Pipeline Review, H1 2016’, provides an overview of the Osteoarthritis pipeline landscape.

    The report provides comprehensive information on the therapeutics under development for Osteoarthritis,...

  • Market Report
  • Life Sciences
  • Global
  • $2,000.00
  • Report 05IB-GMDHC7811IDB has a star rating of 4.9 out of 5
  • Go to More information on Report 05IB-GMDHC7811IDB
  • View Report: Research and Experts Market Report: Juvenile Macular Degeneration (Stargardt Disease) - Pipeline Review, H1 2016

    Juvenile Macular Degeneration (Stargardt Disease) - Pipeline Review, H1 2016


    2016-03-22
    Global Markets Direct’s, ‘Juvenile Macular Degeneration (Stargardt Disease) - Pipeline Review, H1 2016’, provides an overview of the Juvenile Macular Degeneration (Stargardt Disease) pipeline landscape.

    The report provides comprehensive...

  • Market Report
  • Life Sciences
  • Global
  • $2,000.00
  • Report 05IB-GMDHC7774IDB has a star rating of 4.3 out of 5
  • Go to More information on Report 05IB-GMDHC7774IDB
  • View Report: Research and Experts Market Report: African Trypanosomiasis - Pipeline Review, H1 2016

    African Trypanosomiasis - Pipeline Review, H1 2016


    2016-03-22
    Global Markets Direct’s, ‘African Trypanosomiasis - Pipeline Review, H1 2016’, provides an overview of the African Trypanosomiasis pipeline landscape.

    The report provides comprehensive information on the therapeutics under development...

  • Market Report
  • Life Sciences
  • Global
  • $2,000.00
  • Report 05IB-GMDHC7754IDB has a star rating of 4.3 out of 5
  • Go to More information on Report 05IB-GMDHC7754IDB
  • View Report: Research and Experts Market Report: Open-Angle Glaucoma - Pipeline Review, H1 2016

    Open-Angle Glaucoma - Pipeline Review, H1 2016


    2016-03-22
    Global Markets Direct’s, ‘Open-Angle Glaucoma - Pipeline Review, H1 2016’, provides an overview of the Open-Angle Glaucoma pipeline landscape.

    The report provides comprehensive information on the therapeutics under development for Open-Angle...

  • Market Report
  • Life Sciences
  • Global
  • $2,000.00
  • Report 05IB-GMDHC7719IDB has a star rating of 4.7 out of 5
  • Go to More information on Report 05IB-GMDHC7719IDB
  • View Report: Research and Experts Market Report: Ocular Hypertension - Pipeline Review, H1 2016

    Ocular Hypertension - Pipeline Review, H1 2016


    2016-03-22
    Global Markets Direct’s, ‘Ocular Hypertension - Pipeline Review, H1 2016’, provides an overview of the Ocular Hypertension pipeline landscape.

    The report provides comprehensive information on the therapeutics under development for Ocular...

  • Market Report
  • Life Sciences
  • Global
  • $2,000.00
  • Report 05IB-GMDHC7715IDB has a star rating of 4.7 out of 5
  • Go to More information on Report 05IB-GMDHC7715IDB
  • View Report: Research and Experts Market Report: Metastatic Adenocarcinoma of The Pancreas - Pipeline Review, H1 2016

    Metastatic Adenocarcinoma of The Pancreas - Pipeline Review, H1 2016


    2016-03-22
    Global Markets Direct’s, ‘Metastatic Adenocarcinoma of The Pancreas - Pipeline Review, H1 2016’, provides an overview of the Metastatic Adenocarcinoma of The Pancreas pipeline landscape.

    The report provides comprehensive information on...

  • Market Report
  • Life Sciences
  • Global
  • $2,000.00
  • Report 05IB-GMDHC7714IDB has a star rating of 4.8 out of 5
  • Go to More information on Report 05IB-GMDHC7714IDB
  • View Report: Research and Experts Market Report: Congestive Heart Failure (Heart Failure) - Pipeline Review, H1 2016

    Congestive Heart Failure (Heart Failure) - Pipeline Review, H1 2016


    2016-03-22
    Global Markets Direct’s, ‘Congestive Heart Failure (Heart Failure) - Pipeline Review, H1 2016’, provides an overview of the Congestive Heart Failure (Heart Failure) pipeline landscape.

    The report provides comprehensive information on...

  • Market Report
  • Life Sciences
  • Global
  • $2,000.00
  • Report 05IB-GMDHC7552IDB has a star rating of 4.9 out of 5
  • Go to More information on Report 05IB-GMDHC7552IDB
  • View Report: Research and Experts Market Report: Hemostats - Medical Devices Pipeline Assessment, 2016

    Hemostats - Medical Devices Pipeline Assessment, 2016


    2016-03-11
    GlobalData's Medical Devices sector report, “Hemostats - Medical Devices Pipeline Assessment, 2016" provides an overview of Hemostats currently in pipeline stage.

    The report provides comprehensive information on the pipeline products with...

  • Market Report
  • Medical Devices
  • Global
  • $4,000.00
  • Report 05IC-GDME0161EPD has a star rating of 4.3 out of 5
  • Go to More information on Report 05IC-GDME0161EPD
  • View Report: Research and Experts Market Report: Peripheral Neuropathy (Sensory Neuropathy) Global Clinical Trials Review, H1, 2016

    Peripheral Neuropathy (Sensory Neuropathy) Global Clinical Trials Review, H1, 2016


    2016-03-16
    GlobalData's clinical trial report, “Peripheral Neuropathy (Sensory Neuropathy) Global Clinical Trials Review, H1, 2016" provides an overview of Peripheral Neuropathy (Sensory Neuropathy) clinical trials scenario. This report provides top...
  • Market Report
  • Iron and steel Construction
  • Global
  • $2,500.00
  • Report 05IC-GDHC3299CTIDB has a star rating of 4.7 out of 5
  • Go to More information on Report 05IC-GDHC3299CTIDB
  • View Report: Research and Experts Market Report: Cholecystitis Global Clinical Trials Review, H1, 2016

    Cholecystitis Global Clinical Trials Review, H1, 2016


    2016-03-11
    GlobalData's clinical trial report, “Cholecystitis Global Clinical Trials Review, H1, 2016" provides an overview of Cholecystitis clinical trials scenario. This report provides top line data relating to the clinical trials on Cholecystitis....
  • Market Report
  • Iron and steel Construction
  • Global
  • $2,500.00
  • Report 05IC-GDHC3284CTIDB has a star rating of 4.2 out of 5
  • Go to More information on Report 05IC-GDHC3284CTIDB
  • View Report: Research and Experts Market Report: Ascites Global Clinical Trials Review, H1, 2016

    Ascites Global Clinical Trials Review, H1, 2016


    2016-03-11
    GlobalData's clinical trial report, “Ascites Global Clinical Trials Review, H1, 2016" provides an overview of Ascites clinical trials scenario. This report provides top line data relating to the clinical trials on Ascites. Report includes...
  • Market Report
  • Iron and steel Construction
  • Global
  • $2,500.00
  • Report 05IC-GDHC3280CTIDB has a star rating of 4.3 out of 5
  • Go to More information on Report 05IC-GDHC3280CTIDB
  • View Report: Research and Experts Market Report: Colitis Global Clinical Trials Review, H1, 2016

    Colitis Global Clinical Trials Review, H1, 2016


    2016-03-11
    GlobalData's clinical trial report, “Colitis Global Clinical Trials Review, H1, 2016" provides an overview of Colitis clinical trials scenario. This report provides top line data relating to the clinical trials on Colitis. Report includes...
  • Market Report
  • Iron and steel Construction
  • Global
  • $2,500.00
  • Report 05IC-GDHC3279CTIDB has a star rating of 4.2 out of 5
  • Go to More information on Report 05IC-GDHC3279CTIDB
  • View Report: Research and Experts Market Report: Alzheimer

    Alzheimer's Disease - Pipeline Review, H1 2016


    2016-03-16
    Global Markets Direct’s, ‘Alzheimer’s Disease - Pipeline Review, H1 2016’, provides an overview of the Alzheimer’s Disease pipeline landscape.

    The report provides comprehensive information on the therapeutics under development...

  • Market Report
  • Iron and steel Construction
  • Global
  • $2,500.00
  • Report 05IB-GMDHC7570IDB has a star rating of 4.8 out of 5
  • Go to More information on Report 05IB-GMDHC7570IDB
  • View Report: Research and Experts Market Report: Tuberculosis Global Clinical Trials Review, H1, 2016

    Tuberculosis Global Clinical Trials Review, H1, 2016


    2016-02-29
    GlobalData's clinical trial report, “Tuberculosis Global Clinical Trials Review, H1, 2016" provides an overview of Tuberculosis clinical trials scenario. This report provides top line data relating to the clinical trials on Tuberculosis....
  • Market Report
  • Iron and steel Construction
  • Global
  • $2,500.00
  • Report 05IC-GDHC3267CTIDB has a star rating of 4.9 out of 5
  • Go to More information on Report 05IC-GDHC3267CTIDB
  • View Report: Research and Experts Market Report: Malaria Global Clinical Trials Review, H1, 2016

    Malaria Global Clinical Trials Review, H1, 2016


    2016-02-29
    GlobalData's clinical trial report, “Malaria Global Clinical Trials Review, H1, 2016" provides an overview of Malaria clinical trials scenario. This report provides top line data relating to the clinical trials on Malaria. Report includes...
  • Market Report
  • Iron and steel Construction
  • Global
  • $2,500.00
  • Report 05IC-GDHC3266CTIDB has a star rating of 4.8 out of 5
  • Go to More information on Report 05IC-GDHC3266CTIDB
  • View Report: Research and Experts Market Report: Trypanosomiasis Global Clinical Trials Review, H1, 2016

    Trypanosomiasis Global Clinical Trials Review, H1, 2016


    2016-02-29
    GlobalData's clinical trial report, “Trypanosomiasis Global Clinical Trials Review, H1, 2016" provides an overview of Trypanosomiasis clinical trials scenario. This report provides top line data relating to the clinical trials on Trypanosomiasis...
  • Market Report
  • Iron and steel Construction
  • Global
  • $2,500.00
  • Report 05IC-GDHC3255CTIDB has a star rating of 4.6 out of 5
  • Go to More information on Report 05IC-GDHC3255CTIDB
  • View Report: Research and Experts Market Report: Cholera Global Clinical Trials Review, H1, 2016

    Cholera Global Clinical Trials Review, H1, 2016


    2016-02-29
    GlobalData's clinical trial report, “Cholera Global Clinical Trials Review, H1, 2016" provides an overview of Cholera clinical trials scenario. This report provides top line data relating to the clinical trials on Cholera. Report includes...
  • Market Report
  • Iron and steel Construction
  • Global
  • $2,500.00
  • Report 05IC-GDHC3254CTIDB has a star rating of 4.3 out of 5
  • Go to More information on Report 05IC-GDHC3254CTIDB
  • View Report: Research and Experts Market Report: Genital Herpes Global Clinical Trials Review, H1, 2016

    Genital Herpes Global Clinical Trials Review, H1, 2016


    2016-02-29
    GlobalData's clinical trial report, “Genital Herpes Global Clinical Trials Review, H1, 2016" provides an overview of Genital Herpes clinical trials scenario. This report provides top line data relating to the clinical trials on Genital...
  • Market Report
  • Iron and steel Construction
  • Global
  • $2,500.00
  • Report 05IC-GDHC3246CTIDB has a star rating of 4.2 out of 5
  • Go to More information on Report 05IC-GDHC3246CTIDB
  • View Report: Research and Experts Market Report: OpportunityAnalyzer: Vasculitis - Opportunity Analysis and Forecast to 2024

    OpportunityAnalyzer: Vasculitis - Opportunity Analysis and Forecast to 2024


    2016-01-01
    Vasculitis is a family of rare autoimmune diseases, causing inflammation of the blood vessels, arteries, veins or capillaries. The different forms of vasculitis are classified by the size and location of the affected blood vessels . This report specifical...
  • Market Report
  • Iron and steel Construction
  • Global
  • $10,995.00
  • Report 05IC-GDHC045POA has a star rating of 4.2 out of 5
  • Go to More information on Report 05IC-GDHC045POA
  • View Report: Research and Experts Company Report: F. Hoffmann-La Roche Ltd. (ROG) - Medical Equipment - Deals and Alliances Profile

    F. Hoffmann-La Roche Ltd. (ROG) - Medical Equipment - Deals and Alliances Profile


    2016-02-24
    F. Hoffmann-La Roche Ltd. (Roche) is a research-focused healthcare company. It is one of the leading providers of biopharmaceuticals, cancer medicines and in vitro diagnostics (IVD) systems. Its major products include medicines to treat cancers, brain...
  • Company Report
  • Medical Devices
  • Switzerland
  • $250.00
  • Report 05IB-GDME756D has a star rating of 4.2 out of 5
  • Go to More information on Report 05IB-GDME756D
  • View Report: Research and Experts Company Report: Johnson & Johnson (JNJ) - Medical Equipment - Deals and Alliances Profile

    Johnson & Johnson (JNJ) - Medical Equipment - Deals and Alliances Profile


    2016-02-24
    Johnson & Johnson (J&J) is a pharmaceutical holding company. It carries out the manufacture and sale of a wide range of pharmaceutical products and medical devices. It provides products for human health and well-being. J&J’s product offerings...
  • Company Report
  • Medical Devices
  • United States
  • $250.00
  • Report 05IB-GDME659D has a star rating of 4.2 out of 5
  • Go to More information on Report 05IB-GDME659D
  • View Report: Research and Experts Company Report: Merck & Co., Inc. (MRK) - Medical Equipment - Deals and Alliances Profile

    Merck & Co., Inc. (MRK) - Medical Equipment - Deals and Alliances Profile


    2016-02-24
    Merck & Co., Inc. (Merck) is a healthcare company, which focuses on the discovery, development, manufacture and commercialization of branded pharmaceuticals, biologic therapies, prescription and over-the-counter (OTC) medicines, vaccines, consumer...
  • Company Report
  • Medical Devices
  • United States
  • $250.00
  • Report 05IB-GDME6319D has a star rating of 4.2 out of 5
  • Go to More information on Report 05IB-GDME6319D
  • View Report: Research and Experts Company Report: Merck KGaA (MRK) - Medical Equipment - Deals and Alliances Profile

    Merck KGaA (MRK) - Medical Equipment - Deals and Alliances Profile


    2016-02-24
    Merck KGaA (Merck) is a pharmaceutical and chemical company, which operates its business in three markets namely, pharmaceuticals market, high-tech materials market and life sciences market. Its business operations include promoting prescription drugs...
  • Company Report
  • Medical Devices
  • Germany
  • $250.00
  • Report 05IB-GDME48505D has a star rating of 4.3 out of 5
  • Go to More information on Report 05IB-GDME48505D
  • View Report: Research and Experts Company Report: GlaxoSmithKline Plc (GSK) - Medical Equipment - Deals and Alliances Profile

    GlaxoSmithKline Plc (GSK) - Medical Equipment - Deals and Alliances Profile


    2016-02-24
    GlaxoSmithKline plc (GSK) is a healthcare company, which focuses on the development, manufacture and commercialization of pharmaceuticals, vaccines and consumer healthcare products. It offers drugs for the treatment of respiratory, cardiovascular, metabol...
  • Company Report
  • Medical Devices
  • United Kingdom
  • $250.00
  • Report 05IB-GDME4279D has a star rating of 4.2 out of 5
  • Go to More information on Report 05IB-GDME4279D
  • View Report: Research and Experts Company Report: Pfizer Inc. (PFE) - Medical Equipment - Deals and Alliances Profile

    Pfizer Inc. (PFE) - Medical Equipment - Deals and Alliances Profile


    2016-02-24
    Pfizer Inc. (Pfizer) is a biopharmaceutical company, which focuses on the discovery, development, manufacture and marketing of healthcare products such as medicines, vaccines and consumer health care products. It offers products for the treatment of respi...
  • Company Report
  • Medical Devices
  • United States
  • $250.00
  • Report 05IB-GDME32190D has a star rating of 4.2 out of 5
  • Go to More information on Report 05IB-GDME32190D
  • View Report: Research and Experts Company Report: Novartis AG (NOVN) - Medical Equipment - Deals and Alliances Profile

    Novartis AG (NOVN) - Medical Equipment - Deals and Alliances Profile


    2016-02-24
    Novartis AG (Novartis) is a healthcare company that focuses on the discovery, development, manufacture and marketing of prescription and generic products for the treatment of diseases and disorders in humans and animals. It provides drugs for the treatmen...
  • Company Report
  • Medical Devices
  • Switzerland
  • $250.00
  • Report 05IB-GDME24864D has a star rating of 4.2 out of 5
  • Go to More information on Report 05IB-GDME24864D
  • View Report: Research and Experts Company Report: Biogen, Inc. (BIIB) - Medical Equipment - Deals and Alliances Profile

    Biogen, Inc. (BIIB) - Medical Equipment - Deals and Alliances Profile


    2016-02-24
    Biogen, Inc. (Biogen) is a global biotechnology company that discovers, develops, manufactures and commercializes therapies for treating neurodegenerative diseases, hematologic conditions and autoimmune disorders. The company’s marketed product portfolio...
  • Company Report
  • Medical Devices
  • United States
  • $250.00
  • Report 05IB-GDME1307D has a star rating of 4.2 out of 5
  • Go to More information on Report 05IB-GDME1307D
  • View Report: Research and Experts Company Report: Bristol-Myers Squibb Company (BMY) - Medical Equipment - Deals and Alliances Profile

    Bristol-Myers Squibb Company (BMY) - Medical Equipment - Deals and Alliances Profile


    2016-02-24
    Bristol-Myers Squibb Company (BMS) is global biopharmaceutical company focused at addressing the unmet medical needs of patients with serious diseases. It undertakes the discovery, development, licensing, manufacture, marketing and distribution of biophar...
  • Company Report
  • Medical Devices
  • United States
  • $250.00
  • Report 05IB-GDME10D has a star rating of 4.2 out of 5
  • Go to More information on Report 05IB-GDME10D
  • View Report: Research and Experts Company Report: Merck KGaA (MRK) - Financial and Strategic SWOT Analysis Review

    Merck KGaA (MRK) - Financial and Strategic SWOT Analysis Review


    2016-03-01
    Merck KGaA (Merck) is a pharmaceutical and chemical company, which operates its business in three markets namely, pharmaceuticals market, high-tech materials market and life sciences market. Its business operations include promoting prescription drugs...
  • Company Report
  • Iron and steel Construction
  • Germany
  • $125.00
  • Report 05IB-GDPH48505FSA has a star rating of 4.1 out of 5
  • Go to More information on Report 05IB-GDPH48505FSA
  • View Report: Research and Experts Company Report: Pfizer Inc. (PFE) - Financial and Strategic SWOT Analysis Review

    Pfizer Inc. (PFE) - Financial and Strategic SWOT Analysis Review


    2016-03-01
    Pfizer Inc. (Pfizer) is a biopharmaceutical company, which focuses on the discovery, development, manufacture and marketing of healthcare products such as medicines, vaccines and consumer health care products. It offers products for the treatment of respi...
  • Company Report
  • Iron and steel Construction
  • United States
  • $125.00
  • Report 05IB-GDPH32190FSA has a star rating of 4.1 out of 5
  • Go to More information on Report 05IB-GDPH32190FSA
  • View Report: Research and Experts Company Report: Novartis AG (NOVN) - Financial and Strategic SWOT Analysis Review

    Novartis AG (NOVN) - Financial and Strategic SWOT Analysis Review


    2016-03-01
    Novartis AG (Novartis) is a healthcare company that focuses on the discovery, development, manufacture and marketing of prescription and generic products for the treatment of diseases and disorders in humans and animals. It provides drugs for the treatmen...
  • Company Report
  • Iron and steel Construction
  • Switzerland
  • $125.00
  • Report 05IB-GDPH24864FSA has a star rating of 4.1 out of 5
  • Go to More information on Report 05IB-GDPH24864FSA
  • View Report: Research and Experts Market Report: Duchenne Muscular Dystrophy - Pipeline Review, H1 2016

    Duchenne Muscular Dystrophy - Pipeline Review, H1 2016


    2016-02-29
    Global Markets Direct’s, ‘Duchenne Muscular Dystrophy - Pipeline Review, H1 2016’, provides an overview of the Duchenne Muscular Dystrophy pipeline landscape.

    The report provides comprehensive information on the therapeutics under development...

  • Market Report
  • Iron and steel Construction
  • Global
  • $2,000.00
  • Report 05IB-GMDHC7604IDB has a star rating of 4.9 out of 5
  • Go to More information on Report 05IB-GMDHC7604IDB
  • View Report: Research and Experts Market Report: Insulin Resistance - Pipeline Review, H1 2016

    Insulin Resistance - Pipeline Review, H1 2016


    2016-02-24
    Global Markets Direct’s, ‘Insulin Resistance - Pipeline Review, H1 2016’, provides an overview of the Insulin Resistance pipeline landscape.

    The report provides comprehensive information on the therapeutics under development for Insulin...

  • Market Report
  • Iron and steel Construction
  • Global
  • $2,000.00
  • Report 05IB-GMDHC7651IDB has a star rating of 4.2 out of 5
  • Go to More information on Report 05IB-GMDHC7651IDB
  • View Report: Research and Experts Market Report: Hypoglycemia - Pipeline Review, H1 2016

    Hypoglycemia - Pipeline Review, H1 2016


    2016-02-24
    Global Markets Direct’s, ‘Hypoglycemia - Pipeline Review, H1 2016’, provides an overview of the Hypoglycemia pipeline landscape.

    The report provides comprehensive information on the therapeutics under development for Hypoglycemia, complete...

  • Market Report
  • Iron and steel Construction
  • Global
  • $2,000.00
  • Report 05IB-GMDHC7650IDB has a star rating of 4.3 out of 5
  • Go to More information on Report 05IB-GMDHC7650IDB
  • View Report: Research and Experts Market Report: Peripheral Neuropathy (Sensory Neuropathy) - Pipeline Review, H1 2016

    Peripheral Neuropathy (Sensory Neuropathy) - Pipeline Review, H1 2016


    2016-02-24
    Global Markets Direct’s, ‘Peripheral Neuropathy (Sensory Neuropathy) - Pipeline Review, H1 2016’, provides an overview of the Peripheral Neuropathy (Sensory Neuropathy) pipeline landscape.

    The report provides comprehensive information...

  • Market Report
  • Iron and steel Construction
  • Global
  • $2,000.00
  • Report 05IB-GMDHC7571IDB has a star rating of 4.5 out of 5
  • Go to More information on Report 05IB-GMDHC7571IDB
  • View Report: Research and Experts Market Report: Thromboembolism - Pipeline Review, H1 2016

    Thromboembolism - Pipeline Review, H1 2016


    2016-02-24
    Global Markets Direct’s, ‘Thromboembolism - Pipeline Review, H1 2016’, provides an overview of the Thromboembolism pipeline landscape.

    The report provides comprehensive information on the therapeutics under development for Thromboembolism,...

  • Market Report
  • Iron and steel Construction
  • Global
  • $2,000.00
  • Report 05IB-GMDHC7556IDB has a star rating of 4.6 out of 5
  • Go to More information on Report 05IB-GMDHC7556IDB
  • View Report: Research and Experts Market Report: Typhoid Fever - Pipeline Review, H1 2016

    Typhoid Fever - Pipeline Review, H1 2016


    2016-02-24
    Global Markets Direct’s, ‘Typhoid Fever - Pipeline Review, H1 2016’, provides an overview of the Typhoid Fever pipeline landscape.

    The report provides comprehensive information on the therapeutics under development for Typhoid Fever,...

  • Market Report
  • Iron and steel Construction
  • Global
  • $2,000.00
  • Report 05IB-GMDHC7622IDB has a star rating of 4.2 out of 5
  • Go to More information on Report 05IB-GMDHC7622IDB
  • View Report: Research and Experts Market Report: Dilated Cardiomyopathy - Pipeline Review, H1 2016

    Dilated Cardiomyopathy - Pipeline Review, H1 2016


    2016-02-24
    Global Markets Direct’s, ‘Dilated Cardiomyopathy - Pipeline Review, H1 2016’, provides an overview of the Dilated Cardiomyopathy pipeline landscape.

    The report provides comprehensive information on the therapeutics under development for...

  • Market Report
  • Iron and steel Construction
  • Global
  • $2,000.00
  • Report 05IB-GMDHC7551IDB has a star rating of 4.3 out of 5
  • Go to More information on Report 05IB-GMDHC7551IDB
  • View Report: Research and Experts Market Report: Reperfusion Injury Global Clinical Trials Review, H1, 2016

    Reperfusion Injury Global Clinical Trials Review, H1, 2016


    2016-02-25
    GlobalData's clinical trial report, “Reperfusion Injury Global Clinical Trials Review, H1, 2016" provides an overview of Reperfusion Injury clinical trials scenario. This report provides top line data relating to the clinical trials on...
  • Market Report
  • Iron and steel Construction
  • Global
  • $2,500.00
  • Report 05IC-GDHC3238CTIDB has a star rating of 4.5 out of 5
  • Go to More information on Report 05IC-GDHC3238CTIDB
  • View Report: Research and Experts Market Report: Venous Thromboembolism Global Clinical Trials Review, H1, 2016

    Venous Thromboembolism Global Clinical Trials Review, H1, 2016


    2016-02-25
    GlobalData's clinical trial report, “Venous Thromboembolism Global Clinical Trials Review, H1, 2016" provides an overview of Venous Thromboembolism clinical trials scenario. This report provides top line data relating to the clinical trials...
  • Market Report
  • Iron and steel Construction
  • Global
  • $2,500.00
  • Report 05IC-GDHC3233CTIDB has a star rating of 4.9 out of 5
  • Go to More information on Report 05IC-GDHC3233CTIDB
  • View Report: Research and Experts Market Report: Thromboembolism Global Clinical Trials Review, H1, 2016

    Thromboembolism Global Clinical Trials Review, H1, 2016


    2016-02-25
    GlobalData's clinical trial report, “Thromboembolism Global Clinical Trials Review, H1, 2016" provides an overview of Thromboembolism clinical trials scenario. This report provides top line data relating to the clinical trials on Thromboembolism...
  • Market Report
  • Iron and steel Construction
  • Global
  • $2,500.00
  • Report 05IC-GDHC3232CTIDB has a star rating of 4.8 out of 5
  • Go to More information on Report 05IC-GDHC3232CTIDB
  • View Report: Research and Experts Market Report: Osteoarthritis Global Clinical Trials Review, H1, 2016

    Osteoarthritis Global Clinical Trials Review, H1, 2016


    2016-02-25
    GlobalData's clinical trial report, “Osteoarthritis Global Clinical Trials Review, H1, 2016" provides an overview of Osteoarthritis clinical trials scenario. This report provides top line data relating to the clinical trials on Osteoarthritis....
  • Market Report
  • Iron and steel Construction
  • Global
  • $2,500.00
  • Report 05IC-GDHC3231CTIDB has a star rating of 4.9 out of 5
  • Go to More information on Report 05IC-GDHC3231CTIDB
  • View Report: Research and Experts Market Report: OpportunityAnalyzer: Sjögren

    OpportunityAnalyzer: Sjögren's Syndrome - Opportunity Analysis and Forecast to 2024


    2015-12-19
    Sjögren’s syndrome (SS) is a slow progressing chronic autoimmune disease, which predominantly affects middle-aged women, and is characterized by lymphocytic infiltration of the exocrine glands, mainly the lacrimal and salivary glands, resulting...
  • Market Report
  • Iron and steel Construction
  • Global
  • $10,995.00
  • Report 05IC-GDHC048POA has a star rating of 4.1 out of 5
  • Go to More information on Report 05IC-GDHC048POA
  • View Report: Research and Experts Market Report: OpportunityAnalyzer: Bladder Cancer - Opportunity Analysis and Forecasts to 2017

    OpportunityAnalyzer: Bladder Cancer - Opportunity Analysis and Forecasts to 2017


    2015-12-19
    The bladder cancer market has remained largely unchanged in the past 10-20 years. However, significant expansion is expected starting in 2016, with the introduction of several new therapies that are projected to fuel market growth. In addition, bladder...
  • Market Report
  • Iron and steel Construction
  • Global
  • $10,995.00
  • Report 05IC-GDHC015EPOA has a star rating of 4.1 out of 5
  • Go to More information on Report 05IC-GDHC015EPOA
  • View Report: Research and Experts Market Report: Liver Cirrhosis Global Clinical Trials Review, H1, 2016

    Liver Cirrhosis Global Clinical Trials Review, H1, 2016


    2016-02-17
    GlobalData's clinical trial report, “Liver Cirrhosis Global Clinical Trials Review, H1, 2016" provides an overview of Liver Cirrhosis clinical trials scenario. This report provides top line data relating to the clinical trials on Liver...
  • Market Report
  • Iron and steel Construction
  • Global
  • $2,500.00
  • Report 05IC-GDHC3227CTIDB has a star rating of 4.7 out of 5
  • Go to More information on Report 05IC-GDHC3227CTIDB
  • View Report: Research and Experts Market Report: Atopic Dermatitis Global Clinical Trials Review, H1, 2016

    Atopic Dermatitis Global Clinical Trials Review, H1, 2016


    2016-02-17
    GlobalData's clinical trial report, “Atopic Dermatitis Global Clinical Trials Review, H1, 2016" provides an overview of Atopic Dermatitis clinical trials scenario. This report provides top line data relating to the clinical trials on Atopic...
  • Market Report
  • Iron and steel Construction
  • Global
  • $2,500.00
  • Report 05IC-GDHC3226CTIDB has a star rating of 4.8 out of 5
  • Go to More information on Report 05IC-GDHC3226CTIDB
  • View Report: Research and Experts Market Report: Dermatitis Global Clinical Trials Review, H1, 2016

    Dermatitis Global Clinical Trials Review, H1, 2016


    2016-02-17
    GlobalData's clinical trial report, “Dermatitis Global Clinical Trials Review, H1, 2016" provides an overview of Dermatitis clinical trials scenario. This report provides top line data relating to the clinical trials on Dermatitis. Report...
  • Market Report
  • Iron and steel Construction
  • Global
  • $2,500.00
  • Report 05IC-GDHC3225CTIDB has a star rating of 4.9 out of 5
  • Go to More information on Report 05IC-GDHC3225CTIDB
  • View Report: Research and Experts Market Report: Ventricular Fibrillation Global Clinical Trials Review, H1, 2016

    Ventricular Fibrillation Global Clinical Trials Review, H1, 2016


    2016-02-17
    GlobalData's clinical trial report, “Ventricular Fibrillation Global Clinical Trials Review, H1, 2016" provides an overview of Ventricular Fibrillation clinical trials scenario. This report provides top line data relating to the clinical...
  • Market Report
  • Iron and steel Construction
  • Global
  • $2,500.00
  • Report 05IC-GDHC3220CTIDB has a star rating of 4.2 out of 5
  • Go to More information on Report 05IC-GDHC3220CTIDB
  • View Report: Research and Experts Market Report: Pompe Disease Global Clinical Trials Review, H1, 2016

    Pompe Disease Global Clinical Trials Review, H1, 2016


    2016-02-17
    GlobalData's clinical trial report, “Pompe Disease Global Clinical Trials Review, H1, 2016" provides an overview of Pompe Disease clinical trials scenario. This report provides top line data relating to the clinical trials on Pompe Disease....
  • Market Report
  • Iron and steel Construction
  • Global
  • $2,500.00
  • Report 05IC-GDHC3219CTIDB has a star rating of 4.2 out of 5
  • Go to More information on Report 05IC-GDHC3219CTIDB
  • View Report: Research and Experts Market Report: Atrial Flutter Global Clinical Trials Review, H1, 2016

    Atrial Flutter Global Clinical Trials Review, H1, 2016


    2016-02-17
    GlobalData's clinical trial report, “Atrial Flutter Global Clinical Trials Review, H1, 2016" provides an overview of Atrial Flutter clinical trials scenario. This report provides top line data relating to the clinical trials on Atrial Flutter....
  • Market Report
  • Iron and steel Construction
  • Global
  • $2,500.00
  • Report 05IC-GDHC3218CTIDB has a star rating of 4.3 out of 5
  • Go to More information on Report 05IC-GDHC3218CTIDB
  • View Report: Research and Experts Market Report: Joint Pain Global Clinical Trials Review, H1, 2016

    Joint Pain Global Clinical Trials Review, H1, 2016


    2016-02-17
    GlobalData's clinical trial report, “Joint Pain Global Clinical Trials Review, H1, 2016" provides an overview of Joint Pain clinical trials scenario. This report provides top line data relating to the clinical trials on Joint Pain. Report...
  • Market Report
  • Iron and steel Construction
  • Global
  • $2,500.00
  • Report 05IC-GDHC3216CTIDB has a star rating of 4.4 out of 5
  • Go to More information on Report 05IC-GDHC3216CTIDB
  • View Report: Research and Experts Market Report: PharmaPoint: Methicillin-Resistant Staphylococcus Aureus (MRSA) - Global Drug Forecast and Market Analysis to 2024

    PharmaPoint: Methicillin-Resistant Staphylococcus Aureus (MRSA) - Global Drug Forecast and Market Analysis to 2024


    2015-12-16
    With the discovery of penicillin, the first naturally-occurring antibiotic, in 1928, and its mass production in the early 1940s, infections with Staphylococcus aureus were mostly treatable, without any major complications. However, clinicians soon observe...
  • Market Report
  • Iron and steel Construction
  • Global
  • $10,995.00
  • Report 05IC-GDHC108PIDR has a star rating of 4.3 out of 5
  • Go to More information on Report 05IC-GDHC108PIDR
  • View Report: Research and Experts Market Report: OpportunityAnalyzer: Graft-Versus-Host Disease - Opportunity Analysis and Forecasts to 2023

    OpportunityAnalyzer: Graft-Versus-Host Disease - Opportunity Analysis and Forecasts to 2023


    2015-12-01
    The main drivers of growth in graft versus host disease over the 2013-2023 forecast period include the increasing numbers of allogeneic hematopoietic stem cell transplants and the increasing use of biologic off-label and marketed therapies in the 6MM.

    Sa...

  • Market Report
  • Life Sciences
  • Global
  • $10,995.00
  • Report 05IC-GDHC014EPOA has a star rating of 4.1 out of 5
  • Go to More information on Report 05IC-GDHC014EPOA
  • View Report: Research and Experts Market Report: OpportunityAnalyzer: Acute Myeloid Leukemia (AML) - Opportunity Analysis and Forecasts to 2024

    OpportunityAnalyzer: Acute Myeloid Leukemia (AML) - Opportunity Analysis and Forecasts to 2024


    2015-12-01
    Acute myeloid (myelogenous, myelocytic) leukemia (AML) is a rapidly progressing blood cancer with an extremely poor overall prognosis. AML predominantly affects the elderly population and this subgroup of patients has an exceptionally high level of unmet...
  • Market Report
  • Life Sciences
  • Global
  • $10,995.00
  • Report 05IC-GDHC051POA has a star rating of 4.1 out of 5
  • Go to More information on Report 05IC-GDHC051POA
  • View Report: Research and Experts Market Report: PharmaPoint: Meningococcal Vaccines - Global Drug Forecast and Market Analysis to 2022

    PharmaPoint: Meningococcal Vaccines - Global Drug Forecast and Market Analysis to 2022


    2015-12-01
    Meningococcal disease is an acute infection caused by the bacterium Neisseria meningitidis, an aerobic, gram-negative diplococcal microbe that is only pathogenic in humans. Different N. meningitides strains are typically classified into serotypes based...
  • Market Report
  • Life Sciences
  • Global
  • $10,995.00
  • Report 05IC-GDHC013EPIDR has a star rating of 4.2 out of 5
  • Go to More information on Report 05IC-GDHC013EPIDR
  • View Report: Research and Experts Market Report: Dengue Fever Global Clinical Trials Review, H1, 2016

    Dengue Fever Global Clinical Trials Review, H1, 2016


    2016-01-20
    GlobalData's clinical trial report, “Dengue Fever Global Clinical Trials Review, H1, 2016" provides an overview of Dengue Fever clinical trials scenario. This report provides top line data relating to the clinical trials on Dengue Fever....
  • Market Report
  • Healthcare
  • Global
  • $2,500.00
  • Report 05IC-GDHC3194CTIDB has a star rating of 4.2 out of 5
  • Go to More information on Report 05IC-GDHC3194CTIDB
  • View Report: Research and Experts Market Report: Swine Influenza Global Clinical Trials Review, H1, 2016

    Swine Influenza Global Clinical Trials Review, H1, 2016


    2016-01-20
    GlobalData's clinical trial report, “Swine Influenza Global Clinical Trials Review, H1, 2016" provides an overview of Swine Influenza clinical trials scenario. This report provides top line data relating to the clinical trials on Swine...
  • Market Report
  • Healthcare
  • Global
  • $2,500.00
  • Report 05IC-GDHC3192CTIDB has a star rating of 4.5 out of 5
  • Go to More information on Report 05IC-GDHC3192CTIDB
  • View Report: Research and Experts Market Report: H5N1 Infection (Avian Influenza) Global Clinical Trials Review, H1, 2016

    H5N1 Infection (Avian Influenza) Global Clinical Trials Review, H1, 2016


    2016-01-20
    GlobalData's clinical trial report, “H5N1 Infection (Avian Influenza) Global Clinical Trials Review, H1, 2016" provides an overview of H5N1 Infection (Avian Influenza) clinical trials scenario. This report provides top line data relating...
  • Market Report
  • Healthcare
  • Global
  • $2,500.00
  • Report 05IC-GDHC3191CTIDB has a star rating of 4.4 out of 5
  • Go to More information on Report 05IC-GDHC3191CTIDB
  • View Report: Research and Experts Market Report: Influenza A Infections Global Clinical Trials Review, H1, 2016

    Influenza A Infections Global Clinical Trials Review, H1, 2016


    2016-01-20
    GlobalData's clinical trial report, “Influenza A Infections Global Clinical Trials Review, H1, 2016" provides an overview of Influenza A Infections clinical trials scenario. This report provides top line data relating to the clinical trials...
  • Market Report
  • Healthcare
  • Global
  • $2,500.00
  • Report 05IC-GDHC3190CTIDB has a star rating of 4.8 out of 5
  • Go to More information on Report 05IC-GDHC3190CTIDB
  • View Report: Research and Experts Market Report: Haemophilus influenzae Infections Global Clinical Trials Review, H1, 2016

    Haemophilus influenzae Infections Global Clinical Trials Review, H1, 2016


    2016-01-20
    GlobalData's clinical trial report, “Haemophilus influenzae Infections Global Clinical Trials Review, H1, 2016" provides an overview of Haemophilus influenzae Infections clinical trials scenario. This report provides top line data relating...
  • Market Report
  • Healthcare
  • Global
  • $2,500.00
  • Report 05IC-GDHC3189CTIDB has a star rating of 4.6 out of 5
  • Go to More information on Report 05IC-GDHC3189CTIDB
  • View Report: Research and Experts Market Report: Haemophilus influenzae Type B Infections Global Clinical Trials Review, H1, 2016

    Haemophilus influenzae Type B Infections Global Clinical Trials Review, H1, 2016


    2016-01-20
    GlobalData's clinical trial report, “Haemophilus influenzae Type B Infections Global Clinical Trials Review, H1, 2016" provides an overview of Haemophilus influenzae Type B Infections clinical trials scenario. This report provides top line...
  • Market Report
  • Healthcare
  • Global
  • $2,500.00
  • Report 05IC-GDHC3188CTIDB has a star rating of 4.6 out of 5
  • Go to More information on Report 05IC-GDHC3188CTIDB
  • View Report: Research and Experts Market Report: Pandemic Influenza Global Clinical Trials Review, H1, 2016

    Pandemic Influenza Global Clinical Trials Review, H1, 2016


    2016-01-20
    GlobalData's clinical trial report, “Pandemic Influenza Global Clinical Trials Review, H1, 2016" provides an overview of Pandemic Influenza clinical trials scenario. This report provides top line data relating to the clinical trials on...
  • Market Report
  • Healthcare
  • Global
  • $2,500.00
  • Report 05IC-GDHC3187CTIDB has a star rating of 4.3 out of 5
  • Go to More information on Report 05IC-GDHC3187CTIDB
  • View Report: Research and Experts Company Report: ratiopharm GmbH - Strategic SWOT Analysis Review

    ratiopharm GmbH - Strategic SWOT Analysis Review


    2017-02-08
    ratiopharm GmbH (ratiopharm), a subsidiary of Teva Pharmaceutical Industries Ltd (Teva) is a pharmaceutical company that develops, manufactures and sells generic medicines and biosimilars. The company’s product portfolio comprises original products,...
  • Company Report
  • Life Sciences
  • Germany
  • $125.00
  • Report 05IC-GDPH66604SA has a star rating of 4.1 out of 5
  • Go to More information on Report 05IC-GDPH66604SA
  • View Report: Research and Experts Market Report: Familial Hypercholesterolemia (Type II Hyperlipoproteinemia) - Pipeline Review, H2 2015

    Familial Hypercholesterolemia (Type II Hyperlipoproteinemia) - Pipeline Review, H2 2015


    2015-10-30
    Familial Hypercholesterolemia (Type II Hyperlipoproteinemia) - Pipeline Review, H2 2015

    Summary

    Global Markets Direct’s, ‘Familial Hypercholesterolemia (Type II Hyperlipoproteinemia) - Pipeline Review, H2 2015’, provides an overview of...

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,000.00
  • Report 05IB-GMDHC7251IDB has a star rating of 4.4 out of 5
  • Go to More information on Report 05IB-GMDHC7251IDB
  • View Report: Research and Experts Market Report: Chagas Disease (American Trypanosomiasis) - Pipeline Review, H2 2015

    Chagas Disease (American Trypanosomiasis) - Pipeline Review, H2 2015


    2015-10-30
    Chagas Disease (American Trypanosomiasis) - Pipeline Review, H2 2015

    Summary

    Global Markets Direct’s, ‘Chagas Disease (American Trypanosomiasis) - Pipeline Review, H2 2015’, provides an overview of the Chagas Disease (American Trypanosomiasis)’s...

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,000.00
  • Report 05IB-GMDHC7235IDB has a star rating of 4.3 out of 5
  • Go to More information on Report 05IB-GMDHC7235IDB
  • View Report: Research and Experts Market Report: Overactive Bladder - Pipeline Review, H2 2015

    Overactive Bladder - Pipeline Review, H2 2015


    2015-10-30
    Overactive Bladder - Pipeline Review, H2 2015

    Summary

    Global Markets Direct’s, ‘Overactive Bladder - Pipeline Review, H2 2015’, provides an overview of the Overactive Bladder’s therapeutic pipeline.

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,000.00
  • Report 05IB-GMDHC7219IDB has a star rating of 4.5 out of 5
  • Go to More information on Report 05IB-GMDHC7219IDB
  • View Report: Research and Experts Market Report: Epithelial Ovarian Cancer - Pipeline Review, H2 2015

    Epithelial Ovarian Cancer - Pipeline Review, H2 2015


    2015-10-30
    Epithelial Ovarian Cancer - Pipeline Review, H2 2015

    Summary

    Global Markets Direct’s, ‘Epithelial Ovarian Cancer - Pipeline Review, H2 2015’, provides an overview of the Epithelial Ovarian Cancer’s therapeutic pipeline.

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,000.00
  • Report 05IB-GMDHC7214IDB has a star rating of 4.7 out of 5
  • Go to More information on Report 05IB-GMDHC7214IDB
  • View Report: Research and Experts Market Report: Adenocarcinoma of the Gastroesophageal Junction - Pipeline Review, H2 2015

    Adenocarcinoma of the Gastroesophageal Junction - Pipeline Review, H2 2015


    2015-10-30
    Adenocarcinoma of the Gastroesophageal Junction - Pipeline Review, H2 2015

    Summary

    Global Markets Direct’s, ‘Adenocarcinoma Of The Gastroesophageal Junction - Pipeline Review, H2 2015’, provides an overview of the Adenocarcinoma Of The...

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,000.00
  • Report 05IB-GMDHC7228IDB has a star rating of 4.7 out of 5
  • Go to More information on Report 05IB-GMDHC7228IDB
  • View Report: Research and Experts Market Report: Metastatic Hormone Refractory (Castration Resistant, Androgen-Independent) Prostate Cancer - Pipeline Review, H2 2015

    Metastatic Hormone Refractory (Castration Resistant, Androgen-Independent) Prostate Cancer - Pipeline Review, H2 2015


    2015-10-30
    Metastatic Hormone Refractory (Castration Resistant, Androgen-Independent) Prostate Cancer - Pipeline Review, H2 2015

    Summary

    Global Markets Direct’s, ‘Metastatic Hormone Refractory (Castration Resistant, Androgen-Independent) Prostate Cancer...

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,000.00
  • Report 05IB-GMDHC7211IDB has a star rating of 4.7 out of 5
  • Go to More information on Report 05IB-GMDHC7211IDB
  • View Report: Research and Experts Market Report: Food Allergy - Pipeline Review, H2 2015

    Food Allergy - Pipeline Review, H2 2015


    2015-10-28
    Food Allergy - Pipeline Review, H2 2015

    Summary

    Global Markets Direct’s, ‘Food Allergy - Pipeline Review, H2 2015’, provides an overview of the Food Allergy’s therapeutic pipeline.

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,000.00
  • Report 05IB-GMDHC7261IDB has a star rating of 4.1 out of 5
  • Go to More information on Report 05IB-GMDHC7261IDB
  • View Report: Research and Experts Market Report: Pertussis - Pipeline Review, H2 2015

    Pertussis - Pipeline Review, H2 2015


    2015-10-21
    Pertussis - Pipeline Review, H2 2015

    Summary

    Global Markets Direct’s, ‘Pertussis - Pipeline Review, H2 2015’, provides an overview of the Pertussis’s therapeutic pipeline.

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,000.00
  • Report 05IB-GMDHC6849IDB has a star rating of 4.4 out of 5
  • Go to More information on Report 05IB-GMDHC6849IDB
  • View Report: Research and Experts Market Report: Brain Cancer - Pipeline Review, H2 2015

    Brain Cancer - Pipeline Review, H2 2015


    2015-10-21
    Brain Cancer - Pipeline Review, H2 2015

    Summary

    Global Markets Direct’s, ‘Brain Cancer - Pipeline Review, H2 2015’, provides an overview of the Brain Cancer’s therapeutic pipeline.

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,000.00
  • Report 05IB-GMDHC6838IDB has a star rating of 4.7 out of 5
  • Go to More information on Report 05IB-GMDHC6838IDB
  • View Report: Research and Experts Market Report: Refractory Multiple Myeloma - Pipeline Review, H2 2015

    Refractory Multiple Myeloma - Pipeline Review, H2 2015


    2015-09-30
    Refractory Multiple Myeloma - Pipeline Review, H2 2015

    Summary

    Global Markets Direct’s, ‘Refractory Multiple Myeloma - Pipeline Review, H2 2015’, provides an overview of the Refractory Multiple Myeloma’s therapeutic pipeline.

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,000.00
  • Report 05IB-GMDHC7074IDB has a star rating of 4.6 out of 5
  • Go to More information on Report 05IB-GMDHC7074IDB
  • View Report: Research and Experts Market Report: Oligodendroglioma - Pipeline Review, H2 2015

    Oligodendroglioma - Pipeline Review, H2 2015


    2015-09-30
    Oligodendroglioma - Pipeline Review, H2 2015

    Summary

    Global Markets Direct’s, ‘Oligodendroglioma - Pipeline Review, H2 2015’, provides an overview of the Oligodendroglioma’s therapeutic pipeline.

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,000.00
  • Report 05IB-GMDHC7173IDB has a star rating of 4.5 out of 5
  • Go to More information on Report 05IB-GMDHC7173IDB
  • View Report: Research and Experts Market Report: Metastatic Adenocarcinoma of The Pancreas - Pipeline Review, H2 2015

    Metastatic Adenocarcinoma of The Pancreas - Pipeline Review, H2 2015


    2015-09-30
    Metastatic Adenocarcinoma of The Pancreas - Pipeline Review, H2 2015

    Summary

    Global Markets Direct’s, ‘Metastatic Adenocarcinoma of The Pancreas - Pipeline Review, H2 2015’, provides an overview of the Metastatic Adenocarcinoma of The...

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,000.00
  • Report 05IB-GMDHC6979IDB has a star rating of 4.6 out of 5
  • Go to More information on Report 05IB-GMDHC6979IDB
  • View Report: Research and Experts Market Report: Tetanus - Pipeline Review, H2 2015

    Tetanus - Pipeline Review, H2 2015


    2015-09-23
    Tetanus - Pipeline Review, H2 2015

    Summary

    Global Markets Direct’s, ‘Tetanus - Pipeline Review, H2 2015’, provides an overview of the Tetanus’s therapeutic pipeline.

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,000.00
  • Report 05IB-GMDHC7091IDB has a star rating of 4.3 out of 5
  • Go to More information on Report 05IB-GMDHC7091IDB
  • View Report: Research and Experts Market Report: Cardiomyopathy - Pipeline Review, H2 2015

    Cardiomyopathy - Pipeline Review, H2 2015


    2015-09-23
    Cardiomyopathy - Pipeline Review, H2 2015

    Summary

    Global Markets Direct’s, ‘Cardiomyopathy - Pipeline Review, H2 2015’, provides an overview of the Cardiomyopathy’s therapeutic pipeline.

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,000.00
  • Report 05IB-GMDHC7090IDB has a star rating of 4.5 out of 5
  • Go to More information on Report 05IB-GMDHC7090IDB
  • View Report: Research and Experts Market Report: Herpes Simplex Infections - Pipeline Review, H2 2015

    Herpes Simplex Infections - Pipeline Review, H2 2015


    2015-09-23
    Herpes Simplex Infections - Pipeline Review, H2 2015

    Summary

    Global Markets Direct’s, ‘Herpes Simplex Infections - Pipeline Review, H2 2015’, provides an overview of the Herpes Simplex Infections’s therapeutic pipeline.

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,000.00
  • Report 05IB-GMDHC7082IDB has a star rating of 4.6 out of 5
  • Go to More information on Report 05IB-GMDHC7082IDB
  • View Report: Research and Experts Market Report: Arterial Thrombosis - Pipeline Review, H2 2015

    Arterial Thrombosis - Pipeline Review, H2 2015


    2015-09-16
    Arterial Thrombosis - Pipeline Review, H2 2015

    Summary

    Global Markets Direct’s, ‘Arterial Thrombosis - Pipeline Review, H2 2015’, provides an overview of the Arterial Thrombosis’s therapeutic pipeline.

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,000.00
  • Report 05IB-GMDHC7120IDB has a star rating of 4.0 out of 5
  • Go to More information on Report 05IB-GMDHC7120IDB
  • View Report: Research and Experts Market Report: African Trypanosomiasis - Pipeline Review, H2 2015

    African Trypanosomiasis - Pipeline Review, H2 2015


    2015-09-16
    African Trypanosomiasis - Pipeline Review, H2 2015

    Summary

    Global Markets Direct’s, ‘African Trypanosomiasis - Pipeline Review, H2 2015’, provides an overview of the African Trypanosomiasis’s therapeutic pipeline.

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,000.00
  • Report 05IB-GMDHC7118IDB has a star rating of 4.0 out of 5
  • Go to More information on Report 05IB-GMDHC7118IDB
  • View Report: Research and Experts Market Report: Peripheral T-Cell Lymphomas (PTCL) - Pipeline Review, H2 2015

    Peripheral T-Cell Lymphomas (PTCL) - Pipeline Review, H2 2015


    2015-09-16
    Peripheral T-Cell Lymphomas (PTCL) - Pipeline Review, H2 2015

    Summary

    Global Markets Direct’s, ‘Peripheral T-Cell Lymphomas (PTCL) - Pipeline Review, H2 2015’, provides an overview of the Peripheral T-Cell Lymphomas (PTCL)’s therapeutic...

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,000.00
  • Report 05IB-GMDHC7108IDB has a star rating of 4.6 out of 5
  • Go to More information on Report 05IB-GMDHC7108IDB
  • View Report: Research and Experts Market Report: T-Cell Leukemia - Pipeline Review, H2 2015

    T-Cell Leukemia - Pipeline Review, H2 2015


    2015-09-16
    T-Cell Leukemia - Pipeline Review, H2 2015

    Summary

    Global Markets Direct’s, ‘T-Cell Leukemia - Pipeline Review, H2 2015’, provides an overview of the T-Cell Leukemia’s therapeutic pipeline.

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,000.00
  • Report 05IB-GMDHC7107IDB has a star rating of 4.2 out of 5
  • Go to More information on Report 05IB-GMDHC7107IDB
  • View Report: Research and Experts Market Report: Transitional Cell Cancer (Urothelial Cell Cancer) - Pipeline Review, H2 2015

    Transitional Cell Cancer (Urothelial Cell Cancer) - Pipeline Review, H2 2015


    2015-09-16
    Transitional Cell Cancer (Urothelial Cell Cancer) - Pipeline Review, H2 2015

    Summary

    Global Markets Direct’s, ‘Transitional Cell Cancer (Urothelial Cell Cancer) - Pipeline Review, H2 2015’, provides an overview of the Transitional Cell...

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,000.00
  • Report 05IB-GMDHC7098IDB has a star rating of 4.7 out of 5
  • Go to More information on Report 05IB-GMDHC7098IDB
  • View Report: Research and Experts Market Report: Ocular Hypertension - Pipeline Review, H2 2015

    Ocular Hypertension - Pipeline Review, H2 2015


    2015-09-16
    Ocular Hypertension - Pipeline Review, H2 2015

    Summary

    Global Markets Direct’s, ‘Ocular Hypertension - Pipeline Review, H2 2015’, provides an overview of the Ocular Hypertension’s therapeutic pipeline.

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,000.00
  • Report 05IB-GMDHC7097IDB has a star rating of 4.5 out of 5
  • Go to More information on Report 05IB-GMDHC7097IDB
  • View Report: Research and Experts Market Report: Cutaneous T-Cell Lymphoma - Pipeline Review, H2 2015

    Cutaneous T-Cell Lymphoma - Pipeline Review, H2 2015


    2015-09-16
    Cutaneous T-Cell Lymphoma - Pipeline Review, H2 2015

    Summary

    Global Markets Direct’s, ‘Cutaneous T-Cell Lymphoma - Pipeline Review, H2 2015’, provides an overview of the Cutaneous T-Cell Lymphoma’s therapeutic pipeline.

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,000.00
  • Report 05IB-GMDHC7095IDB has a star rating of 4.6 out of 5
  • Go to More information on Report 05IB-GMDHC7095IDB
  • View Report: Research and Experts Market Report: Liposarcoma - Pipeline Review, H2 2015

    Liposarcoma - Pipeline Review, H2 2015


    2015-09-09
    Liposarcoma - Pipeline Review, H2 2015

    Summary

    Global Markets Direct’s, ‘Liposarcoma - Pipeline Review, H2 2015’, provides an overview of the Liposarcoma’s therapeutic pipeline.

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,000.00
  • Report 05IB-GMDHC7131IDB has a star rating of 4.5 out of 5
  • Go to More information on Report 05IB-GMDHC7131IDB
  • View Report: Research and Experts Market Report: Systemic Lupus Erythematosus - Pipeline Review, H2 2015

    Systemic Lupus Erythematosus - Pipeline Review, H2 2015


    2015-08-31
    Systemic Lupus Erythematosus - Pipeline Review, H2 2015

    Summary

    Global Markets Direct’s, ‘Systemic Lupus Erythematosus - Pipeline Review, H2 2015’, provides an overview of the Systemic Lupus Erythematosus’s therapeutic pipeline.

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,000.00
  • Report 05IB-GMDHC7059IDB has a star rating of 4.5 out of 5
  • Go to More information on Report 05IB-GMDHC7059IDB
  • View Report: Research and Experts Market Report: Mild Cognitive Impairment - Pipeline Review, H2 2015

    Mild Cognitive Impairment - Pipeline Review, H2 2015


    2015-08-31
    Mild Cognitive Impairment - Pipeline Review, H2 2015

    Summary

    Global Markets Direct’s, ‘Mild cognitive impairment - Pipeline Review, H2 2015’, provides an overview of the Mild cognitive impairment’s therapeutic pipeline.

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,000.00
  • Report 05IB-GMDHC7058IDB has a star rating of 4.2 out of 5
  • Go to More information on Report 05IB-GMDHC7058IDB
  • View Report: Research and Experts Market Report: Open-Angle Glaucoma - Pipeline Review, H2 2015

    Open-Angle Glaucoma - Pipeline Review, H2 2015


    2015-08-31
    Open-Angle Glaucoma - Pipeline Review, H2 2015

    Summary

    Global Markets Direct’s, ‘Open-Angle Glaucoma - Pipeline Review, H2 2015’, provides an overview of the Open-Angle Glaucoma’s therapeutic pipeline.

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,000.00
  • Report 05IB-GMDHC6985IDB has a star rating of 4.3 out of 5
  • Go to More information on Report 05IB-GMDHC6985IDB
  • View Report: Research and Experts Market Report: Gastric Cancer - Pipeline Review, H2 2015

    Gastric Cancer - Pipeline Review, H2 2015


    2015-08-26
    Gastric Cancer - Pipeline Review, H2 2015

    Summary

    Global Markets Direct’s, ‘Gastric Cancer - Pipeline Review, H2 2015’, provides an overview of the Gastric Cancer’s therapeutic pipeline.

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,000.00
  • Report 05IB-GMDHC7055IDB has a star rating of 4.6 out of 5
  • Go to More information on Report 05IB-GMDHC7055IDB
  • View Report: Research and Experts Market Report: Germ Cell Tumors - Pipeline Review, H2 2015

    Germ Cell Tumors - Pipeline Review, H2 2015


    2015-08-26
    Germ Cell Tumors - Pipeline Review, H2 2015

    Summary

    Global Markets Direct’s, ‘Germ Cell Tumors - Pipeline Review, H2 2015’, provides an overview of the Germ Cell Tumors’s therapeutic pipeline.

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,000.00
  • Report 05IB-GMDHC7014IDB has a star rating of 4.1 out of 5
  • Go to More information on Report 05IB-GMDHC7014IDB
  • View Report: Research and Experts Market Report: Acute Myelocytic Leukemia (AML, Acute Myeloblastic Leukemia) - Pipeline Review, H2 2015

    Acute Myelocytic Leukemia (AML, Acute Myeloblastic Leukemia) - Pipeline Review, H2 2015


    2015-08-19
    Acute Myelocytic Leukemia (AML, Acute Myeloblastic Leukemia) - Pipeline Review, H2 2015

    Summary

    Global Markets Direct’s, ‘Acute Myelocytic Leukemia (AML, Acute Myeloblastic Leukemia) - Pipeline Review, H2 2015’, provides an overview of...

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,500.00
  • Report 05IB-GMDHC7054IDB has a star rating of 4.7 out of 5
  • Go to More information on Report 05IB-GMDHC7054IDB
  • View Report: Research and Experts Market Report: Dilated Cardiomyopathy - Pipeline Review, H2 2015

    Dilated Cardiomyopathy - Pipeline Review, H2 2015


    2015-08-12
    Dilated Cardiomyopathy - Pipeline Review, H2 2015

    Summary

    Global Markets Direct’s, ‘Dilated Cardiomyopathy - Pipeline Review, H2 2015’, provides an overview of the Dilated Cardiomyopathy’s therapeutic pipeline.

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,000.00
  • Report 05IB-GMDHC7032IDB has a star rating of 4.1 out of 5
  • Go to More information on Report 05IB-GMDHC7032IDB
  • View Report: Research and Experts Market Report: Bladder Cancer - Pipeline Review, H2 2015

    Bladder Cancer - Pipeline Review, H2 2015


    2015-07-31
    Bladder Cancer - Pipeline Review, H2 2015

    Summary

    Global Markets Direct’s, ‘Bladder Cancer - Pipeline Review, H2 2015’, provides an overview of the Bladder Cancer’s therapeutic pipeline.

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,000.00
  • Report 05IB-GMDHC6939IDB has a star rating of 4.5 out of 5
  • Go to More information on Report 05IB-GMDHC6939IDB
  • View Report: Research and Experts Market Report: Thromboembolism - Pipeline Review, H2 2015

    Thromboembolism - Pipeline Review, H2 2015


    2015-07-31
    Thromboembolism - Pipeline Review, H2 2015

    Summary

    Global Markets Direct’s, ‘Thromboembolism - Pipeline Review, H2 2015’, provides an overview of the Thromboembolism’s therapeutic pipeline.

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,000.00
  • Report 05IB-GMDHC6873IDB has a star rating of 4.2 out of 5
  • Go to More information on Report 05IB-GMDHC6873IDB
  • View Report: Research and Experts Market Report: Insulin Resistance - Pipeline Review, H2 2015

    Insulin Resistance - Pipeline Review, H2 2015


    2015-07-31
    Insulin Resistance - Pipeline Review, H2 2015

    Summary

    Global Markets Direct’s, ‘Insulin Resistance - Pipeline Review, H2 2015’, provides an overview of the Insulin Resistance’s therapeutic pipeline.

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,000.00
  • Report 05IB-GMDHC6867IDB has a star rating of 4.0 out of 5
  • Go to More information on Report 05IB-GMDHC6867IDB
  • View Report: Research and Experts Market Report: Brain Metastasis - Pipeline Review, H2 2015

    Brain Metastasis - Pipeline Review, H2 2015


    2015-07-29
    Brain Metastasis - Pipeline Review, H2 2015

    Summary

    Global Markets Direct’s, ‘Brain metastasis - Pipeline Review, H2 2015’, provides an overview of the Brain metastasis’s therapeutic pipeline.

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,000.00
  • Report 05IB-GMDHC6938IDB has a star rating of 4.5 out of 5
  • Go to More information on Report 05IB-GMDHC6938IDB
  • View Report: Research and Experts Market Report: Juvenile Macular Degeneration (Stargardt Disease) - Pipeline Review, H2 2015

    Juvenile Macular Degeneration (Stargardt Disease) - Pipeline Review, H2 2015


    2015-07-22
    Juvenile Macular Degeneration (Stargardt Disease) - Pipeline Review, H2 2015

    Summary

    Global Markets Direct’s, ‘Juvenile Macular Degeneration (Stargardt Disease) - Pipeline Review, H2 2015’, provides an overview of the Juvenile Macular...

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,000.00
  • Report 05IB-GMDHC6903IDB has a star rating of 3.9 out of 5
  • Go to More information on Report 05IB-GMDHC6903IDB
  • View Report: Research and Experts Market Report: Hyperphosphatemia - Pipeline Review, H2 2015

    Hyperphosphatemia - Pipeline Review, H2 2015


    2015-07-15
    Hyperphosphatemia - Pipeline Review, H2 2015

    Summary

    Global Markets Direct’s, ‘Hyperphosphatemia - Pipeline Review, H2 2015’, provides an overview of the Hyperphosphatemia’s therapeutic pipeline.

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,000.00
  • Report 05IB-GMDHC6931IDB has a star rating of 4.2 out of 5
  • Go to More information on Report 05IB-GMDHC6931IDB
  • View Report: Research and Experts Market Report: Glioblastoma Multiforme (GBM) - Pipeline Review, H1 2015

    Glioblastoma Multiforme (GBM) - Pipeline Review, H1 2015


    2015-06-30
    Glioblastoma Multiforme (GBM) - Pipeline Review, H1 2015

    Summary

    Global Markets Direct’s, ‘Glioblastoma Multiforme (GBM) - Pipeline Review, H1 2015’, provides an overview of the Glioblastoma Multiforme (GBM)’s therapeutic pipeline....

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,500.00
  • Report 05IB-GMDHC6676IDB has a star rating of 4.5 out of 5
  • Go to More information on Report 05IB-GMDHC6676IDB
  • View Report: Research and Experts Market Report: Ovarian Cancer - Pipeline Review, H1 2015

    Ovarian Cancer - Pipeline Review, H1 2015


    2015-06-30
    Ovarian Cancer - Pipeline Review, H1 2015

    Summary

    Global Markets Direct’s, ‘Ovarian Cancer - Pipeline Review, H1 2015’, provides an overview of the Ovarian Cancer’s therapeutic pipeline.

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,500.00
  • Report 05IB-GMDHC6675IDB has a star rating of 4.5 out of 5
  • Go to More information on Report 05IB-GMDHC6675IDB
  • View Report: Research and Experts Market Report: Pancreatic Cancer - Pipeline Review, H1 2015

    Pancreatic Cancer - Pipeline Review, H1 2015


    2015-06-30
    Pancreatic Cancer - Pipeline Review, H1 2015

    Summary

    Global Markets Direct’s, ‘Pancreatic Cancer - Pipeline Review, H1 2015’, provides an overview of the Pancreatic Cancer’s therapeutic pipeline.

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,500.00
  • Report 05IB-GMDHC6674IDB has a star rating of 4.4 out of 5
  • Go to More information on Report 05IB-GMDHC6674IDB
  • View Report: Research and Experts Market Report: Multiple Myeloma (Kahler

    Multiple Myeloma (Kahler's Disease) - Pipeline Review, H1 2015


    2015-06-30
    Multiple Myeloma (Kahler's Disease) - Pipeline Review, H1 2015

    Summary

    Global Markets Direct’s, ‘Multiple Myeloma (Kahler's Disease) - Pipeline Review, H1 2015’, provides an overview of the Multiple Myeloma (Kahler's Disease)’s...

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,500.00
  • Report 05IB-GMDHC6505IDB has a star rating of 4.5 out of 5
  • Go to More information on Report 05IB-GMDHC6505IDB
  • View Report: Research and Experts Market Report: Colorectal Cancer - Pipeline Review, H1 2015

    Colorectal Cancer - Pipeline Review, H1 2015


    2015-06-30
    Colorectal Cancer - Pipeline Review, H1 2015

    Summary

    Global Markets Direct’s, ‘Colorectal Cancer - Pipeline Review, H1 2015’, provides an overview of the Colorectal Cancer’s therapeutic pipeline.

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,500.00
  • Report 05IB-GMDHC6504IDB has a star rating of 4.5 out of 5
  • Go to More information on Report 05IB-GMDHC6504IDB
  • View Report: Research and Experts Market Report: Prostate Cancer - Pipeline Review, H1 2015

    Prostate Cancer - Pipeline Review, H1 2015


    2015-06-30
    Prostate Cancer - Pipeline Review, H1 2015

    Summary

    Global Markets Direct’s, ‘Prostate Cancer - Pipeline Review, H1 2015’, provides an overview of the Prostate Cancer’s therapeutic pipeline.

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,500.00
  • Report 05IB-GMDHC6502IDB has a star rating of 4.5 out of 5
  • Go to More information on Report 05IB-GMDHC6502IDB
  • View Report: Research and Experts Market Report: Non-Hodgkin Lymphoma - Pipeline Review, H1 2015

    Non-Hodgkin Lymphoma - Pipeline Review, H1 2015


    2015-06-30
    Non-Hodgkin Lymphoma - Pipeline Review, H1 2015

    Summary

    Global Markets Direct’s, ‘Non-Hodgkin Lymphoma - Pipeline Review, H1 2015’, provides an overview of the Non-Hodgkin Lymphoma’s therapeutic pipeline.

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,000.00
  • Report 05IB-GMDHC6498IDB has a star rating of 4.4 out of 5
  • Go to More information on Report 05IB-GMDHC6498IDB
  • View Report: Research and Experts Market Report: Non-Small Cell Lung Cancer - Pipeline Review, H1 2015

    Non-Small Cell Lung Cancer - Pipeline Review, H1 2015


    2015-06-30
    Non-Small Cell Lung Cancer - Pipeline Review, H1 2015

    Summary

    Global Markets Direct’s, ‘Non-Small Cell Lung Cancer - Pipeline Review, H1 2015’, provides an overview of the Non-Small Cell Lung Cancer’s therapeutic pipeline.

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,500.00
  • Report 05IB-GMDHC6495IDB has a star rating of 4.5 out of 5
  • Go to More information on Report 05IB-GMDHC6495IDB
  • View Report: Research and Experts Market Report: Chronic Lymphocytic Leukemia (CLL) - Pipeline Review, H1 2015

    Chronic Lymphocytic Leukemia (CLL) - Pipeline Review, H1 2015


    2015-06-30
    Chronic Lymphocytic Leukemia (CLL) - Pipeline Review, H1 2015

    Summary

    Global Markets Direct’s, ‘Chronic Lymphocytic Leukemia (CLL) - Pipeline Review, H1 2015’, provides an overview of the Chronic Lymphocytic Leukemia (CLL)’s therapeutic...

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,000.00
  • Report 05IB-GMDHC6567IDB has a star rating of 4.5 out of 5
  • Go to More information on Report 05IB-GMDHC6567IDB
  • View Report: Research and Experts Market Report: Parkinson

    Parkinson's Disease - Pipeline Review, H1 2015


    2015-06-30
    Parkinson's Disease - Pipeline Review, H1 2015

    Summary

    Global Markets Direct’s, ‘Parkinson's Disease - Pipeline Review, H1 2015’, provides an overview of the Parkinson's Disease’s therapeutic pipeline.

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,500.00
  • Report 05IB-GMDHC6562IDB has a star rating of 4.5 out of 5
  • Go to More information on Report 05IB-GMDHC6562IDB
  • View Report: Research and Experts Market Report: Acute Lymphocytic Leukemia (ALL, Acute Lymphoblastic Leukemia) - Pipeline Review, H1 2015

    Acute Lymphocytic Leukemia (ALL, Acute Lymphoblastic Leukemia) - Pipeline Review, H1 2015


    2015-06-30
    Acute Lymphocytic Leukemia (ALL, Acute Lymphoblastic Leukemia) - Pipeline Review, H1 2015

    Summary

    Global Markets Direct’s, ‘Acute Lymphocytic Leukemia (ALL, Acute Lymphoblastic Leukemia) - Pipeline Review, H1 2015’, provides an overview...

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,000.00
  • Report 05IB-GMDHC6509IDB has a star rating of 4.4 out of 5
  • Go to More information on Report 05IB-GMDHC6509IDB
  • View Report: Research and Experts Market Report: Multiple Sclerosis - Pipeline Review, H1 2015

    Multiple Sclerosis - Pipeline Review, H1 2015


    2015-06-30
    Multiple Sclerosis - Pipeline Review, H1 2015

    Summary

    Global Markets Direct’s, ‘Multiple Sclerosis - Pipeline Review, H1 2015’, provides an overview of the Multiple Sclerosis’s therapeutic pipeline.

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,500.00
  • Report 05IB-GMDHC6497IDB has a star rating of 4.5 out of 5
  • Go to More information on Report 05IB-GMDHC6497IDB
  • View Report: Research and Experts Market Report: HIV / AIDS - Pipeline Review, H1 2015

    HIV / AIDS - Pipeline Review, H1 2015


    2015-06-30
    HIV / AIDS - Pipeline Review, H1 2015

    Summary

    Global Markets Direct’s, ‘HIV / AIDS - Pipeline Review, H1 2015’, provides an overview of the HIV / AIDS’s therapeutic pipeline.

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,500.00
  • Report 05IB-GMDHC6496IDB has a star rating of 4.5 out of 5
  • Go to More information on Report 05IB-GMDHC6496IDB
  • View Report: Research and Experts Market Report: Transitional Cell Carcinoma (Urothelial Cell Carcinoma) - Pipeline Review, H1 2015

    Transitional Cell Carcinoma (Urothelial Cell Carcinoma) - Pipeline Review, H1 2015


    2015-06-30
    Transitional Cell Carcinoma (Urothelial Cell Carcinoma) - Pipeline Review, H1 2015

    Summary

    Global Markets Direct’s, ‘Transitional Cell Carcinoma (Urothelial Cell Carcinoma) - Pipeline Review, H1 2015’, provides an overview of the Transitional...

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,000.00
  • Report 05IB-GMDHC6814IDB has a star rating of 4.3 out of 5
  • Go to More information on Report 05IB-GMDHC6814IDB
  • View Report: Research and Experts Market Report: Malaria - Pipeline Review, H1 2015

    Malaria - Pipeline Review, H1 2015


    2015-06-30
    Malaria - Pipeline Review, H1 2015

    Summary

    Global Markets Direct’s, ‘Malaria - Pipeline Review, H1 2015’, provides an overview of the Malaria’s therapeutic pipeline.

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,000.00
  • Report 05IB-GMDHC6677IDB has a star rating of 4.5 out of 5
  • Go to More information on Report 05IB-GMDHC6677IDB
  • View Report: Research and Experts Market Report: Osteoarthritis - Pipeline Review, H1 2015

    Osteoarthritis - Pipeline Review, H1 2015


    2015-06-30
    Osteoarthritis - Pipeline Review, H1 2015

    Summary

    Global Markets Direct’s, ‘Osteoarthritis - Pipeline Review, H1 2015’, provides an overview of the Osteoarthritis’s therapeutic pipeline.

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,000.00
  • Report 05IB-GMDHC6571IDB has a star rating of 4.5 out of 5
  • Go to More information on Report 05IB-GMDHC6571IDB
  • View Report: Research and Experts Market Report: Tuberculosis - Pipeline Review, H1 2015

    Tuberculosis - Pipeline Review, H1 2015


    2015-06-30
    Tuberculosis - Pipeline Review, H1 2015

    Summary

    Global Markets Direct’s, ‘Tuberculosis - Pipeline Review, H1 2015’, provides an overview of the Tuberculosis’s therapeutic pipeline.

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,000.00
  • Report 05IB-GMDHC6566IDB has a star rating of 4.4 out of 5
  • Go to More information on Report 05IB-GMDHC6566IDB
  • View Report: Research and Experts Market Report: Hypertension - Pipeline Review, H1 2015

    Hypertension - Pipeline Review, H1 2015


    2015-06-30
    Hypertension - Pipeline Review, H1 2015

    Summary

    Global Markets Direct’s, ‘Hypertension - Pipeline Review, H1 2015’, provides an overview of the Hypertension’s therapeutic pipeline.

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,000.00
  • Report 05IB-GMDHC6565IDB has a star rating of 4.5 out of 5
  • Go to More information on Report 05IB-GMDHC6565IDB
  • View Report: Research and Experts Market Report: Thrombosis - Pipeline Review, H1 2015

    Thrombosis - Pipeline Review, H1 2015


    2015-06-30
    Thrombosis - Pipeline Review, H1 2015

    Summary

    Global Markets Direct’s, ‘Thrombosis - Pipeline Review, H1 2015’, provides an overview of the Thrombosis’s therapeutic pipeline.

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,000.00
  • Report 05IB-GMDHC6511IDB has a star rating of 4.4 out of 5
  • Go to More information on Report 05IB-GMDHC6511IDB
  • View Report: Research and Experts Market Report: Kidney Cancer - Pipeline Review, H1 2015

    Kidney Cancer - Pipeline Review, H1 2015


    2015-06-30
    Kidney Cancer - Pipeline Review, H1 2015

    Summary

    Global Markets Direct’s, ‘Kidney Cancer - Pipeline Review, H1 2015’, provides an overview of the Kidney Cancer’s therapeutic pipeline.

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,000.00
  • Report 05IB-GMDHC6492IDB has a star rating of 4.4 out of 5
  • Go to More information on Report 05IB-GMDHC6492IDB
  • View Report: Research and Experts Market Report: Acute Myelocytic Leukemia (AML, Acute Myeloblastic Leukemia) - Pipeline Review, H1 2015

    Acute Myelocytic Leukemia (AML, Acute Myeloblastic Leukemia) - Pipeline Review, H1 2015


    2015-06-30
    Acute Myelocytic Leukemia (AML, Acute Myeloblastic Leukemia) - Pipeline Review, H1 2015

    Summary

    Global Markets Direct’s, ‘Acute Myelocytic Leukemia (AML, Acute Myeloblastic Leukemia) - Pipeline Review, H1 2015’, provides an overview of...

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,500.00
  • Report 05IB-GMDHC6490IDB has a star rating of 4.5 out of 5
  • Go to More information on Report 05IB-GMDHC6490IDB
  • View Report: Research and Experts Market Report: Wounds - Pipeline Review, H1 2015

    Wounds - Pipeline Review, H1 2015


    2015-06-30
    Wounds - Pipeline Review, H1 2015

    Summary

    Global Markets Direct’s, ‘Wounds - Pipeline Review, H1 2015’, provides an overview of the Wounds’s therapeutic pipeline.

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,000.00
  • Report 05IB-GMDHC6573IDB has a star rating of 4.5 out of 5
  • Go to More information on Report 05IB-GMDHC6573IDB
  • View Report: Research and Experts Market Report: Metastatic Hormone Refractory (Castration Resistant, Androgen-Independent) Prostate Cancer - Pipeline Review, H1 2015

    Metastatic Hormone Refractory (Castration Resistant, Androgen-Independent) Prostate Cancer - Pipeline Review, H1 2015


    2015-06-30
    Metastatic Hormone Refractory (Castration Resistant, Androgen-Independent) Prostate Cancer - Pipeline Review, H1 2015

    Summary

    Global Markets Direct’s, ‘Metastatic Hormone Refractory (Castration Resistant, Androgen-Independent) Prostate Cancer...

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,000.00
  • Report 05IB-GMDHC6518IDB has a star rating of 4.5 out of 5
  • Go to More information on Report 05IB-GMDHC6518IDB
  • View Report: Research and Experts Market Report: Cervical Cancer - Pipeline Review, H1 2015

    Cervical Cancer - Pipeline Review, H1 2015


    2015-06-30
    Cervical Cancer - Pipeline Review, H1 2015

    Summary

    Global Markets Direct’s, ‘Cervical Cancer - Pipeline Review, H1 2015’, provides an overview of the Cervical Cancer’s therapeutic pipeline.

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,000.00
  • Report 05IB-GMDHC6517IDB has a star rating of 4.5 out of 5
  • Go to More information on Report 05IB-GMDHC6517IDB
  • View Report: Research and Experts Market Report: Refractory Chronic Lymphocytic Leukemia (CLL) - Pipeline Review, H1 2015

    Refractory Chronic Lymphocytic Leukemia (CLL) - Pipeline Review, H1 2015


    2015-06-24
    Refractory Chronic Lymphocytic Leukemia (CLL) - Pipeline Review, H1 2015

    Summary

    Global Markets Direct’s, ‘Refractory Chronic Lymphocytic Leukemia (CLL) - Pipeline Review, H1 2015’, provides an overview of the Refractory Chronic Lymphocytic...

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,000.00
  • Report 05IB-GMDHC6697IDB has a star rating of 4.4 out of 5
  • Go to More information on Report 05IB-GMDHC6697IDB
  • View Report: Research and Experts Market Report: Hypercholesterolemia - Pipeline Review, H1 2015

    Hypercholesterolemia - Pipeline Review, H1 2015


    2015-06-24
    Hypercholesterolemia - Pipeline Review, H1 2015

    Summary

    Global Markets Direct’s, ‘Hypercholesterolemia - Pipeline Review, H1 2015’, provides an overview of the Hypercholesterolemia’s therapeutic pipeline.

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,000.00
  • Report 05IB-GMDHC6694IDB has a star rating of 4.4 out of 5
  • Go to More information on Report 05IB-GMDHC6694IDB
  • View Report: Research and Experts Market Report: Systemic Lupus Erythematosus - Pipeline Review, H1 2015

    Systemic Lupus Erythematosus - Pipeline Review, H1 2015


    2015-06-24
    Systemic Lupus Erythematosus - Pipeline Review, H1 2015

    Summary

    Global Markets Direct’s, ‘Systemic Lupus Erythematosus - Pipeline Review, H1 2015’, provides an overview of the Systemic Lupus Erythematosus’s therapeutic pipeline.

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,000.00
  • Report 05IB-GMDHC6687IDB has a star rating of 4.5 out of 5
  • Go to More information on Report 05IB-GMDHC6687IDB
  • View Report: Research and Experts Market Report: Bladder Cancer - Pipeline Review, H1 2015

    Bladder Cancer - Pipeline Review, H1 2015


    2015-06-24
    Bladder Cancer - Pipeline Review, H1 2015

    Summary

    Global Markets Direct’s, ‘Bladder Cancer - Pipeline Review, H1 2015’, provides an overview of the Bladder Cancer’s therapeutic pipeline.

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,000.00
  • Report 05IB-GMDHC6683IDB has a star rating of 4.5 out of 5
  • Go to More information on Report 05IB-GMDHC6683IDB
  • View Report: Research and Experts Market Report: Gliosarcoma - Pipeline Review, H1 2015

    Gliosarcoma - Pipeline Review, H1 2015


    2015-06-17
    Gliosarcoma - Pipeline Review, H1 2015

    Summary

    Global Markets Direct’s, ‘Gliosarcoma - Pipeline Review, H1 2015’, provides an overview of the Gliosarcoma’s therapeutic pipeline.

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,000.00
  • Report 05IB-GMDHC6801IDB has a star rating of 3.9 out of 5
  • Go to More information on Report 05IB-GMDHC6801IDB
  • View Report: Research and Experts Market Report: Retinitis Pigmentosa (Retinitis) - Pipeline Review, H1 2015

    Retinitis Pigmentosa (Retinitis) - Pipeline Review, H1 2015


    2015-06-17
    Retinitis Pigmentosa (Retinitis) - Pipeline Review, H1 2015

    Summary

    Global Markets Direct’s, ‘Retinitis Pigmentosa (Retinitis) - Pipeline Review, H1 2015’, provides an overview of the Retinitis Pigmentosa (Retinitis)’s therapeutic...

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,000.00
  • Report 05IB-GMDHC6700IDB has a star rating of 4.3 out of 5
  • Go to More information on Report 05IB-GMDHC6700IDB
  • View Report: Research and Experts Market Report: Relapsed Chronic Lymphocytic Leukemia (CLL) - Pipeline Review, H1 2015

    Relapsed Chronic Lymphocytic Leukemia (CLL) - Pipeline Review, H1 2015


    2015-06-17
    Relapsed Chronic Lymphocytic Leukemia (CLL) - Pipeline Review, H1 2015

    Summary

    Global Markets Direct’s, ‘Relapsed Chronic Lymphocytic Leukemia (CLL) - Pipeline Review, H1 2015’, provides an overview of the Relapsed Chronic Lymphocytic...

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,000.00
  • Report 05IB-GMDHC6699IDB has a star rating of 4.4 out of 5
  • Go to More information on Report 05IB-GMDHC6699IDB
  • View Report: Research and Experts Market Report: Diphtheria - Pipeline Review, H1 2015

    Diphtheria - Pipeline Review, H1 2015


    2015-06-10
    Diphtheria - Pipeline Review, H1 2015

    Summary

    Global Markets Direct’s, ‘Diphtheria - Pipeline Review, H1 2015’, provides an overview of the Diphtheria’s therapeutic pipeline.

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,000.00
  • Report 05IB-GMDHC6707IDB has a star rating of 4.1 out of 5
  • Go to More information on Report 05IB-GMDHC6707IDB
  • View Report: Research and Experts Market Report: Bile Duct Cancer (Cholangiocarcinoma) - Pipeline Review, H1 2015

    Bile Duct Cancer (Cholangiocarcinoma) - Pipeline Review, H1 2015


    2015-06-10
    Bile Duct Cancer (Cholangiocarcinoma) - Pipeline Review, H1 2015

    Summary

    Global Markets Direct’s, ‘Bile Duct Cancer (Cholangiocarcinoma) - Pipeline Review, H1 2015’, provides an overview of the Bile Duct Cancer (Cholangiocarcinoma)’s...

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,000.00
  • Report 05IB-GMDHC6705IDB has a star rating of 4.4 out of 5
  • Go to More information on Report 05IB-GMDHC6705IDB
  • View Report: Research and Experts Market Report: Leishmaniasis (Kala-Azar) - Pipeline Review, H1 2015

    Leishmaniasis (Kala-Azar) - Pipeline Review, H1 2015


    2015-06-10
    Leishmaniasis (Kala-Azar) - Pipeline Review, H1 2015

    Summary

    Global Markets Direct’s, ‘Leishmaniasis (Kala-Azar) - Pipeline Review, H1 2015’, provides an overview of the Leishmaniasis (Kala-Azar)’s therapeutic pipeline.

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,000.00
  • Report 05IB-GMDHC6703IDB has a star rating of 4.1 out of 5
  • Go to More information on Report 05IB-GMDHC6703IDB
  • View Report: Research and Experts Market Report: Endometrial Cancer - Pipeline Review, H1 2015

    Endometrial Cancer - Pipeline Review, H1 2015


    2015-05-29
    Endometrial Cancer - Pipeline Review, H1 2015

    Summary

    Global Markets Direct’s, ‘Endometrial Cancer - Pipeline Review, H1 2015’, provides an overview of the Endometrial Cancer’s therapeutic pipeline.

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,000.00
  • Report 05IB-GMDHC6584IDB has a star rating of 4.3 out of 5
  • Go to More information on Report 05IB-GMDHC6584IDB
  • View Report: Research and Experts Market Report: Sickle Cell Disease - Pipeline Review, H1 2015

    Sickle Cell Disease - Pipeline Review, H1 2015


    2015-05-29
    Sickle Cell Disease - Pipeline Review, H1 2015

    Summary

    Global Markets Direct’s, ‘Sickle Cell Disease - Pipeline Review, H1 2015’, provides an overview of the Sickle Cell Disease’s therapeutic pipeline.

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,000.00
  • Report 05IB-GMDHC6583IDB has a star rating of 4.3 out of 5
  • Go to More information on Report 05IB-GMDHC6583IDB
  • View Report: Research and Experts Market Report: Soft Tissue Sarcoma - Pipeline Review, H1 2015

    Soft Tissue Sarcoma - Pipeline Review, H1 2015


    2015-05-29
    Soft Tissue Sarcoma - Pipeline Review, H1 2015

    Summary

    Global Markets Direct’s, ‘Soft Tissue Sarcoma - Pipeline Review, H1 2015’, provides an overview of the Soft Tissue Sarcoma’s therapeutic pipeline.

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,000.00
  • Report 05IB-GMDHC6580IDB has a star rating of 4.3 out of 5
  • Go to More information on Report 05IB-GMDHC6580IDB
  • View Report: Research and Experts Market Report: Epithelial Ovarian Cancer - Pipeline Review, H1 2015

    Epithelial Ovarian Cancer - Pipeline Review, H1 2015


    2015-05-29
    Epithelial Ovarian Cancer - Pipeline Review, H1 2015

    Summary

    Global Markets Direct’s, ‘Epithelial Ovarian Cancer - Pipeline Review, H1 2015’, provides an overview of the Epithelial Ovarian Cancer’s therapeutic pipeline.

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,000.00
  • Report 05IB-GMDHC6521IDB has a star rating of 4.3 out of 5
  • Go to More information on Report 05IB-GMDHC6521IDB
  • View Report: Research and Experts Market Report: High-Grade Glioma - Pipeline Review, H1 2015

    High-Grade Glioma - Pipeline Review, H1 2015


    2015-05-29
    High-Grade Glioma - Pipeline Review, H1 2015

    Summary

    Global Markets Direct’s, ‘High-Grade Glioma - Pipeline Review, H1 2015’, provides an overview of the High-Grade Glioma’s therapeutic pipeline.

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,000.00
  • Report 05IB-GMDHC6725IDB has a star rating of 4.1 out of 5
  • Go to More information on Report 05IB-GMDHC6725IDB
  • View Report: Research and Experts Market Report: Lung Adenocarcinoma - Pipeline Review, H1 2015

    Lung Adenocarcinoma - Pipeline Review, H1 2015


    2015-05-29
    Lung Adenocarcinoma - Pipeline Review, H1 2015

    Summary

    Global Markets Direct’s, ‘Lung Adenocarcinoma - Pipeline Review, H1 2015’, provides an overview of the Lung Adenocarcinoma’s therapeutic pipeline.

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,000.00
  • Report 05IB-GMDHC6718IDB has a star rating of 4.1 out of 5
  • Go to More information on Report 05IB-GMDHC6718IDB
  • View Report: Research and Experts Market Report: Chronic Heart Failure - Pipeline Review, H1 2015

    Chronic Heart Failure - Pipeline Review, H1 2015


    2015-05-29
    Chronic Heart Failure - Pipeline Review, H1 2015

    Summary

    Global Markets Direct’s, ‘Chronic Heart Failure - Pipeline Review, H1 2015’, provides an overview of the Chronic Heart Failure’s therapeutic pipeline.

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,000.00
  • Report 05IB-GMDHC6597IDB has a star rating of 4.2 out of 5
  • Go to More information on Report 05IB-GMDHC6597IDB
  • View Report: Research and Experts Market Report: Brain Metastasis - Pipeline Review, H1 2015

    Brain Metastasis - Pipeline Review, H1 2015


    2015-05-29
    Brain Metastasis - Pipeline Review, H1 2015

    Summary

    Global Markets Direct’s, ‘Brain Metastasis - Pipeline Review, H1 2015’, provides an overview of the Brain Metastasis’s therapeutic pipeline.

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,000.00
  • Report 05IB-GMDHC6593IDB has a star rating of 4.3 out of 5
  • Go to More information on Report 05IB-GMDHC6593IDB
  • View Report: Research and Experts Market Report: Relapsing Remitting Multiple Sclerosis (RRMS) - Pipeline Review, H1 2015

    Relapsing Remitting Multiple Sclerosis (RRMS) - Pipeline Review, H1 2015


    2015-05-29
    Relapsing Remitting Multiple Sclerosis (RRMS) - Pipeline Review, H1 2015

    Summary

    Global Markets Direct’s, ‘Relapsing Remitting Multiple Sclerosis (RRMS) - Pipeline Review, H1 2015’, provides an overview of the Relapsing Remitting Multiple...

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,000.00
  • Report 05IB-GMDHC6590IDB has a star rating of 4.3 out of 5
  • Go to More information on Report 05IB-GMDHC6590IDB
  • View Report: Research and Experts Market Report: Diabetic Foot Ulcers - Pipeline Review, H1 2015

    Diabetic Foot Ulcers - Pipeline Review, H1 2015


    2015-05-29
    Diabetic Foot Ulcers - Pipeline Review, H1 2015

    Summary

    Global Markets Direct’s, ‘Diabetic Foot Ulcers - Pipeline Review, H1 2015’, provides an overview of the Diabetic Foot Ulcers’s therapeutic pipeline.

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,000.00
  • Report 05IB-GMDHC6588IDB has a star rating of 4.3 out of 5
  • Go to More information on Report 05IB-GMDHC6588IDB
  • View Report: Research and Experts Market Report: Adenocarcinoma Of The Gastroesophageal Junction - Pipeline Review, H1 2015

    Adenocarcinoma Of The Gastroesophageal Junction - Pipeline Review, H1 2015


    2015-05-29
    Adenocarcinoma Of The Gastroesophageal Junction - Pipeline Review, H1 2015

    Summary

    Global Markets Direct’s, ‘Adenocarcinoma Of The Gastroesophageal Junction - Pipeline Review, H1 2015’, provides an overview of the Adenocarcinoma Of The...

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,000.00
  • Report 05IB-GMDHC6533IDB has a star rating of 4.3 out of 5
  • Go to More information on Report 05IB-GMDHC6533IDB
  • View Report: Research and Experts Market Report: Overactive Bladder - Pipeline Review, H1 2015

    Overactive Bladder - Pipeline Review, H1 2015


    2015-05-29
    Overactive Bladder - Pipeline Review, H1 2015

    Summary

    Global Markets Direct’s, ‘Overactive Bladder - Pipeline Review, H1 2015’, provides an overview of the Overactive Bladder’s therapeutic pipeline.

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,000.00
  • Report 05IB-GMDHC6525IDB has a star rating of 4.1 out of 5
  • Go to More information on Report 05IB-GMDHC6525IDB
  • View Report: Research and Experts Market Report: Type 1 Diabetes (Juvenile Diabetes) - Pipeline Review, H1 2015

    Type 1 Diabetes (Juvenile Diabetes) - Pipeline Review, H1 2015


    2015-05-13
    Type 1 Diabetes (Juvenile Diabetes) - Pipeline Review, H1 2015

    Summary

    Global Markets Direct’s, ‘Type 1 Diabetes (Juvenile Diabetes) - Pipeline Review, H1 2015’, provides an overview of the Type 1 Diabetes (Juvenile Diabetes)’s therapeutic...

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,000.00
  • Report 05IB-GMDHC6506IDB has a star rating of 4.3 out of 5
  • Go to More information on Report 05IB-GMDHC6506IDB
  • View Report: Research and Experts Market Report: Anaplastic Astrocytoma - Pipeline Review, H1 2015

    Anaplastic Astrocytoma - Pipeline Review, H1 2015


    2015-05-13
    Anaplastic Astrocytoma - Pipeline Review, H1 2015

    Summary

    Global Markets Direct’s, ‘Anaplastic Astrocytoma - Pipeline Review, H1 2015’, provides an overview of the Anaplastic Astrocytoma’s therapeutic pipeline.

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,000.00
  • Report 05IB-GMDHC6750IDB has a star rating of 4.0 out of 5
  • Go to More information on Report 05IB-GMDHC6750IDB
  • View Report: Research and Experts Market Report: Japanese Encephalitis - Pipeline Review, H1 2015

    Japanese Encephalitis - Pipeline Review, H1 2015


    2015-05-13
    Japanese Encephalitis - Pipeline Review, H1 2015

    Summary

    Global Markets Direct’s, ‘Japanese Encephalitis - Pipeline Review, H1 2015’, provides an overview of the Japanese Encephalitis’s therapeutic pipeline.

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,000.00
  • Report 05IB-GMDHC6752IDB has a star rating of 3.7 out of 5
  • Go to More information on Report 05IB-GMDHC6752IDB
  • View Report: Research and Experts Market Report: Rabies - Pipeline Review, H1 2015

    Rabies - Pipeline Review, H1 2015


    2015-04-30
    Rabies - Pipeline Review, H1 2015

    Summary

    Global Markets Direct’s, ‘Rabies - Pipeline Review, H1 2015’, provides an overview of the Rabies’s therapeutic pipeline.

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,000.00
  • Report 05IB-GMDHC6601IDB has a star rating of 3.8 out of 5
  • Go to More information on Report 05IB-GMDHC6601IDB
  • View Report: Research and Experts Market Report: Mild Cognitive Impairment - Pipeline Review, H1 2015

    Mild Cognitive Impairment - Pipeline Review, H1 2015


    2015-04-30
    Mild Cognitive Impairment - Pipeline Review, H1 2015

    Summary

    Global Markets Direct’s, ‘Mild Cognitive Impairment - Pipeline Review, H1 2015’, provides an overview of the Mild Cognitive Impairment’s therapeutic pipeline.

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,000.00
  • Report 05IB-GMDHC6544IDB has a star rating of 3.9 out of 5
  • Go to More information on Report 05IB-GMDHC6544IDB
  • View Report: Research and Experts Market Report: Chagas Disease (American Trypanosomiasis) - Pipeline Review, H1 2015

    Chagas Disease (American Trypanosomiasis) - Pipeline Review, H1 2015


    2015-04-30
    Chagas Disease (American Trypanosomiasis) - Pipeline Review, H1 2015

    Summary

    Global Markets Direct’s, ‘Chagas Disease (American Trypanosomiasis) - Pipeline Review, H1 2015’, provides an overview of the Chagas Disease (American Trypanosomiasis)’s...

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,000.00
  • Report 05IB-GMDHC6540IDB has a star rating of 3.8 out of 5
  • Go to More information on Report 05IB-GMDHC6540IDB
  • View Report: Research and Experts Market Report: Venous Thromboembolism - Pipeline Review, H1 2015

    Venous Thromboembolism - Pipeline Review, H1 2015


    2015-04-29
    Venous Thromboembolism - Pipeline Review, H1 2015

    Summary

    Global Markets Direct’s, ‘Venous Thromboembolism - Pipeline Review, H1 2015’, provides an overview of the Venous Thromboembolism’s therapeutic pipeline.

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,000.00
  • Report 05IB-GMDHC6627IDB has a star rating of 3.8 out of 5
  • Go to More information on Report 05IB-GMDHC6627IDB
  • View Report: Research and Experts Market Report: Primary Immune Deficiency (PID) - Pipeline Review, H1 2015

    Primary Immune Deficiency (PID) - Pipeline Review, H1 2015


    2015-04-29
    Primary Immune Deficiency (PID) - Pipeline Review, H1 2015

    Summary

    Global Markets Direct’s, ‘Primary Immune Deficiency (PID) - Pipeline Review, H1 2015’, provides an overview of the Primary Immune Deficiency (PID)’s therapeutic pipeline....

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,000.00
  • Report 05IB-GMDHC6614IDB has a star rating of 3.8 out of 5
  • Go to More information on Report 05IB-GMDHC6614IDB
  • View Report: Research and Experts Market Report: Relapsed Multiple Myeloma - Pipeline Review, H1 2015

    Relapsed Multiple Myeloma - Pipeline Review, H1 2015


    2015-03-31
    Relapsed Multiple Myeloma - Pipeline Review, H1 2015

    Summary

    Global Markets Direct’s, ‘Relapsed Multiple Myeloma - Pipeline Review, H1 2015’, provides an overview of the Relapsed Multiple Myeloma’s therapeutic pipeline.

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,000.00
  • Report 05IB-GMDHC6247IDB has a star rating of 4.1 out of 5
  • Go to More information on Report 05IB-GMDHC6247IDB
  • View Report: Research and Experts Market Report: Cognitive Impairment - Pipeline Review, H1 2015

    Cognitive Impairment - Pipeline Review, H1 2015


    2015-03-31
    Cognitive Impairment - Pipeline Review, H1 2015

    Summary

    Global Markets Direct’s, ‘Cognitive Impairment - Pipeline Review, H1 2015’, provides an overview of the Cognitive Impairment’s therapeutic pipeline.

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,000.00
  • Report 05IB-GMDHC6243IDB has a star rating of 4.1 out of 5
  • Go to More information on Report 05IB-GMDHC6243IDB
  • View Report: Research and Experts Market Report: Gastric Cancer - Pipeline Review, H1 2015

    Gastric Cancer - Pipeline Review, H1 2015


    2015-03-31
    Gastric Cancer - Pipeline Review, H1 2015

    Summary

    Global Markets Direct’s, ‘Gastric Cancer - Pipeline Review, H1 2015’, provides an overview of the Gastric Cancer’s therapeutic pipeline.

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,000.00
  • Report 05IB-GMDHC6238IDB has a star rating of 4.1 out of 5
  • Go to More information on Report 05IB-GMDHC6238IDB
  • View Report: Research and Experts Market Report: Idiopathic Pulmonary Fibrosis - Pipeline Review, H1 2015

    Idiopathic Pulmonary Fibrosis - Pipeline Review, H1 2015


    2015-03-26
    Idiopathic Pulmonary Fibrosis - Pipeline Review, H1 2015

    Summary

    Global Markets Direct’s, ‘Idiopathic Pulmonary Fibrosis - Pipeline Review, H1 2015’, provides an overview of the Idiopathic Pulmonary Fibrosis’s therapeutic pipeline....

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,000.00
  • Report 05IB-GMDHC6473IDB has a star rating of 4.0 out of 5
  • Go to More information on Report 05IB-GMDHC6473IDB
  • View Report: Research and Experts Market Report: Familial Hypercholesterolemia (Type II Hyperlipoproteinemia) - Pipeline Review, H1 2015

    Familial Hypercholesterolemia (Type II Hyperlipoproteinemia) - Pipeline Review, H1 2015


    2015-03-26
    Familial Hypercholesterolemia (Type II Hyperlipoproteinemia) - Pipeline Review, H1 2015

    Summary

    Global Markets Direct’s, ‘Familial Hypercholesterolemia (Type II Hyperlipoproteinemia) - Pipeline Review, H1 2015’, provides an overview of...

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,000.00
  • Report 05IB-GMDHC6413IDB has a star rating of 3.7 out of 5
  • Go to More information on Report 05IB-GMDHC6413IDB
  • View Report: Research and Experts Market Report: Oligodendroglioma - Pipeline Review, H1 2015

    Oligodendroglioma - Pipeline Review, H1 2015


    2015-03-19
    Oligodendroglioma - Pipeline Review, H1 2015

    Summary

    Global Markets Direct’s, ‘Oligodendroglioma - Pipeline Review, H1 2015’, provides an overview of the Oligodendroglioma’s therapeutic pipeline.

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,000.00
  • Report 05IB-GMDHC6462IDB has a star rating of 3.7 out of 5
  • Go to More information on Report 05IB-GMDHC6462IDB
  • View Report: Research and Experts Market Report: Food Allergy - Pipeline Review, H1 2015

    Food Allergy - Pipeline Review, H1 2015


    2015-03-19
    Food Allergy - Pipeline Review, H1 2015

    Summary

    Global Markets Direct’s, ‘Food Allergy - Pipeline Review, H1 2015’, provides an overview of the Food Allergy’s therapeutic pipeline.

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,000.00
  • Report 05IB-GMDHC6423IDB has a star rating of 3.5 out of 5
  • Go to More information on Report 05IB-GMDHC6423IDB
  • View Report: Research and Experts Market Report: Tetanus - Pipeline Review, H1 2015

    Tetanus - Pipeline Review, H1 2015


    2015-03-11
    Tetanus - Pipeline Review, H1 2015

    Summary

    Global Markets Direct’s, ‘Tetanus - Pipeline Review, H1 2015’, provides an overview of the Tetanus’s therapeutic pipeline.

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,000.00
  • Report 05IB-GMDHC6264IDB has a star rating of 3.7 out of 5
  • Go to More information on Report 05IB-GMDHC6264IDB
  • View Report: Research and Experts Market Report: Cardiomyopathy - Pipeline Review, H1 2015

    Cardiomyopathy - Pipeline Review, H1 2015


    2015-03-11
    Cardiomyopathy - Pipeline Review, H1 2015

    Summary

    Global Markets Direct’s, ‘Cardiomyopathy - Pipeline Review, H1 2015’, provides an overview of the Cardiomyopathy’s therapeutic pipeline.

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,000.00
  • Report 05IB-GMDHC6263IDB has a star rating of 3.8 out of 5
  • Go to More information on Report 05IB-GMDHC6263IDB
  • View Report: Research and Experts Market Report: Herpes Simplex Infections - Pipeline Review, H1 2015

    Herpes Simplex Infections - Pipeline Review, H1 2015


    2015-03-11
    Herpes Simplex Infections - Pipeline Review, H1 2015

    Summary

    Global Markets Direct’s, ‘Herpes Simplex Infections - Pipeline Review, H1 2015’, provides an overview of the Herpes Simplex Infections’s therapeutic pipeline.

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,000.00
  • Report 05IB-GMDHC6255IDB has a star rating of 4.1 out of 5
  • Go to More information on Report 05IB-GMDHC6255IDB
  • View Report: Research and Experts Market Report: Cutaneous T-Cell Lymphoma - Pipeline Review, H1 2015

    Cutaneous T-Cell Lymphoma - Pipeline Review, H1 2015


    2015-02-28
    Cutaneous T-Cell Lymphoma - Pipeline Review, H1 2015

    Summary

    Global Markets Direct’s, ‘Cutaneous T-Cell Lymphoma - Pipeline Review, H1 2015’, provides an overview of the Cutaneous T-Cell Lymphoma’s therapeutic pipeline.

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,000.00
  • Report 05IB-GMDHC6268IDB has a star rating of 4.0 out of 5
  • Go to More information on Report 05IB-GMDHC6268IDB
  • View Report: Research and Experts Market Report: Cough - Pipeline Review, H1 2015

    Cough - Pipeline Review, H1 2015


    2015-02-24
    Cough - Pipeline Review, H1 2015

    Summary

    Global Markets Direct’s, ‘Cough - Pipeline Review, H1 2015’, provides an overview of the Cough’s therapeutic pipeline.

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,000.00
  • Report 05IB-GMDHC6352IDB has a star rating of 4.0 out of 5
  • Go to More information on Report 05IB-GMDHC6352IDB
  • View Report: Research and Experts Market Report: Hyperphosphatemia - Pipeline Review, H1 2015

    Hyperphosphatemia - Pipeline Review, H1 2015


    2015-02-24
    Hyperphosphatemia - Pipeline Review, H1 2015

    Summary

    Global Markets Direct’s, ‘Hyperphosphatemia - Pipeline Review, H1 2015’, provides an overview of the Hyperphosphatemia’s therapeutic pipeline.

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,000.00
  • Report 05IB-GMDHC6283IDB has a star rating of 3.6 out of 5
  • Go to More information on Report 05IB-GMDHC6283IDB
  • View Report: Research and Experts Market Report: Peripheral T-Cell Lymphomas (PTCL) - Pipeline Review, H1 2015

    Peripheral T-Cell Lymphomas (PTCL) - Pipeline Review, H1 2015


    2015-02-24
    Peripheral T-Cell Lymphomas (PTCL) - Pipeline Review, H1 2015

    Summary

    Global Markets Direct’s, ‘Peripheral T-Cell Lymphomas (PTCL) - Pipeline Review, H1 2015’, provides an overview of the Peripheral T-Cell Lymphomas (PTCL)’s therapeutic...

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,000.00
  • Report 05IB-GMDHC6281IDB has a star rating of 3.8 out of 5
  • Go to More information on Report 05IB-GMDHC6281IDB
  • View Report: Research and Experts Market Report: T-Cell Leukemia - Pipeline Review, H1 2015

    T-Cell Leukemia - Pipeline Review, H1 2015


    2015-02-24
    T-Cell Leukemia - Pipeline Review, H1 2015

    Summary

    Global Markets Direct’s, ‘T-Cell Leukemia - Pipeline Review, H1 2015’, provides an overview of the T-Cell Leukemia’s therapeutic pipeline.

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,000.00
  • Report 05IB-GMDHC6280IDB has a star rating of 3.7 out of 5
  • Go to More information on Report 05IB-GMDHC6280IDB
  • View Report: Research and Experts Market Report: Transitional Cell Cancer (Urothelial Cell Cancer) - Pipeline Review, H1 2015

    Transitional Cell Cancer (Urothelial Cell Cancer) - Pipeline Review, H1 2015


    2015-02-24
    Transitional Cell Cancer (Urothelial Cell Cancer) - Pipeline Review, H1 2015

    Summary

    Global Markets Direct’s, ‘Transitional Cell Cancer (Urothelial Cell Cancer) - Pipeline Review, H1 2015’, provides an overview of the Transitional Cell...

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,000.00
  • Report 05IB-GMDHC6271IDB has a star rating of 3.8 out of 5
  • Go to More information on Report 05IB-GMDHC6271IDB
  • View Report: Research and Experts Market Report: Liposarcoma - Pipeline Review, H1 2015

    Liposarcoma - Pipeline Review, H1 2015


    2015-02-18
    Liposarcoma - Pipeline Review, H1 2015

    Summary

    Global Markets Direct’s, ‘Liposarcoma - Pipeline Review, H1 2015’, provides an overview of the Liposarcoma’s therapeutic pipeline.

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,000.00
  • Report 05IB-GMDHC6305IDB has a star rating of 3.6 out of 5
  • Go to More information on Report 05IB-GMDHC6305IDB
  • View Report: Research and Experts Market Report: Arterial Thrombosis - Pipeline Review, H1 2015

    Arterial Thrombosis - Pipeline Review, H1 2015


    2015-02-18
    Arterial Thrombosis - Pipeline Review, H1 2015

    Summary

    Global Markets Direct’s, ‘Arterial Thrombosis - Pipeline Review, H1 2015’, provides an overview of the Arterial Thrombosis’s therapeutic pipeline.

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,000.00
  • Report 05IB-GMDHC6294IDB has a star rating of 3.4 out of 5
  • Go to More information on Report 05IB-GMDHC6294IDB
  • View Report: Research and Experts Market Report: African Trypanosomiasis - Pipeline Review, H1 2015

    African Trypanosomiasis - Pipeline Review, H1 2015


    2015-02-18
    African Trypanosomiasis - Pipeline Review, H1 2015

    Summary

    Global Markets Direct’s, ‘African Trypanosomiasis - Pipeline Review, H1 2015’, provides an overview of the African Trypanosomiasis’s therapeutic pipeline.

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,000.00
  • Report 05IB-GMDHC6292IDB has a star rating of 3.5 out of 5
  • Go to More information on Report 05IB-GMDHC6292IDB
  • View Report: Research and Experts Market Report: B-Cell Non-Hodgkin Lymphoma - Pipeline Review, H1 2015

    B-Cell Non-Hodgkin Lymphoma - Pipeline Review, H1 2015


    2015-02-18
    B-Cell Non-Hodgkin Lymphoma - Pipeline Review, H1 2015

    Summary

    Global Markets Direct’s, ‘B-Cell Non-Hodgkin Lymphoma - Pipeline Review, H1 2015’, provides an overview of the B-Cell Non-Hodgkin Lymphoma’s therapeutic pipeline.

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,000.00
  • Report 05IB-GMDHC6127IDB has a star rating of 4.0 out of 5
  • Go to More information on Report 05IB-GMDHC6127IDB
  • View Report: Research and Experts Market Report: Obesity - Pipeline Review, H1 2015

    Obesity - Pipeline Review, H1 2015


    2015-02-10
    Obesity - Pipeline Review, H1 2015

    Summary

    Global Markets Direct’s, ‘Obesity - Pipeline Review, H1 2015’, provides an overview of the Obesity’s therapeutic pipeline.

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,000.00
  • Report 05IB-GMDHC6235IDB has a star rating of 4.0 out of 5
  • Go to More information on Report 05IB-GMDHC6235IDB
  • View Report: Research and Experts Market Report: Type 2 Diabetes - Pipeline Review, H1 2015

    Type 2 Diabetes - Pipeline Review, H1 2015


    2015-02-10
    Type 2 Diabetes - Pipeline Review, H1 2015

    Summary

    Global Markets Direct’s, ‘Type 2 Diabetes - Pipeline Review, H1 2015’, provides an overview of the Type 2 Diabetes’s therapeutic pipeline.

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,500.00
  • Report 05IB-GMDHC6121IDB has a star rating of 4.0 out of 5
  • Go to More information on Report 05IB-GMDHC6121IDB
  • View Report: Research and Experts Market Report: Dilated Cardiomyopathy - Pipeline Review, H1 2015

    Dilated Cardiomyopathy - Pipeline Review, H1 2015


    2015-01-30
    Dilated Cardiomyopathy - Pipeline Review, H1 2015

    Summary

    Global Markets Direct’s, ‘Dilated Cardiomyopathy - Pipeline Review, H1 2015’, provides an overview of the Dilated Cardiomyopathy’s therapeutic pipeline.

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,000.00
  • Report 05IB-GMDHC6209IDB has a star rating of 3.4 out of 5
  • Go to More information on Report 05IB-GMDHC6209IDB
  • View Report: Research and Experts Market Report: Refractory Multiple Myeloma - Pipeline Review, H1 2015

    Refractory Multiple Myeloma - Pipeline Review, H1 2015


    2015-01-30
    Refractory Multiple Myeloma - Pipeline Review, H1 2015

    Summary

    Global Markets Direct’s, ‘Refractory Multiple Myeloma - Pipeline Review, H1 2015’, provides an overview of the Refractory Multiple Myeloma’s therapeutic pipeline.

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,000.00
  • Report 05IB-GMDHC6135IDB has a star rating of 3.9 out of 5
  • Go to More information on Report 05IB-GMDHC6135IDB
  • View Report: Research and Experts Market Report: Duchenne Muscular Dystrophy - Pipeline Review, H1 2015

    Duchenne Muscular Dystrophy - Pipeline Review, H1 2015


    2015-01-30
    Duchenne Muscular Dystrophy - Pipeline Review, H1 2015

    Summary

    Global Markets Direct’s, ‘Duchenne Muscular Dystrophy - Pipeline Review, H1 2015’, provides an overview of the Duchenne Muscular Dystrophy’s therapeutic pipeline.

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,000.00
  • Report 05IB-GMDHC6134IDB has a star rating of 3.8 out of 5
  • Go to More information on Report 05IB-GMDHC6134IDB
  • View Report: Research and Experts Market Report: Alzheimer

    Alzheimer's Disease - Pipeline Review, H1 2015


    2015-01-30
    Alzheimer's Disease - Pipeline Review, H1 2015

    Summary

    Global Markets Direct’s, ‘Alzheimer's Disease - Pipeline Review, H1 2015’, provides an overview of the Alzheimer's Disease’s therapeutic pipeline.

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,500.00
  • Report 05IB-GMDHC6229IDB has a star rating of 4.0 out of 5
  • Go to More information on Report 05IB-GMDHC6229IDB
  • View Report: Research and Experts Market Report: Metastatic Adenocarcinoma of The Pancreas - Pipeline Review, H1 2015

    Metastatic Adenocarcinoma of The Pancreas - Pipeline Review, H1 2015


    2015-01-30
    Metastatic Adenocarcinoma of The Pancreas - Pipeline Review, H1 2015

    Summary

    Global Markets Direct’s, ‘Metastatic Adenocarcinoma of The Pancreas - Pipeline Review, H1 2015’, provides an overview of the Metastatic Adenocarcinoma of The...

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,000.00
  • Report 05IB-GMDHC6158IDB has a star rating of 3.8 out of 5
  • Go to More information on Report 05IB-GMDHC6158IDB
  • View Report: Research and Experts Market Report: Congestive Heart Failure (Heart Failure) - Pipeline Review, H1 2015

    Congestive Heart Failure (Heart Failure) - Pipeline Review, H1 2015


    2015-01-30
    Congestive Heart Failure (Heart Failure) - Pipeline Review, H1 2015

    Summary

    Global Markets Direct’s, ‘Congestive Heart Failure (Heart Failure) - Pipeline Review, H1 2015’, provides an overview of the Congestive Heart Failure (Heart Failure)’s...

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,000.00
  • Report 05IB-GMDHC6130IDB has a star rating of 3.9 out of 5
  • Go to More information on Report 05IB-GMDHC6130IDB
  • View Report: Research and Experts Market Report: Metastatic Melanoma - Pipeline Review, H1 2015

    Metastatic Melanoma - Pipeline Review, H1 2015


    2015-01-30
    Metastatic Melanoma - Pipeline Review, H1 2015

    Summary

    Global Markets Direct’s, ‘Metastatic Melanoma - Pipeline Review, H1 2015’, provides an overview of the Metastatic Melanoma’s therapeutic pipeline.

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,000.00
  • Report 05IB-GMDHC6013IDB has a star rating of 3.9 out of 5
  • Go to More information on Report 05IB-GMDHC6013IDB
  • View Report: Research and Experts Market Report: Juvenile Macular Degeneration (Stargardt Disease) - Pipeline Review, H1 2015

    Juvenile Macular Degeneration (Stargardt Disease) - Pipeline Review, H1 2015


    2015-01-22
    Juvenile Macular Degeneration (Stargardt Disease) - Pipeline Review, H1 2015

    Summary

    Global Markets Direct’s, ‘Juvenile Macular Degeneration (Stargardt Disease) - Pipeline Review, H1 2015’, provides an overview of the Juvenile Macular...

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,000.00
  • Report 05IB-GMDHC6089IDB has a star rating of 3.4 out of 5
  • Go to More information on Report 05IB-GMDHC6089IDB
  • View Report: Research and Experts Market Report: Ulcerative Colitis - Pipeline Review, H1 2015

    Ulcerative Colitis - Pipeline Review, H1 2015


    2015-01-22
    Ulcerative Colitis - Pipeline Review, H1 2015

    Summary

    Global Markets Direct’s, ‘Ulcerative Colitis - Pipeline Review, H1 2015’, provides an overview of the Ulcerative Colitis’s therapeutic pipeline.

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,000.00
  • Report 05IB-GMDHC6015IDB has a star rating of 3.8 out of 5
  • Go to More information on Report 05IB-GMDHC6015IDB
  • View Report: Research and Experts Market Report: Recurrent Malignant Glioma - Pipeline Review, H1 2015

    Recurrent Malignant Glioma - Pipeline Review, H1 2015


    2015-01-22
    Recurrent Malignant Glioma - Pipeline Review, H1 2015

    Summary

    Global Markets Direct’s, ‘Recurrent Malignant Glioma - Pipeline Review, H1 2015’, provides an overview of the Recurrent Malignant Glioma’s therapeutic pipeline.

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,000.00
  • Report 05IB-GMDHC6070IDB has a star rating of 3.3 out of 5
  • Go to More information on Report 05IB-GMDHC6070IDB
  • View Report: Research and Experts Market Report: Thromboembolism - Pipeline Review, H1 2015

    Thromboembolism - Pipeline Review, H1 2015


    2015-01-22
    Thromboembolism - Pipeline Review, H1 2015

    Summary

    Global Markets Direct’s, ‘Thromboembolism - Pipeline Review, H1 2015’, provides an overview of the Thromboembolism’s therapeutic pipeline.

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,000.00
  • Report 05IB-GMDHC6059IDB has a star rating of 3.5 out of 5
  • Go to More information on Report 05IB-GMDHC6059IDB
  • View Report: Research and Experts Market Report: Malignant Glioma - Pipeline Review, H1 2015

    Malignant Glioma - Pipeline Review, H1 2015


    2015-01-22
    Malignant Glioma - Pipeline Review, H1 2015

    Summary

    Global Markets Direct’s, ‘Malignant Glioma - Pipeline Review, H1 2015’, provides an overview of the Malignant Glioma’s therapeutic pipeline.

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,000.00
  • Report 05IB-GMDHC6058IDB has a star rating of 3.6 out of 5
  • Go to More information on Report 05IB-GMDHC6058IDB
  • View Report: Research and Experts Market Report: Insulin Resistance - Pipeline Review, H1 2015

    Insulin Resistance - Pipeline Review, H1 2015


    2015-01-22
    Insulin Resistance - Pipeline Review, H1 2015

    Summary

    Global Markets Direct’s, ‘Insulin Resistance - Pipeline Review, H1 2015’, provides an overview of the Insulin Resistance’s therapeutic pipeline.

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,000.00
  • Report 05IB-GMDHC6053IDB has a star rating of 3.4 out of 5
  • Go to More information on Report 05IB-GMDHC6053IDB
  • View Report: Research and Experts Market Report: Pertussis - Pipeline Review, H1 2015

    Pertussis - Pipeline Review, H1 2015


    2015-01-22
    Pertussis - Pipeline Review, H1 2015

    Summary

    Global Markets Direct’s, ‘Pertussis - Pipeline Review, H1 2015’, provides an overview of the Pertussis’s therapeutic pipeline.

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,000.00
  • Report 05IB-GMDHC6035IDB has a star rating of 3.6 out of 5
  • Go to More information on Report 05IB-GMDHC6035IDB
  • View Report: Research and Experts Market Report: Brain Cancer - Pipeline Review, H1 2015

    Brain Cancer - Pipeline Review, H1 2015


    2015-01-22
    Brain Cancer - Pipeline Review, H1 2015

    Summary

    Global Markets Direct’s, ‘Brain Cancer - Pipeline Review, H1 2015’, provides an overview of the Brain Cancer’s therapeutic pipeline.

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,000.00
  • Report 05IB-GMDHC6024IDB has a star rating of 3.8 out of 5
  • Go to More information on Report 05IB-GMDHC6024IDB
  • View Report: Research and Experts Market Report: Metastatic Pancreatic Cancer - Pipeline Review, H1 2015

    Metastatic Pancreatic Cancer - Pipeline Review, H1 2015


    2015-01-22
    Metastatic Pancreatic Cancer - Pipeline Review, H1 2015

    Summary

    Global Markets Direct’s, ‘Metastatic Pancreatic Cancer - Pipeline Review, H1 2015’, provides an overview of the Metastatic Pancreatic Cancer’s therapeutic pipeline.

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,000.00
  • Report 05IB-GMDHC6022IDB has a star rating of 4.0 out of 5
  • Go to More information on Report 05IB-GMDHC6022IDB
  • View Report: Research and Experts Market Report: Dyslipidemia - Pipeline Review, H1 2015

    Dyslipidemia - Pipeline Review, H1 2015


    2015-01-22
    Dyslipidemia - Pipeline Review, H1 2015

    Summary

    Global Markets Direct’s, ‘Dyslipidemia - Pipeline Review, H1 2015’, provides an overview of the Dyslipidemia’s therapeutic pipeline.

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,000.00
  • Report 05IB-GMDHC6020IDB has a star rating of 3.8 out of 5
  • Go to More information on Report 05IB-GMDHC6020IDB
  • View Report: Research and Experts Market Report: Pulmonary Fibrosis - Pipeline Review, H1 2015

    Pulmonary Fibrosis - Pipeline Review, H1 2015


    2015-01-22
    Pulmonary Fibrosis - Pipeline Review, H1 2015

    Summary

    Global Markets Direct’s, ‘Pulmonary Fibrosis - Pipeline Review, H1 2015’, provides an overview of the Pulmonary Fibrosis’s therapeutic pipeline.

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,000.00
  • Report 05IB-GMDHC6017IDB has a star rating of 3.9 out of 5
  • Go to More information on Report 05IB-GMDHC6017IDB
  • View Report: Research and Experts Market Report: Breast Cancer - Pipeline Review, H1 2015

    Breast Cancer - Pipeline Review, H1 2015


    2015-01-22
    Breast Cancer - Pipeline Review, H1 2015

    Summary

    Global Markets Direct’s, ‘Breast Cancer - Pipeline Review, H1 2015’, provides an overview of the Breast Cancer’s therapeutic pipeline.

  • Market Report
  • Pharmaceuticals
  • Global
  • $2,500.00
  • Report 05IB-GMDHC6006IDB has a star rating of 3.9 out of 5
  • Go to More information on Report 05IB-GMDHC6006IDB
  • View Report: Research and Experts Company Report: Sanofi (SAN) - Product Pipeline Analysis, 2015 Update

    Sanofi (SAN) - Product Pipeline Analysis, 2015 Update


    2015-03-26
    Summary

    Sanofi is a diversified global healthcare company. It undertakes the discovery, development and marketing of therapeutic solutions. The company offers a broad range of prescription medicines, and consumer healthcare and generic products worldwide...

  • Company Report
  • Medical Devices
  • France
  • $750.00
  • Report 05IC-GDME3811PD has a star rating of 3.8 out of 5
  • Go to More information on Report 05IC-GDME3811PD
  • View Report: Research and Experts Company Report: Astex Pharmaceuticals Inc - Strategic SWOT Analysis Review

    Astex Pharmaceuticals Inc - Strategic SWOT Analysis Review


    2017-01-19
    Astex Pharmaceuticals Inc (Astex Pharmaceuticals), is a novel drug discovery and development company with a focus on cancer and central nervous system (CNS) diseases. It discovers and develops small molecule treatments. The company’s lead product,...
  • Company Report
  • Life Sciences
  • United States
  • $125.00
  • Report 05IC-GDPH33284SA has a star rating of 4.1 out of 5
  • Go to More information on Report 05IC-GDPH33284SA
  • View Report: Research and Experts Company Report: ALK-Abello AS (ALKB) - Financial and Strategic SWOT Analysis Review

    ALK-Abello AS (ALKB) - Financial and Strategic SWOT Analysis Review


    2016-06-01
    ALK-Abello A/S (ALK) is a research-driven pharmaceutical company which discovers, develops and commercializes immune-therapeutics for allergy prevention, diagnosis and treatment. The company specializes in allergy research and allergy immunotherapy. Its...
  • Company Report
  • Life Sciences
  • Denmark
  • $125.00
  • Report 05IC-GDPH27183FSA has a star rating of 4.1 out of 5
  • Go to More information on Report 05IC-GDPH27183FSA
  • View Report: Research and Experts Company Report: Biogen Inc (BIIB) - Financial and Strategic SWOT Analysis Review

    Biogen Inc (BIIB) - Financial and Strategic SWOT Analysis Review


    2016-11-29
    Biogen Inc (Biogen) is a global biotechnology company that discovers, develops, manufactures and commercializes therapies for treating neurodegenerative diseases, hematologic conditions and autoimmune disorders. The company’s marketed product portfolio...
  • Company Report
  • Life Sciences
  • United States
  • $125.00
  • Report 05IC-GDPH1307FSA has a star rating of 4.2 out of 5
  • Go to More information on Report 05IC-GDPH1307FSA
  • View Report: Research and Experts Company Report: Regeneron Pharmaceuticals, Inc. (REGN) - Financial and Strategic SWOT Analysis Review

    Regeneron Pharmaceuticals, Inc. (REGN) - Financial and Strategic SWOT Analysis Review


    2016-04-26
    Regeneron Pharmaceuticals, Inc. (Regeneron) is a biopharmaceutical company which discovers, develops, manufactures, and commercializes medicines for the treatment of serious medical conditions. It develops pharmaceutical products for the treatment of...
  • Company Report
  • Life Sciences
  • United States
  • $125.00
  • Report 05IC-GDPH81628FSA has a star rating of 4.1 out of 5
  • Go to More information on Report 05IC-GDPH81628FSA
  • View Report: Research and Experts Company Report: Ipsen S.A. (IPN) - Financial and Strategic SWOT Analysis Review

    Ipsen S.A. (IPN) - Financial and Strategic SWOT Analysis Review


    2016-03-22
    Ipsen S.A (Ipsen) is a global specialty biotechnology company. It manufactures and distributes drugs to treat cancer, urological, endocrine and neurological diseases. The company’s flagship products include Decapeptyl for the treatment of prostate...
  • Company Report
  • Life Sciences
  • France
  • $125.00
  • Report 05IC-GDPH15876FSA has a star rating of 4.1 out of 5
  • Go to More information on Report 05IC-GDPH15876FSA
  • View Report: Research and Experts Company Report: Ypsomed Holding AG (YPSN) - Financial and Strategic SWOT Analysis Review

    Ypsomed Holding AG (YPSN) - Financial and Strategic SWOT Analysis Review


    2016-06-14
    Ypsomed Holding AG (Ypsomed) is a medical device company. It designs, develops and manufactures injection systems. Its offers pen injectors, autoinjectors, dual chamber pens and other custom products. The company also offers contract manufacturing, indust...
  • Company Report
  • Medical Devices
  • Switzerland
  • $125.00
  • Report 05IC-GDME2603FSA has a star rating of 4.1 out of 5
  • Go to More information on Report 05IC-GDME2603FSA